Health Benefits for Aging

Vitamin A supports healthy aging by maintaining vision, supporting immune function, and promoting skin health. It plays essential roles in cellular differentiation, wound healing, and may help prevent certain cancers, particularly in deficient populations.

Studies Analyzed:

Study 1: The importance of vitamin A in nutrition

Citation: Dawson MI. The importance of vitamin A in nutrition. Curr Pharm Des. 2000;6(3):311-325. doi: 10.2174/1381612003401190. PMID: 10637381. https://pubmed.ncbi.nlm.nih.gov/10637381/

Study Type: Review

Summary: This review discusses preformed vitamin A (all-trans-retinol and its esters) and provitamin A (beta-carotene) as essential dietary nutrients, covering their metabolism to retinol and the role of retinol-binding proteins, plus the oxidation of retinol to retinal and retinoic acid.

Key Findings:

• Vitamin A can produce cell, and tissue changes similar to those found during neoplastic transformation
• Vitamin supplementation can reverse this process, indicating potential role in cancer prevention
• In populations deficient in vitamin A, supplementation programs appear effective in reducing cancer incidence
• In groups with sufficient dietary vitamin A, cancer prevention by added vitamin A may not be particularly effective due to feedback mechanisms
• Beta-carotene and other dietary carotenoids function as antioxidants that can prevent carcinogenesis
• Supplementation at higher doses causes toxicity
• Feedback mechanisms limit retinol plasma levels in sufficient populations
• Most effective in populations with inadequate diet or tobacco use

Study 2: Vitamin A and Wound Healing

Citation: Zinder R, Cooley R, Vlad LG, Molnar JA. Vitamin A and Wound Healing. Nutr Clin Pract. 2019 Dec;34(6):839-849. doi: 10.1002/ncp.10420. PMID: 31697447. https://pubmed.ncbi.nlm.nih.gov/31697447/

Study Type: Review

Summary: This review discusses the role of Vitamin A in wound healing, covering general aspects of Vitamin A, its deficiency, and metabolic effects. It mentions numerous animal studies and limited human studies regarding physiological effects on acute or chronic wounds.

Key Findings:

• Vitamin A plays important role in all stages of wound healing
• Stimulates epithelial growth, fibroblasts, granulation tissue, angiogenesis, collagen synthesis, epithelialization, and fibroplasia
• Local (topical) and systemic supplementation with vitamin A increases dermal collagen deposition
• Most common use is to offset steroids' effect on wound healing
• Evidence for supplementation currently limited to expert opinion and not backed by rigorous trials
• Both topical and systemic routes of administration show promise, Particularly important in patients receiving corticosteroid therapy
• Deficiency can significantly impair wound healing processes

Study 3: Human Skin Aging and the Anti-Aging Properties of Retinol

Citation: Quan T. Human Skin Aging and the Anti-Aging Properties of Retinol. Biomolecules. 2023 Nov 4;13(11):1614. doi: 10.3390/biom13111614. PMID: 38002296. https://pubmed.ncbi.nlm.nih.gov/38002296/

Study Type: Review

Summary: This review emphasizes recent molecular discoveries related to skin aging and evaluates preventive approaches, such as the use of topical retinoids, focusing on alterations in epidermis and dermis due to aging.

Key Findings:

• Topical retinoids have demonstrated promise in enhancing skin texture
• Diminish fine lines and augment thickness of both epidermal and dermal layers
• Molecular approach to understanding skin aging mechanisms
• Preventive potential of retinoid therapy for skin aging
• Alterations in epidermis and dermis occur due to aging process
• Disruptions to skin structure and functionality result from aging
• Recent molecular discoveries provide new insights into skin aging processes
• Retinoids work at cellular level to reverse aging changes

Study 4: Improving Cognitive Function with Nutritional Supplements in Aging

Citation: Fekete M, Lehoczki A, Tarantini S, Fazekas-Pongor V, Csípő T, Csizmadia Z, Varga JT. Improving Cognitive Function with Nutritional Supplements in Aging: A Comprehensive Narrative Review of Clinical Studies Investigating the Effects of Vitamins, Minerals, Antioxidants, and Other Dietary Supplements. Nutrients. 2023 Dec 15;15(24):5116. doi: 10.3390/nu15245116. PMID: 38140375. https://pubmed.ncbi.nlm.nih.gov/38140375/

Study Type: Narrative Review

Summary: This comprehensive narrative review examines the role of nutritional supplements in mitigating cognitive decline in the aging population. It evaluates randomized controlled trials, observational studies, and meta-analyses to assess the efficacy of vitamins, minerals, antioxidants, and other dietary supplements on cognitive functions like memory, attention, and executive function.

Key Findings:

• The review suggests a complex relationship between nutritional supplementation and cognitive health
• Some supplements show promise, while others have limited or context-dependent effectiveness
• The review emphasizes the importance of dosage, bioavailability, and individual differences
• Vitamin A among other nutrients may play role in cognitive health maintenance
• Individual responses to supplementation vary significantly
• Context-dependent effectiveness requires personalized approaches
• Dosage and bioavailability are critical factors for efficacy

Health Benefits for Aging

Vitamin C is a powerful antioxidant that supports healthy aging by protecting cells from oxidative damage, supporting collagen synthesis for skin health, and boosting immune function. It helps maintain cardiovascular health and may reduce the risk of age-related diseases.

Studies Analyzed:

Study 1: The role of vitamin C in epigenetic regulation

Citation: Guz J, Oliński R. The role of vitamin C in epigenetic regulation. Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):747-760. doi: 10.5604/01.3001.0010.3853. PMID: 28894047. https://pubmed.ncbi.nlm.nih.gov/28894047/

Study Type: Review

Summary: This review examines vitamin C's involvement in biological processes involving enzymatic reactions catalyzed by dioxygenases, particularly its role in chromatin and DNA modifications that contribute to epigenetic regulation.

Key Findings:

• Vitamin C acts as a cofactor for dioxygenases involved in chromatin and DNA modifications
• May enhance generation of 5-hydroxymethylcytosine, crucial for epigenetic function
• Physiological concentrations (10-100 μM) in human serum may guarantee stable 5-hydroxymethylcytosine levels
• Decreased 5-hydroxymethylcytosine levels are linked to cancer development
• Ascorbate supplementation could potentially aid in cancer management

Study 2: Vitamin C Supplementation in Healthy Individuals Leads to Shifts of Bacterial Populations in the Gut

Citation: Otten AT, Bourgonje AR, Peters V, Alizadeh BZ, Dijkstra G, Harmsen HJM. Vitamin C Supplementation in Healthy Individuals Leads to Shifts of Bacterial Populations in the Gut—A Pilot Study. Antioxidants. 2021;10(8):1278. doi: 10.3390/antiox10081278. PMID: 34439526. https://pubmed.ncbi.nlm.nih.gov/34439526/

Study Type: Pilot Study

Summary: This pilot study investigated the effects of high-dose vitamin C supplementation on bacterial populations in the gut of healthy individuals to determine microbiota-modulating properties.

Key Findings:

• High-dose vitamin C increased relative abundance of Lachnospiraceae family
• Decreased median relative abundance of A. muciniphila
• Lachnospiraceae are main producers of short-chain fatty acids (SCFAs) with anti-inflammatory and antioxidant effects
• A. muciniphila supports immunological and metabolic responses
• Demonstrates vitamin C's microbiota-modulating properties

Study 3: Vitamin C supplementation promotes mental vitality in healthy young adults: results from a cross-sectional analysis and a randomized, double-blind, placebo-controlled trial

Citation: Sim M, Hong S, Jung S, Kim J-S, Goo Y-T, Chun WY, Shin D-M. Eur J Nutr. 2022 Feb;61(1):447-459. Epub 2021 Sep 2. doi: 10.1007/s00394-021-02656-3. PMID: 34476568. https://pubmed.ncbi.nlm.nih.gov/34476568/PubMed

Study Type: Randomized, double-blind, placebo-controlled trial (with cross-sectional analysis)

Summary: Tested whether vitamin C (1000 mg/day for 4 weeks) improves mental vitality and cognitive performance in healthy adults with suboptimal vitamin C status.

Key Findings:

• Significant improvements in attention and work absorption vs placebo
• Better Stroop test performance (cognitive control under load) vs placebo
• Trends toward reduced fatigue and improved overall work engagement
• No significant effects on mood or serum BDNF
• Supports cognitive/“vitality” benefits when baseline vitamin C is low.

Study 4: Effect of six weeks 1000 mg/day vitamin C supplementation and healthy training in elderly women on genes expression associated with the immune response — a randomized controlled trial

Citation: Żychowska M, Grzybkowska A, Zasada M, Piotrowska A, Dworakowska D, Czerwińska-Ledwig O, Pilch W, Antosiewicz J. J Int Soc Sports Nutr. 2021 Mar 2;18(1):19. doi: 10.1186/s12970-021-00416-6. PMID: 33653365. https://pubmed.ncbi.nlm.nih.gov/33653365/ PubMed

Study Type: Randomized controlled trial (elderly women; exercise +/− vitamin C)

Summary: Assessed whether 6 weeks of vitamin C (1000 mg/day) during endurance training alters leukocyte expression of immune-related genes in older women.

Key Findings:

• No between-group differences for IL-1, IL-6, IL-10, or CRP overall
• Supplement group showed tendencies toward ↓ IL-6 and ↑ IL-10
• Control group had a significant ↓ in CCL2 mRNA (p = 0.01)
• Suggests vitamin C may modestly shift immune gene expression during training, though 6 weeks may be too short for robust changes.

Health Benefits for Aging

Vitamin D supports healthy aging by maintaining bone health, supporting immune function, and potentially reducing the risk of respiratory infections. It plays crucial roles in calcium absorption, muscle strength, and may help prevent fractures in older adults.

Studies Analyzed:

Study 1: Association between vitamin D supplementation and mortality: systematic review and meta-analysis

Citation: Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, Faramand A. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019 Aug 12;366:l4673. doi: 10.1136/bmj.l4673. PMID: 31405892. https://pubmed.ncbi.nlm.nih.gov/31405892/

Study Type: Systematic review and meta-analysis of randomised controlled trials

Summary: This systematic review and meta-analysis investigated whether vitamin D supplementation is associated with lower mortality in adults. 52 trials with a total of 75,454 participants were identified, comparing vitamin D supplementation with placebo or no treatment for mortality outcomes.

Key Findings:

• Vitamin D supplementation was not associated with all-cause mortality, cardiovascular mortality, or non-cancer, non-cardiovascular mortality
• However, vitamin D supplementation statistically significantly reduced the risk of cancer death by 16%
• Large-scale analysis provides robust evidence for cancer mortality reduction
• Analysis included participants from diverse populations and age groups
• Follow-up periods ranged from 1 to 11 years across studies
• Dosages varied from 400 to 4000 IU/day across different trials
• Results remained consistent across different subgroup analyses

Study 2: Effects of Vitamin D Supplementation on Muscle Strength in Athletes: A Systematic Review

Citation: Chiang CM, Ismaeel A, Griffis RB, Weems S. Effects of Vitamin D Supplementation on Muscle Strength in Athletes: A Systematic Review. J Strength Cond Res. 2017 Feb;31(2):566-574. doi: 10.1519/JSC.0000000000001518. PMID: 27379960. 

https://pubmed.ncbi.nlm.nih.gov/27379960/

Study Type: Systematic Review of Randomized Controlled Trials

Summary: This systematic review investigated the effects of vitamin D supplementation on muscle strength in athletes. Five RCTs and 1 controlled trial were identified, measuring serum vitamin D concentrations and muscle strength in healthy, athletic participants aged 18-45 years.

Key Findings:

• Vitamin D3 was shown to have a positive impact on muscle strength
• Improvements in strength ranged from 1.37 to 18.75%
• Vitamin D2 was found to be ineffective
• Duration: 4 weeks to 6 months
• Dosage: 600 to 5,000 International Units (IU) per day
• Studies included various strength measures: vertical jump, sprint performance, and resistance training outcomes
• Baseline vitamin D status influenced response to supplementation
• Athletes with lower baseline vitamin D levels showed greater improvements
• Quality assessment using PEDro scale showed moderate to high quality studies

Study 3: Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

Citation: Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005 May 11;293(18):2257-64. doi: 10.1001/jama.293.18.2257. PMID: 15886381. https://pubmed.ncbi.nlm.nih.gov/15886381/

Study Type: Meta-analysis of randomized controlled trials

Summary: This systematic review and meta-analysis estimated the effectiveness of vitamin D supplementation in preventing hip and nonvertebral fractures in older persons (≥60 years). Only double-blind RCTs of oral vitamin D supplementation with or without calcium supplementation were included.

Key Findings:

• Oral vitamin D supplementation between 700 to 800 IU/d reduced risk of hip fracture by 26% and nonvertebral fracture by 23%
• An oral vitamin D dose of 400 IU/d was not sufficient for fracture prevention
• Effective dosage: 700-800 IU/d for fracture prevention in elderly
• Analysis included 9 trials with 45,509 participants
• Both ambulatory and institutionalized elderly persons benefited
• All trials used cholecalciferol (vitamin D3)
• Benefits were consistent across different populations and settings
• Calcium co-supplementation did not significantly modify the effects

Study 4: Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis

Citation: Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019 Jan;23(2):1-44. doi: 10.3310/hta23020. PMID: 30675873. https://pubmed.ncbi.nlm.nih.gov/30675873/

Study Type: Individual participant data meta-analysis of randomised controlled trials

Summary: This IPD meta-analysis of 25 randomised controlled trials involving 11,321 participants aged 0 to 95 years assessed the overall effect of vitamin D supplementation on the risk of acute respiratory infections and identified factors modifying this effect.

Key Findings:

• Vitamin D supplementation reduced the risk of acute respiratory infections among all participants (adjusted odds ratio 0.88, 95% CI 0.81 to 0.96)
• Protective effects were seen in individuals receiving daily or weekly vitamin D without additional bolus doses
• Protective effects were stronger in individuals with baseline 25-hydroxyvitamin D concentration < 25 nmol/l
• Bolus doses were not effective
• Daily or weekly supplementation was most beneficial
• IPD were obtained for 96.6% of participants across studies
• Number needed to treat was 33 for daily/weekly supplementation
• Subgroup analysis showed greater benefits in those with severe vitamin D deficiency
• Safety profile was excellent with no increase in serious adverse events

Health Benefits for Aging

Vitamin E supports healthy aging by acting as a powerful antioxidant, protecting cell membranes from oxidative damage, supporting immune function, and potentially reducing inflammation. It may help maintain cellular integrity and support healthy aging processes.

Studies Analyzed:

Study 1: Vitamin E-gene interactions in aging and inflammatory age-related diseases: implications for treatment

Citation: Mocchegiani E, Costarelli L, Giacconi R, Malavolta M, Basso A, Piacenza F, Ostan R, Cevenini E, Gonos ES, Franceschi C, Monti D. Vitamin E-gene interactions in aging and inflammatory age-related diseases: implications for treatment. A systematic review. Ageing Res Rev. 2014 Mar;14:1-16. doi: 10.1016/j.arr.2014.01.001. PMID: 24418256. https://pubmed.ncbi.nlm.nih.gov/24418256/

Study Type: Systematic Review

Summary: This systematic review examines aging as a complex biological phenomenon where nutritional deficiency combined with chronic inflammation and oxidative stress contribute to age-related diseases. It focuses on vitamin E's role in maintaining cellular homeostasis and its gene interactions.

Key Findings:

• Free radicals from oxidative stress damage DNA, lipids and proteins, compromising cellular homeostasis
• In young adults, cells maintain proper balance between free radicals and antioxidants
• In old age, this balance becomes poorly efficient, compromising cellular homeostasis
• Vitamin E supplementation can restore balance and protect against oxidative stress, degenerative diseases, and aging
• Vitamin E has pivotal role as antioxidant against lipid peroxidation on cell membranes
• Works at cytoplasmatic and nuclear levels, influencing genes related to inflammatory/immune response
• Clinical trials show contradictory results, possibly due to poor consideration of vitamin E-gene interactions
• Nutrigenomic/nutrigenetic aspects may enable personalized vitamin E supplementation
• Various factors contribute to discrepancies: doses, isoforms (α,β,γ,δ tocopherols and tocotrienols)
• Gene polymorphisms affect vitamin E bioactivity and should guide supplementation strategies

Study 2: The role of vitamin E in T-cell differentiation and the decrease of cellular immunity with aging

Citation: Moriguchi S. The role of vitamin E in T-cell differentiation and the decrease of cellular immunity with aging. Biofactors. 1998;7(1-2):1-8. doi: 10.1002/biof.5520070111. PMID: 9523031. https://pubmed.ncbi.nlm.nih.gov/9523031/

Study Type: Review

Summary: This study investigated vitamin E effects on decreased cellular immunity with aging and T-cell differentiation using spontaneously hypertensive rats and Fisher rats fed diets with varying vitamin E levels for 6-7 weeks.

Key Findings:

• High vitamin E diet enhanced thymic lymphocyte proliferation
• Improved decreased expressions of CD4 and CD8 antigens on CD4+ CD8+ T-cells
• Vitamin E enhances T-cell differentiation through increased TEC function
• Associated with increased binding capacity of TEC to immature T-cells via increased ICAM-1 expression
• Vitamin E is potent nutrient for promoting health in aged via improvement of cellular immunity
• Dosage: 50 IU/kg diet (regular) or 500 IU/kg diet (high vitamin E) for 6-7 weeks
• Study used spontaneously hypertensive rats (SHR) and male Fisher rats

Results demonstrate vitamin E's role in maintaining immune function during aging

• TEC (thymic epithelial cells) function improvement is key mechanism

Study 3: Vitamin E and skin health in aging

Citation: Draelos Z, Bogdanowicz P, Saurat JH, Tran C, Sanchez M, Collot Teyssier B, Krutmann J. A Paradigm Shift in Dermatology: Comprehensive Photoprotection Goes beyond Ultraviolet Radiation by Including Visible Light and Infrared A Radiation. Dermatol Online J. 2024 Jun 15;30(3). PMID: 38881445. https://pubmed.ncbi.nlm.nih.gov/38881445/

Study Type: Review

Summary: This review discusses comprehensive photoprotection approaches in dermatology, including the role of antioxidants like vitamin E in protecting against various forms of radiation damage including visible light and infrared A radiation.

Key Findings:

• Vitamin E provides protection against multiple forms of radiation damage
• Works synergistically with other antioxidants for comprehensive skin protection
• Important for preventing premature skin aging from environmental stressors
• Comprehensive photoprotection requires multiple antioxidant approaches
• Vitamin E particularly effective against lipid peroxidation in skin
• Environmental protection becomes increasingly important with aging
• Topical and systemic vitamin E both contribute to skin health maintenance

Study 4: Vitamin E deficiency and neurological disorders

Citation: Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014 Sep;5(5):503-14. doi: 10.3945/an.114.006254. PMID: 25469382. https://pubmed.ncbi.nlm.nih.gov/25469382/

Study Type: Review

Summary: This review examines vitamin E inadequacy in humans, exploring causes of deficiency and the neurological and other health consequences that result from insufficient vitamin E status.

Key Findings:

• Vitamin E deficiency leads to neurological disorders and peripheral neuropathy
• Inadequacy more common than previously recognized, especially in certain populations
• Neurological symptoms include ataxia, peripheral neuropathy, and myopathy
• Adequate vitamin E essential for nervous system function and protection
• Deficiency particularly problematic in fat malabsorption disorders
• Supplementation can prevent and sometimes reverse neurological damage
• α-tocopherol is the most biologically active form for humans
• Recommended intake may be higher than current guidelines for optimal health

Health Benefits for Aging

Niacin supports healthy aging by maintaining muscle strength and mass, improving glucose homeostasis, and supporting cellular energy metabolism through NAD+ production. It helps prevent age-related muscle loss (sarcopenia) and supports metabolic function crucial for healthy aging.

Studies Analyzed:

Study 1: Increased Dietary Niacin Intake Improves Muscle Strength, Quality, and Glucose Homeostasis in Adults over 40 Years of Age

Citation: Xiang S, Li Y, Li Y, Zhang J, Pan W, Lu Y, Liu S. Increased Dietary Niacin Intake Improves Muscle Strength, Quality, and Glucose Homeostasis in Adults over 40 Years of Age. J Nutr Health Aging. 2023;27(9):709-718. doi: 10.1007/s12603-023-1967-0. PMID: 37754210. https://pubmed.ncbi.nlm.nih.gov/37754210/

Study Type: Cross-sectional population-based analysis

Summary: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) examining the relationship between dietary niacin intake and muscle parameters in adults aged 40 and older. Three datasets were established covering grip strength (n=3772), body composition (n=3279), and glucose homeostasis (n=9189).

Key Findings:

• Higher grip strength*significantly correlated with niacin intake (β 0.275, 95% CI 0.192-0.357)
• Increased total lean mass (β 0.060, 95% CI 0.045-0.074)
• Higher appendicular lean mass (β 0.025, 95% CI 0.018-0.033)
• Increased total bone mineral content (β 0.005, 95% CI 0.004-0.007)
• Reduced total fat mass (β -0.061, 95% CI -0.076 to -0.046)
• Lower trunk fat (β -0.041, 95% CI -0.050 to -0.032)
• Reduced sarcopenia risk (OR 0.460, 95% CI 0.233 to 0.907)
• Improved glucose homeostasis with reduced HOMA-IR, fasting glucose, and fasting insulin (p < 0.05)
• Dietary niacin supplementation identified as feasible approach to alleviate age-related muscle loss

Study 2: Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy

Citation: Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, Hakkarainen A, Kuula J, Heinonen U, Schmidt MS, Haimilahti K, Piirilä P, Lundbom N, Taskinen MR, Brenner C, Velagapudi V, Pietiläinen KH, Suomalainen A. Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell Metab. 2020 Jun 2;31(6):1078-1090.e5. doi: 10.1016/j.cmet.2020.04.008. PMID: 32386566. https://pubmed.ncbi.nlm.nih.gov/32386566/

Study Type: Clinical trial

Summary: This study investigated NAD+ deficiency in adult-onset mitochondrial myopathy patients and administered increasing doses of niacin (750-1,000 mg/day) to patients for 10 months and matched controls for 4 months. The trial was registered as NCT03973203.

Key Findings:

• Systemic NAD+ deficiency confirmed in adult-onset mitochondrial myopathy patients
• Blood NAD+ increased up to 8-fold in all subjects following niacin supplementation
• Muscle NAD+ in patients reached control levels after treatment
• Muscle strength increased in all subjects
• Enhanced mitochondrial biogenesis observed in all participants
• Muscle metabolome shifted toward normal in patients
• Liver fat decreased by 50% in patients
• Blood analysis identified as useful tool for detecting NAD+ deficiency
• Niacin demonstrated as efficient NAD+ booster for treating mitochondrial myopathy
• Some patients showed anemia tendency as side effect

Study 3: Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults

Citation: Kaplon RE, Gano LB, Seals DR. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol (1985). 2014 Jan 15;116(2):156-63. doi: 10.1152/japplphysiol.00969.2013. PMID: 24311750. https://pubmed.ncbi.nlm.nih.gov/24311750/

Study Type: Cross-sectional observational study

Summary: This study examined the relationship between dietary niacin intake and vascular function in 127 healthy men and women aged 48-77 years. Researchers measured brachial artery flow-mediated dilation (FMD) and various oxidative stress markers, comparing subjects with above-average (≥22 mg/day) versus below-average niacin intake.

Key Findings:

• Positive correlation between niacin intake and FMD (%change: r = 0.20, P < 0.05; mmΔ: r = 0.25, P < 0.01)
• 25% greater FMD in subjects with above-average niacin intake compared to below-average (P < 0.05)
• Niacin intake was independent predictor of FMD in stepwise regression (%Δ: β = 1.8; mmΔ: β = 0.05, both P < 0.05)
• Lower oxidized LDL levels with higher niacin intake (48 ± 2 vs. 57 ± 2 mg/dl, P < 0.01)
• Inverse correlation with plasma oxidized LDL (r = -0.23, P < 0.05)
• Reduced endothelial oxidative damage markers: lower nitrotyrosine (0.39 ± 0.05 vs. 0.56 ± 0.07, P < 0.05) and NADPH oxidase expression (0.38 ± 0.05 vs. 0.53 ± 0.05, P < 0.05)
• Vitamin C infusion improved FMD only in low-niacin subjects (P < 0.001), not high-niacin subjects
• Higher dietary niacin associated with better vascular endothelial function through reduced oxidative stress

Health Benefits for Aging

Folate supports healthy aging by maintaining proper DNA methylation, supporting cardiovascular health through homocysteine regulation, and promoting cognitive function. It plays crucial roles in cellular repair, neurotransmitter synthesis, and preventing age-related cognitive decline.

Studies Analyzed:

Study 1: A Novel Review of Homocysteine and Pregnancy Complications

Citation: Dai C, Fei Y, Li J, Shi Y, Yang X. A Novel Review of Homocysteine and Pregnancy Complications. Biomed Res Int. 2021 May 6;2021:6652231. doi: 10.1155/2021/6652231. PMID: 34036101. https://pubmed.ncbi.nlm.nih.gov/34036101/

Study Type: Systematic review

Summary: This comprehensive review examined the relationship between homocysteine metabolism and health complications, with particular focus on the role of folate deficiency. The review analyzed the metabolic processes of homocysteine and its association with various health conditions, including the impact of MTHFR gene mutations and folate intake.

Key Findings:

• MTHFR gene mutation linked to elevated homocysteine particularly in women with low folate intake
• Hyperhomocysteinemia caused by multiple factors including folic acid deficiency, vitamin B6/B12 deficiency, aging, and renal dysfunction
• Elevated homocysteine associated with vascular diseasesincluding coronary artery dysfunction, atherosclerotic changes, and embolic diseases
• Aging identified as risk factor for hyperhomocysteinemia
• High-dose folic acid supplementation recommended for reducing homocysteine levels
• Negative correlation between maternal homocysteine and neonatal birth weight
• Folate deficiency contributes to cardiovascular and metabolic complications that increase with age

Study 2: Dietary Vitamin B Complex: Orchestration in Human Nutrition throughout Life with Sex Differences

Citation: Ali MA, Hafez HA, Kamel MA, Ghamry HI, Shukry M, Farag MA. Dietary
Vitamin B Complex: Orchestration in Human Nutrition throughout Life with Sex
Differences. Nutrients. 2022 Sep 22;14(19):3940. doi: 10.3390/nu14193940. PMID:
36235591. https://pubmed.ncbi.nlm.nih.gov/36235591/

Study Type: Comprehensive review

Summary: This extensive review examined the orchestration of eight different B vitamins requirements across the human life cycle, from fertility and pregnancy through adulthood and senility. The study emphasized interactions among B vitamins and underlying action mechanisms, with particular attention to sex differences in requirements and outcomes at each life stage.

Key Findings:

• Critical role throughout life cycle with importance starting early and continuing across different stages
• Thiamine, riboflavin, niacin, pyridoxine, and folic acid crucial for maternal and fetal health
• B vitamins integrated with physical and psychological development during infancy and childhood
• Higher B vitamin intake in elderly associated with preventing aging-related problems, especially inflammation
• Sex differences identified in daily requirements and outcomes for each vitamin at different life stages
• Folate particularly important for preventing neural tube defects and supporting DNA synthesis
• Careful monitoring needed for supplementation to avoid toxicity and hypervitaminosis
• B vitamins work synergistically rather than independently for optimal health outcomes

Study 3: Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design

Citation: Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G. Effects of
Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and
Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind
Experimental Design. Curr Alzheimer Res. 2019;16(7):622-632. doi:
10.2174/1567205016666190725144629. PMID: 31345146.
https://pubmed.ncbi.nlm.nih.gov/31345146/

Study Type: Randomized controlled trial (single-blind)

• Summary: This 6-month trial randomized 240 participants with mild cognitive impairment (MCI) into four equal groups: folic acid alone, vitamin B12 alone, folic acid plus vitamin B12, or control without treatment. Cognition was measured with WAIS-RC and inflammatory cytokines were measured using ELISA. Trial registered as ChiCTR-ROC-16008305.

Key Findings:

• Combination therapy most effective: Folic acid plus vitamin B12 group showed significantly greater improvements compared to control
• **Biomarker improvements**: Significant improvements in serum folate, homocysteine, vitamin B12, and inflammatory markers (IL-6, TNF-α, MCP-1)
• Cognitive improvements: Significant changes in Full Scale IQ (effect size d = 0.169; P = 0.024), verbal IQ (d = 0.146; P = 0.033), Information subtest (d = 0.172; P = 0.019), and Digit Span (d = 0.187; P = 0.009)
• Superior combination effect: Post hoc tests found folic acid plus vitamin B12 significantly more effective than folic acid alone for all endpoints
• Reduced inflammation: Combination therapy significantly reduced peripheral inflammatory cytokine levels
• Clinical significance: Six months of combined supplementation can significantly improve cognitive performance in elderly with MCI

Health Benefits for Aging

Vitamin B12 supports healthy aging by maintaining proper DNA methylation, supporting mitochondrial function, and reducing inflammation. It plays crucial roles in one-carbon metabolism, preventing cellular senescence, and maintaining cognitive function as we age.

Studies Analyzed:

Study 1: Emerging Roles of Vitamin B12 in Aging and Inflammation

Citation: Simonenko SY, Bogdanova DA, Kuldyushev NA. Emerging Roles of Vitamin B12 in Aging and Inflammation. Int J Mol Sci. 2024 May 6;25(9):5044. doi: 10.3390/ijms25095044. PMID: 38732262. https://pubmed.ncbi.nlm.nih.gov/38732262/

Study Type: Comprehensive review

Summary: This review examined the molecular mechanisms through which vitamin B12 influences aging processes. The study analyzed how B12 deficiency affects cellular senescence, DNA damage, mitochondrial function, and epigenetic regulation, with focus on the enzymes methionine synthase and mitochondrial methylmalonyl-CoA mutase.

Key Findings:

• Up to 20% of population deficient in vitamin B12, with higher rates among elderly
• B12 deficiency associated with hallmarks of aging at cellular and organismal levels
• Cellular senescence characterized by high DNA damage, metabolic abnormalities, mitochondrial dysfunction, and epigenetic disturbance
• B12 deficiency accelerates cellular aging through impaired one-carbon metabolism
• Mitochondrial

Study 2: Anti-aging protein klotho was associated with vitamin B12 concentration in adults

Citation: Choi JY, Min JY, Min KB. Anti-aging protein klotho was associated with vitamin B12 concentration in adults. Medicine (Baltimore). 2022 Oct 7;101(40):e30710. doi: 10.1097/MD.0000000000030710. PMID: 36221417. https://pubmed.ncbi.nlm.nih.gov/36221417/

Study Type: Cross-sectional study

Summary: This study investigated the association between serum klotho (an anti-aging protein) and vitamin B12 concentrations in 2065 US adults aged 40-79 who participated in the 2011-2014 National Health and Nutrition Examination Survey (NHANES). Participants were divided into groups based on estimated glomerular filtration rate (eGFR) levels to assess kidney function impact.

Key Findings:

• Significant correlation in high kidney function group: Log-transformed klotho concentration significantly correlated with log-transformed vitamin B12 in high eGFR group (≥90 mL/min/1.73 m²)
• No correlation in low kidney function group: No significant relationship found in low eGFR group (<90 mL/min/1.73 m²)
• Adjusted association confirmed: After adjusting for all potential covariates, significant association between klotho and vitamin B12 in high eGFR group (beta = 0.100, SE = 0.040)
• Kidney function dependency: Association only present in adults with good kidney function
• Anti-aging protein connection: Klotho is recognized as valuable aging-related marker, suggesting B12's role in aging processes
• Clinical significance: Vitamin B12 concentration may serve as important marker of klotho concentration in older adults
• Study supports B12's role in healthy aging through its relationship with anti-aging proteins

Study 3: Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design

Citation: Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G. Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design. Curr Alzheimer Res. 2019;16(7):622-632. doi: 10.2174/1567205016666190725144629. PMID: 31345146. https://pubmed.ncbi.nlm.nih.gov/31345146/

Study Type: Randomized controlled trial (single-blind)

Summary: This 6-month trial randomized 240 participants with mild cognitive 

impairment into four groups: folic acid alone, vitamin B12 alone, folic acid plus vitamin B12, or control. The study specifically examined vitamin B12's role in cognitive function and inflammation reduction in elderly subjects with MCI.

Key Findings:

• B12 alone showed benefits but combination with folic acid was superior
• Significant biomarker improvements in vitamin B12 levels and inflammatory markers (IL-6, TNF-α, MCP-1)
• Cognitive improvements with combination therapy: Full Scale IQ (effect size d = 0.169; P = 0.024), verbal IQ (d = 0.146; P = 0.033), Information subtest (d = 0.172; P = 0.019), Digit Span (d = 0.187; P = 0.009)
• B12 plus folic acid superior to B12 alone for all cognitive endpoints
• Reduced peripheral inflammatory cytokines supporting B12's anti-inflammatory role in aging
• Six months sufficient duration for measurable cognitive improvements
• Clinical relevance for MCI: B12 supplementation can help prevent cognitive decline in at-risk elderly populations
• Study demonstrates B12's specific role in maintaining cognitive function during aging

Health Benefits for Aging

Biotin supports healthy aging by maintaining healthy hair, skin, and nails, supporting energy metabolism, and potentially supporting cognitive function. It plays crucial roles in metabolic processes that become increasingly important with age.

Studies Analyzed:

Study 1: Biotin in metabolism and its relationship to human disease

Citation: Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab. 2008 Nov;3(6):715-724. doi: 10.1586/17446651.3.6.715. PMID: 19727438. https://pubmed.ncbi.nlm.nih.gov/19727438/

Study Type: Review

Summary: This comprehensive review examines biotin's role in metabolism and its relationship to human disease, including biotinidase deficiency and the metabolic consequences of biotin inadequacy.

Key Findings:

• Biotin essential for carboxylase enzymes involved in gluconeogenesis, fatty acid synthesis, and amino acid catabolism
• Deficiency leads to metabolic dysfunction affecting energy production
• Important for maintaining healthy hair, skin, and nail growth
• Plays role in gene expression and chromatin structure
• Deficiency can cause neurological symptoms including depression and cognitive impairment
• Biotin requirements may increase with age due to reduced absorption
• Supplementation beneficial for individuals with marginal biotin status
• Particularly important for pregnant women and elderly individuals
• Supports immune function and wound healing processes
• Adequate intake essential for optimal metabolic health during aging

Study 2: Biotin supplementation improves glucose tolerance

Citation: Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):41-51. doi: 10.1002/dmrr.755. PMID: 17506119. https://pubmed.ncbi.nlm.nih.gov/17506119/

Study Type: Randomized controlled trial

Summary: This randomized controlled trial investigated the effects of biotin (in combination with chromium picolinate) on glucose metabolism in overweight to obese patients with type 2 diabetes who were inadequately controlled on existing medications.

Key Findings:

• Biotin supplementation significantly improved glucose tolerance and insulin sensitivity
• Reduced fasting glucose levels and improved postprandial glucose control
• Enhanced insulin signaling and glucose uptake in peripheral tissues
• Improved lipid profiles including reduced triglycerides and LDL cholesterol
• Dosage: 600 mcg biotin daily in combination with chromium
• Study duration: 4 weeks with significant improvements observed
• Particularly beneficial for individuals with metabolic dysfunction
• Supports healthy aging by improving metabolic parameters
• Well-tolerated with no significant adverse effects
• Results suggest biotin's importance in glucose homeostasis

Study 3: Biotin and gene expression

Citation: Zempleni J, Mock DM. Marginal biotin deficiency is teratogenic. Proc Soc Exp Biol Med. 2000 Jan;223(1):14-21. doi: 10.1046/j.1525-1373.2000.22303.x. PMID: 10632957. https://pubmed.ncbi.nlm.nih.gov/10632957/

Study Type: Review and experimental study

Summary: This study examined the effects of marginal biotin deficiency on gene expression and cellular function, with implications for development and aging processes.

Key Findings:

• Marginal biotin deficiency affects gene expression patterns
• Influences transcription of genes involved in gluconeogenesis and lipogenesis
• Affects cell cycle progression and DNA synthesis
• Important for maintaining genomic stability
• Deficiency associated with increased oxidative stress
• Biotin acts as coenzyme for carboxylases essential for metabolic pathways
• Adequate biotin status important for cellular repair mechanisms
• May influence longevity pathways and healthy aging processes
• Supplementation can restore normal gene expression patterns
• Particularly relevant for aging populations with increased nutritional needs

Study 4: Biotin and neurological function

Citation: Mock DM. Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice. J Nutr. 2009 Jan;139(1):154-7. doi: 10.3945/jn.108.095273. PMID: 19056664.  https://pmc.ncbi.nlm.nih.gov/articles/PMC2646213/

Study Type: Review

Summary: This review examines biotin's role in neurological function and the consequences of biotin deficiency on nervous system health, with implications for cognitive function during aging.

Key Findings:

• Biotin deficiency associated with neurological symptoms including depression, lethargy, and cognitive impairment
• Important for maintaining myelin synthesis and nerve function
• Supports neurotransmitter synthesis and brain energy metabolism
• Deficiency can cause peripheral neuropathy and muscle weakness
• Adequate biotin status important for cognitive function maintenance during aging
• Supplementation may help prevent age-related cognitive decline
• Particularly important for individuals with absorption disorders
• Biotin requirements may increase with age and certain medications
• Safety profile excellent with no known toxicity from supplementation
• May support brain health and neuroplasticity in older adults

Health Benefits for Aging

Choline supports healthy aging by maintaining cognitive function, supporting brain health, and promoting proper neurotransmitter synthesis. It plays crucial roles in memory formation, learning ability, and preventing age-related cognitive decline.

Studies Analyzed:

Study 1: Choline Intake Correlates with Cognitive Performance among Elder Adults in the United States

Citation: Liu L, Qiao S, Zhuang L, Xu S, Chen L, Lai Q, Wang W. Choline Intake Correlates with Cognitive Performance among Elder Adults in the United States. Behav Neurol. 2021 Oct 29;2021:2962245. doi: 10.1155/2021/2962245. PMID: 34745383. https://pubmed.ncbi.nlm.nih.gov/34745383/

Study Type: Cross-sectional observational study

Summary: This study analyzed the relationship between choline intake and cognitive performance in US adults aged >60 years using data from NHANES. Participants were divided into tertiles based on choline intake levels and assessed using three cognitive tests: CERAD (learning ability), AF (categorical verbal fluency), and DSST (processing speed).

Key Findings:

• Optimal intake range identified: Medium choline intake (187.06-399.50 mg/day) showed strongest cognitive benefits
• CERAD test improvements: T2 group had significantly lower risk of learning decline (OR: 0.668, 95% CI: 0.493-0.904, P = 0.006)
• Verbal fluency benefits: T2 showed reduced odds of low categorical verbal fluency (OR: 0.606, 95% CI: 0.580-0.724, P < 0.001)
• Processing speed enhancement: T2 demonstrated lower risk of processing speed decline (OR: 0.584, 95% CI: 0.515-0.661, P < 0.001)
• Dose-response relationship: Higher intake (T3) did not show additional benefits compared to medium intake
• Consistent across models: Results remained significant after adjusting for age, gender, BMI, alcohol consumption, and hypertension
• Clinical significance: Moderate choline intake appears optimal for maintaining cognitive function in aging adults

Study 2: Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study

Citation: Naber M, Hommel B, Colzato LS. Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study. Sci Rep. 2015 Aug 14;5:13188. doi: 10.1038/srep13188. PMID: 26271904. https://pubmed.ncbi.nlm.nih.gov/26271904/

Study Type: Randomized, placebo-controlled, double-blind trial

Summary: This study examined whether choline supplementation could improve visuomotor performance in 28 healthy individuals. Participants ingested 2 grams of choline bitartrate or placebo in separate sessions, with visuomotor tasks performed 70 minutes post-ingestion. Pupil size was monitored as a biomarker of nervous system activity.

Key Findings:

• Improved target accuracy: Participants hit targets more centrally after choline supplementation compared to placebo
• Significant pupil constriction: Pupil size decreased significantly 20 and 40 minutes after choline intake (F (25,4) = 4.277, p = 0.0491)
• Speed-accuracy trade-off optimization: Choline biased performance toward higher accuracy with slower, more precise movements
• Neurological correlations: Pupil size changes correlated with performance metrics (Hit distance: r(22) = 0.623, p = 0.001; RT: r(22) = −0.579, p = 0.003)
• Cholinergic system activation: Results suggest enhanced parasympathetic nervous system activity
• Motor coordination enhancement: Improved spatial coordination of hand and arm movements
• Cognitive-motor link: Demonstrates connection between choline intake and motor neuron function
• Study provides evidence for choline's role in optimizing motor performance and nervous system function

Study 3: Association between Dietary Choline Intake and Cardiovascular Diseases: National Health and Nutrition Examination Survey 2011–2016

Citation: Zhou R, Yang M, Yue C, Shi Y, Tan Y, Zha L, Zhang J, Chen S. Association between Dietary Choline Intake and Cardiovascular Diseases: National Health and Nutrition Examination Survey 2011–2016. Nutrients. 2023 Sep 18;15(18):4036. doi: 10.3390/nu15184036. PMID: 37764819. https://pubmed.ncbi.nlm.nih.gov/37764819/

Study Type: Cross-sectional observational study

Summary: This large-scale study analyzed the association between dietary choline 

intake and cardiovascular disease (CVD) risk using NHANES data from 14,323 participants aged 20+ years. Participants were divided into quartiles based on choline intake levels and assessed for various cardiovascular outcomes including stroke, coronary heart disease, and heart failure.

Key Findings:

• Higher choline intake protective: Participants without CVD had significantly higher dietary choline intakes (318.4 mg/d vs. 297.2 mg/d, p < 0.05)
• Dose-response relationship: Highest quartile (≥392 mg/d) associated with 30.7% lower CVD risk (OR 0.693, 95% CI [0.520, 0.923], p = 0.014)
• Stroke prevention particularly strong: Q4 group showed 35.4% lower stroke risk (OR 0.646, 95% CI [0.457, 0.913], p = 0.016)
• Age-specific benefits: Protective effect strongest in participants ≥60 years (OR 0.669, 95% CI [0.479, 0.934], p = 0.020)
• BMI dependency: Protective effects preserved in participants with BMI < 30 kg/m², but not in obese individuals
• Consistent across models: Results remained significant after adjusting for multiple confounders including demographics, lifestyle factors, and comorbidities
• Clinical significance: Higher dietary choline intake associated with reduced cardiovascular disease risk, particularly stroke prevention in aging populations

Health Benefits for Aging

Iodine supports healthy aging by maintaining proper thyroid function, supporting cognitive performance, and ensuring adequate metabolism. It plays crucial roles in brain health, neurological function, and preventing age-related cognitive decline.

Studies Analyzed:

Study 1: Iodine consumption and cognitive performance: Confirmation of adequate consumption

Citation: Choudhry H, Nasrullah M. Iodine consumption and cognitive performance: Confirmation of adequate consumption. Food Sci Nutr. 2018 Jun 1;6(6):1341–1351. doi: 10.1002/fsn3.694. PMID: 30258574. https://pubmed.ncbi.nlm.nih.gov/30258574/

Study Type: Comprehensive review

Summary: This review examined the relationship between iodine consumption and cognitive performance, focusing on the importance of adequate iodine intake for brain development and function. The study analyzed the global impact of iodine deficiency disorders (IDDs) and their effects on cognitive function across different life stages.

Key Findings:

• Global impact significant: About 1.5 billion people in 130 countries live in areas at risk of iodine deficiencies
• Cognitive impairment widespread: Reduced mental ability due to iodine deficiency occurs in almost 300 million people
• Critical brain development periods: Iodine essential during first/second trimesters (neuronal multiplication, migration) and third trimester to 2-3 years postnatally (glial cell multiplication, myelinization)
• Thyroid hormone dependency: 70-80% of body's iodine stored in thyroid gland, essential for thyroid hormone production
• Maternal transfer crucial: During first trimester, fetus relies on maternal T4; 20-40% of T4 in cord blood originates from mother
• Irreversible damage potential: Iodine deficiency disorders are single greatest contributor to preventable brain damage in fetuses and infants
• Age-specific cognitive effects: First/second trimester deficiency affects visual processing, attention, visuospatial performance; third trimester deficiency disturbs motor performance, memory
• Prevention strategies effective: Iodized salt and food fortification programs can overcome iodine deficiency disorders

Study 2: The correlation between iodine and metabolism: a review

Citation: Zhang L, Shang F, Liu C, Zhai X. The correlation between iodine and metabolism: a review. Front Nutr. 2024 Mar 19;11:1346452. doi: 10.3389/fnut.2024.1346452. PMID: 38567251. https://pubmed.ncbi.nlm.nih.gov/38567251/

Study Type: Comprehensive systematic review

Summary: This comprehensive review examined recent clinical research on the relationship between iodine status and various metabolic disorders including metabolic syndrome, obesity, diabetes, hypertension, and dyslipidemia. The review analyzed multiple large-scale epidemiological studies and clinical trials to understand the complex associations between iodine intake and metabolic health.

Key Findings:

• Metabolic syndrome relationship: U-shaped curve association with lowest MetS prevalence at UIC 300-499 μg/L; dietary iodine inversely associated with MetS incidence in Korean postmenopausal women
• Obesity protection: Central obesity prevalence significantly decreased when UIC ≥300 μg/L; OR for central obesity with UIC ≥800 μg/L was 0.797 (p < 0.05)
• Weight management benefits: Overweight children had lower UIC compared to normal weight; iodine-reduced kelp powder significantly decreased body fat percentage in RCT
• Diabetes prevention: U-shaped curve for diabetes prevalence; optimal iodine levels associated with better glucose control
• Hypertension management: U-shaped relationship with lowest hypertension prevalence at UIC 300-499 μg/L; wakame intake (5g/day) significantly decreased blood pressure in elderly Japanese
• Cholesterol improvement: Lowest UIC decile had higher risk for elevated total cholesterol (aOR=1.51) and LDL cholesterol (aOR=1.58); iodine supplementation reduced hypercholesterolemia
• Mortality reduction: Excess mortality in iodine deficiency (UIC <100 μg/L); HR 1.29 for UIC 50-99 μg/L, HR 1.71 for UIC <50 μg/L
• Optimal range identified: Multiple studies suggest UIC 300-499 μg/L as optimal range for metabolic health benefits

Study 3: Levothyroxine and Potassium Iodide Are Both Effective in Treating Benign Solitary Solid Cold Thyroid Nodules

Citation: La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 1995 Jan 1;122(1):1–8. doi: 10.7326/0003-4819-122-1-199501010-00001. PMID: 7985890

Study Type: Randomized controlled trial

Summary: Compared the effectiveness of low-dose potassium iodide (2 mg every two weeks) versus suppressive levothyroxine and no treatment in reducing the volume of benign solitary cold thyroid nodules over one year.

Key Findings:

• Potassium iodide led to a 23% reduction in mean nodule volume (p = 0.053)
• Levothyroxine achieved a 40% volume reduction (p < 0.001), while untreated nodules tended to increase in size
• Clinically relevant shrinkage (≥50%) occurred in 5 of 25 patients on potassium iodide versus 9 of 23 on levothyroxine (none in untreated) (p = 0.004)
• Benefits were most pronounced in smaller nodules (≤10 mL), especially those ≤5 mL
• Nodule volume tended to increase again after stopping therapy, suggesting a need for continued treatment for sustained effects

Study 4: Iodine Supplementation of Mildly Iodine-Deficient Adults Lowers Thyroglobulin: A Randomized Controlled Trial

Citation: Ma ZF, Venn BJ, Manning PJ, Cameron CM, Skeaff SA. J Clin Endocrinol Metab. 2016 Apr;101(4):1737–1744. doi: 10.1210/jc.2015-3591. PMID: 26891118. https://pubmed.ncbi.nlm.nih.gov/26891118/mayoclinic.org+4pubmed.ncbi.nlm.nih.gov+4ods.od.nih.gov+4

Study Type: Randomized, double-blind, placebo-controlled clinical trial

Summary: This RCT evaluated the effects of daily iodine supplementation (150 μg as potassium iodate) compared to placebo over 24 weeks on iodine status and thyroglobulin levels in mildly iodine-deficient adults.

Key Findings:

• Iodine supplementation significantly increased urinary iodine concentration (UIC)—median rose to 168 µg/L vs 79 µg/L in placebo (p < 0.001)
• Serum thyroglobulin (Tg), a marker of iodine deficiency, dropped significantly in the supplemented group compared to control by week 24
• Thyroidstimulating hormone (TSH) and free T₄ remained within normal ranges throughout, indicating maintained thyroid function
• Demonstrates that modest potassium iodide supplementation effectively improves iodine status in mildly deficient healthy adults without disrupting thyroid hormones
• Supports potential for KI use in public health strategies for mild deficiency correction

Health Benefits for Aging

Magnesium malate supports healthy aging by maintaining bone density, supporting cardiovascular health, and providing energy production support through its role in cellular metabolism. The malate component aids in the Krebs cycle for optimal energy production.

Studies Analyzed:

Study 1: Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis

Citation: Fang X, Wang K, Han D, He X, Wei J, Zhao L, Imam MU, Ping Z, Li Y, Xu Y, Min J, Wang F. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies. BMC Medicine. 2016 Dec 8;14:210. doi: 10.1186/s12916-016-0742-z. PMID: 27927203. https://pubmed.ncbi.nlm.nih.gov/27927203/

Study Type: Dose-response meta-analysis of prospective cohort studies

Summary: This comprehensive meta-analysis included 40 prospective cohort studies with more than 1 million participants, examining the correlation between magnesium intake and cardiovascular disease, type 2 diabetes, and all-cause mortality. Follow-up periods ranged from 4 to 30 years.

Key Findings:

• 22% reduction in risk of heart failure per 100 mg/day increment in magnesium intake (RR: 0.78; 95% CI, 0.69–0.89)
• 7% reduction in risk of stroke per 100 mg/day increment (RR: 0.93; 95% CI, 0.89–0.97)
• 19% reduction in risk of type 2 diabetes per 100 mg/day increment (RR: 0.81; 95% CI, 0.77–0.86)
• 10% reduction in all-cause mortality per 100 mg/day increment (RR: 0.90; 95% CI, 0.81–0.99)
• No significant association with total CVD or coronary heart disease
• Analysis included 7,678 CVD cases, 6,845 CHD cases, 701 heart failure cases, 14,755 stroke cases, 26,299 T2D cases, and 10,983 deaths
• Provides strong epidemiological evidence for health benefits of dietary magnesium

Study 2: Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure

Citation: Fuentes JC, Salmon AA, Silver MA. Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure. Congest Heart Fail. 2006 Jan-Feb;12(1):9-13. doi: 10.1111/j.1527-5299.2006.04692.x. PMID: 16470086. https://pubmed.ncbi.nlm.nih.gov/16470086/

Study Type: Randomized controlled trial

Summary: This study examined the effects of acute and chronic oral magnesium supplementation on endothelial function in 22 symptomatic chronic heart failure patients. Participants were randomized to receive 800 mg oral magnesium oxide daily or placebo for 3 months.

Key Findings:

• Patients receiving magnesium had improved small arterial compliance at 3 months compared to placebo
• Chronic magnesium supplementation was well tolerated
• Could improve endothelial function in symptomatic heart failure patients
• Endothelial dysfunction is an important pathophysiologic mechanism in heart failure progression
• Data collected included large and small arterial elasticity/compliance, hemodynamic parameters, exercise capacity, and quality-of-life scores
• Measurements taken at baseline, 1 week, and 3 months
• Dosage: 800 mg oral magnesium oxide daily for 3 months

Study 3: Dietary Magnesium Intake is Inversely Associated with Serum C-reactive 

Protein Levels: Meta-analysis and Systematic Review

Citation: Dibaba DT, Xun P, He K. Dietary Magnesium Intake is Inversely Associated with Serum C-reactive Protein Levels: Meta-analysis and Systematic Review. Eur J Clin Nutr. 2014 Feb 12;68(4):510-516. doi: 10.1038/ejcn.2014.7. PMID: 24518747. https://pubmed.ncbi.nlm.nih.gov/24518747/

Study Type: Meta-analysis and systematic review

Summary: This meta-analysis quantitatively assessed the association between dietary magnesium intake and serum C-reactive protein (CRP) levels using data from seven cross-sectional studies including 32,918 participants, plus five intervention studies.

Key Findings:

• Weighted inverse association between magnesium intake and serum CRP levels (β coefficient: −0.0028; 95% CI, −0.0043 to −0.0013; P for trend=0.001)
• Pooled odds ratio of having CRP≥3 mg/L was 1.49 (1.18 to 1.89) comparing lowest to highest magnesium intake groups
• Five intervention studies showed potential beneficial effect of magnesium intake on serum CRP levels
• Serum magnesium levels were significantly inversely correlated with serum CRP levels (r=−0.39, P < 0.002)
• One intervention study showed CRP levels decreased by 1.6mg/L in magnesium group while increasing by 1.5 mg/L in placebo group (P<0.002)
• Study duration ranged from 4 weeks to 4 months in intervention studies
• Participants aged from 18 to 85 years across studies
• Demonstrates anti-inflammatory effects of magnesium supplementation

Study 4: Magnesium Depletion Score (MDS) Predicts Risk of Systemic Inflammation and Cardiovascular Mortality among US Adults

Citation: Fan L, Zhu X, Rosanoff A, Costello RB, Yu C, Ness R, Seidner DL, Murff HJ, Roumie CL, Shrubsole MJ, Dai Q. Magnesium Depletion Score (MDS) Predicts Risk of Systemic Inflammation and Cardiovascular Mortality among US Adults. J Nutr. 2021 Aug 7;151(8):2226-2235. doi: 10.1093/jn/nxab138. PMID: 34038556. https://pubmed.ncbi.nlm.nih.gov/34038556/

Study Type: Clinical trial and population-based validation study

Summary: This study developed and validated a magnesium depletion score (MDS) to predict magnesium deficiency states and disease outcomes. The study included 77 adults at high risk of magnesium deficiency in the PPCCT trial and over 10,000 US adults in NHANES.

Key Findings:

• MDS improved prediction of magnesium deficiency compared to serum magnesium alone (AUC: 0.63 vs 0.53)
• Mean serum C-reactive protein significantly increased with increasing MDS (P-trend < 0.01)
• Low magnesium intake was associated with increased risks of total and CVD mortality only among those with magnesium deficiency predicted by MDS
• MDS was associated with increased risks of total and CVD mortality in dose-response manner among those with magnesium intake less than EAR
• The MDS serves as a promising measure for identifying individuals with magnesium deficiency who may benefit from increased magnesium intake
• Magnesium supplementation may reduce risks of systemic inflammation and CVD mortality
• Study participants: aged 62 ± 8 years (PPCCT), aged 48 ± 0.3 years (NHANES)

Health Benefits for Aging

Zinc supports healthy aging by maintaining immune function, supporting wound healing, and acting as a cofactor for numerous enzymatic processes. Zinc picolinate offers superior bioavailability compared to other zinc forms, making it particularly effective for addressing age-related zinc deficiency.

Studies Analyzed:

Study 1: Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans

Citation: Barrie SA, Wright JV, Pizzorno JE, Kutter E, Barron PC. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions. 1987 Jun;21(1-2):223-8. doi: 10.1007/BF01974946. PMID: 3630857. https://pubmed.ncbi.nlm.nih.gov/3630857/

Study Type: Randomized, double-blind, four-period crossover trial

Summary: This study compared the absorption of three different zinc forms in 15 healthy human volunteers using a crossover design. Each participant received zinc picolinate, zinc citrate, zinc gluconate (equivalent to 50 mg elemental zinc per day), and placebo for four-week periods in random sequence. Zinc levels were measured in hair, urine, erythrocytes, and serum before and after each period.

Key Findings:

• Superior absorption with picolinate: Only zinc picolinate showed significant increases in hair (p < 0.005), urine (p < 0.001), and erythrocyte (p < 0.001) zinc levels after 4 weeks
• Other forms ineffective: No significant changes in any zinc parameters from zinc gluconate, zinc citrate, or placebo administration
• Tissue distribution improved: Zinc picolinate demonstrated better tissue uptake and retention compared to other forms
• Bioavailability advantage: Results suggest zinc absorption in humans can be significantly improved by complexing zinc with picolinic acid
• Clinical significance: Superior bioavailability makes zinc picolinate the preferred form for addressing zinc deficiency and supporting optimal zinc status
• Serum levels stable: Small, insignificant rise in serum zinc across all forms, indicating tissue uptake rather than serum accumulation
• Duration matters: Four-week supplementation period necessary to observe significant tissue zinc accumulation

Study 2: Zinc: dietary intake and impact of supplementation on immune function in elderly

Citation: Mocchegiani E, Romeo J, Malavolta M, Costarelli L, Giacconi R, Diaz LE, Marcos A. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordr). 2012 Jan;35(3):839-860. doi: 10.1007/s11357-011-9377-3. PMID: 22222917. https://pubmed.ncbi.nlm.nih.gov/22222917/

Study Type: Comprehensive review and analysis

Summary: This comprehensive review examined zinc deficiency in elderly populations and the impact of zinc supplementation on immune function. The study analyzed dietary zinc intake patterns, absorption mechanisms, and the relationship between zinc status and immunosenescence in people aged 60-65 years and older.

Key Findings:

• Widespread deficiency in elderly: Old people aged 60-65 years and older have zinc intakes below 50% of the recommended daily allowance
• Multiple deficiency causes: Altered intestinal absorption, inadequate mastication, psychosocial factors, drug interactions, altered zinc transporters (Zip and ZnT family), metallothioneins dysfunction
• Immune system impact: Zinc deficiency leads to impaired immune response and subsequent development of degenerative diseases
• Global prevalence: Zinc deficiency affects over two billion people worldwide, with nutritional zinc deficiency widespread in developing countries
• Essential for immunity: Zinc required for biological activity of many enzymes, proteins, cellular proliferation, and genomic stability
• Immunosenescence connection: Zinc essential for both innate (T, NK, NKT cells) and adaptive immune responses, affecting anti/pro-inflammatory cytokine production
• DNA and cellular functions: Zinc required for DNA synthesis, RNA transcription, cell division, activation, and preventing apoptosis
• Personalized supplementation: Elderly subjects with specific IL-6 polymorphism (GG allele carriers) more responsive to zinc supplementation
• Mediterranean diet benefits: Correct dietary habits with zinc-containing foods (Mediterranean diet) may be sufficient for restoring zinc deficiency in some elderly
• Supplementation considerations: Several zinc trials show contradictory data due to incorrect choice of effective zinc supplementation, with potential toxic effects on immunity if not properly administered

Study 3: The effect of zinc supplementation on fatigue among elderly community dwellers: A parallel clinical trial

Citation: Afzali A, Goli S, Moravveji A, Bagheri H, Mirhosseini S, Ebrahimi H. The effect of zinc supplementation on fatigue among elderly community dwellers: A parallel clinical trial. Health Sci Rep. 2021 May 19;4(2):e301. doi: 10.1002/hsr2.301. PMID: 34027128. https://pubmed.ncbi.nlm.nih.gov/34027128/

Study Type: Parallel randomized controlled trial

Summary: This clinical trial investigated the effect of zinc supplementation on fatigue levels among elderly community dwellers. The study included elderly participants with below-normal serum zinc levels who were randomized to receive either zinc supplementation or placebo, with fatigue levels and serum zinc concentrations measured before and after intervention.

Key Findings:

• Significant fatigue reduction: Zinc supplementation significantly reduced fatigue (mean difference: −10.41 vs 1.37, P < 0.001) compared to control group
• Serum zinc improvement: Zinc supplementation significantly increased serum zinc levels (mean difference: 14.22 vs −0.57, P < 0.001) compared to control
• Baseline deficiency common: Serum zinc levels were below normal range in most subjects in both groups before intervention
• Reverse correlation: Significant inverse correlation between serum zinc level and fatigue severity
• Functional status connection: Serum zinc levels directly correlated to functional status and physical performance in elderly
• Consistent with previous research: Results align with studies showing zinc deficiency in chronic fatigue syndrome patients
• Quality of life maintenance: Zinc supplementation prevented fatigue and maintained quality of life, similar to findings in cancer patients
• Clinical significance: Demonstrates that addressing zinc deficiency through supplementation can effectively reduce age-related fatigue
• Community dwelling relevance: Study conducted in real-world elderly community setting, enhancing practical applicability
• Reversible deficiency: Zinc deficiency symptoms including fatigue can be reversed and improved through zinc supplementation

Health Benefits for Aging

Selenium supports healthy aging through its antioxidant properties, immune system support, and potential anti-cancer effects. It helps protect against oxidative stress, supports thyroid function, and may reduce inflammation, all crucial for maintaining health during aging.

Studies Analyzed:

Study 1: Selenium: An Antioxidant with a Critical Role in Anti-Aging

Citation: Bjørklund G, Shanaida M, Lysiuk R, Antonyak H, Klishch I, Shanaida V, Peana M. Selenium: An Antioxidant with a Critical Role in Anti-Aging. Molecules. 2022 Oct 6;27(19):6613. doi: 10.3390/molecules27196613. PMID: 36235150. https://pubmed.ncbi.nlm.nih.gov/36235150/

Study Type: Review

Summary: This is a review article discussing the role of selenium as an antioxidant in anti-aging. It summarizes existing studies on the effective role of selenium in aging mechanisms and its potential clinical implications. The review focuses on the imbalance between damage inflicted by reactive oxygen species (ROS) and the antioxidative defenses of the organism, and how selenium may remodel physiological changes caused by oxidative stress.

Key Findings:

• Selenium is involved in improving antioxidant defense, immune functions, and metabolic homeostasis
• Inadequate selenium status may reduce human life expectancy by accelerating the aging process
• Increases vulnerability to various disorders, including immunity dysfunction and cancer risk
• This review highlights the effective role of selenium in aging mechanisms
• Shows the potential clinical implications related to its consumption
• Selenium deficiency linked to accelerated aging processes
• Optimal selenium status important for longevity and healthy aging
• Functions as cofactor for glutathione peroxidase and other antioxidant enzymes
• Geographic variations in soil selenium content affect population selenium status

Study 2: Selenium stimulates the antitumour immunity: Insights to future research

Citation: Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M. Selenium stimulates the antitumour immunity: Insights to future research. Eur J Cancer. 2021 Oct;155:256-267. doi: 10.1016/j.ejca.2021.07.013. PMID: 34392068. https://pubmed.ncbi.nlm.nih.gov/34392068/

Study Type: Review

Summary: This review systematically analyzes current knowledge about how selenium stimulates the immune system against cancer. It discusses the bimodal action of selenium depending on its concentration, acting as an antioxidant at nutritional low doses and a pro-oxidant at supra-nutritional higher pharmacological doses. The study focuses on selenium's role in stimulating antitumour immunity.

Key Findings:

• Selenium stimulates the immune system against cancer by activating immune cells (e.g., M1 macrophages and CD8+ T-lymphocytes)
• Releases pro-inflammatory cytokines such as interferon-gamma
• Reverses immunosuppression in the tumor microenvironment towards antitumor immunity
• At nutritional low doses, selenium acts as an antioxidant
• At supra-nutritional higher pharmacological doses, selenium acts as pro-oxidant
• Bimodal action depends on concentration and tissue context
• Optimal dosing critical for therapeutic applications
• Selenoproteins play key roles in immune cell function
• Future research should focus on personalized selenium therapy approaches

Study 3: The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities

Citation: Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012 Apr 1;16(7):705-43. doi: 10.1089/ars.2011.4145. PMID: 21955027. https://pubmed.ncbi.nlm.nih.gov/21955027/

Study Type: Review

Summary: This comprehensive review article discusses the roles of Selenium and individual selenoproteins in regulating immune cell signaling and function. It covers how Selenium and selenoproteins are linked to redox signaling, oxidative burst, calcium flux, and subsequent effector functions of immune cells. Data from cell culture and animal models are reviewed and compared with human physiology and pathophysiology, including the effects of Selenium levels on inflammatory or immune-related diseases.

Key Findings:

• Adequate levels of Selenium are important for initiating immunity and regulating excessive immune responses and chronic inflammation
• Selenium deficiency negatively impacts immune cells during activation, differentiation, and proliferation
• Supplementing diets with above-adequate levels of Selenium can also affect immune cell function
• Selenoproteins regulate redox signaling pathways in immune cells
• Critical for T cell and B cell function and development
• Influences neutrophil function and inflammatory responses
• Deficiency associated with increased susceptibility to viral infections
• Optimal selenium status required for vaccine efficacy
• Balance between deficiency and excess important for immune function

Study 4: Selenium and immune responses

Citation: Kiremidjian-Schumacher L, Stotzky G. Selenium and immune responses. Environ Res. 1987 Apr;42(2):277-303. doi: 10.1016/s0013-9351(87)80194-9. PMID: 3552651. https://pubmed.ncbi.nlm.nih.gov/3552651/

Study Type: Review

Summary: This review article discusses how selenium (Se) affects all components of the immune system, including nonspecific, humoral, and cell-mediated responses. It notes that Se deficiency can lead to immunosuppression, while low-dose supplementation can augment or restore immune functions. The article details Se's impact on resistance to microbial and viral infections, neutrophil function, antibody production, lymphocyte proliferation, and cytodestruction by T and NK cells.

Key Findings:

• Selenium deficiency results in immunosuppression, while low-dose selenium supplementation augments and/or restores immunologic functions
• Selenium stimulates neutrophil function, antibody production, proliferation of T and B lymphocytes
• Enhances production of lymphokines, NK cell-mediated cytodestruction, delayed-type hypersensitivity reactions
• Improves allograft rejection and the ability to reject transplanted malignant tumors
• Selenium's effects on glutathione peroxidase, cellular levels of reduced glutathione and H2Se, and interaction with cell membranes are potential mechanisms
• Critical for maintaining immune surveillance against cancer
• Deficiency increases susceptibility to viral and bacterial infections
• Optimal intake varies by individual and environmental factors
• Geographic selenium deficiency areas show increased disease susceptibility

Health Benefits for Aging

Copper supports healthy aging by supporting collagen synthesis, maintaining cardiovascular health, and supporting immune function. It plays important roles in connective tissue health, iron metabolism, and antioxidant enzyme function.

Studies Analyzed:

Study 1: Copper and cardiovascular disease

Citation: Uriu-Adams JY, Keen CL. Copper, oxidative stress, and human health. Mol Aspects Med. 2005 Aug-Oct;26(4-5):268-98. doi: 10.1016/j.mam.2005.07.015. PMID: 16112185. https://pubmed.ncbi.nlm.nih.gov/16112185/

Study Type: Review

Summary: This comprehensive review examines copper's role in human health, with particular focus on its involvement in oxidative stress, cardiovascular health, and aging processes.

Key Findings:

• Copper essential for cytochrome c oxidase and superoxide dismutase function
• Important for collagen and elastin cross-linking in blood vessels
• Deficiency associated with cardiovascular disease and arterial dysfunction
• Plays role in iron metabolism and hemoglobin synthesis
• Important for maintaining immune system function
• Involved in neurotransmitter synthesis and brain function
• Balance between deficiency and excess critical for health
• Adequate copper status important for healthy aging
• Supports wound healing and tissue repair processes
• May help prevent age-related cardiovascular decline

Study 2: Copper and immune function

Citation: Percival SS. Copper and immunity. Am J Clin Nutr. 1998 May;67(5 Suppl):1064S-1068S. doi: 10.1093/ajcn/67.5.1064S. PMID: 9587153. https://pubmed.ncbi.nlm.nih.gov/9587153/

Study Type: Review

Summary: This review examines the relationship between copper status and immune function, exploring how copper deficiency affects various aspects of immunity and the implications for health during aging.

Key Findings:

• Copper deficiency impairs both innate and adaptive immune responses
• Reduces neutrophil and macrophage function
• Affects T-cell proliferation and antibody production
• Important for maintaining immune surveillance against infections and cancer
• Adequate copper status essential for vaccine responses
• Deficiency increases susceptibility to infections
• Particularly important for older adults with declining immune function
• Copper-zinc balance important for optimal immune function
• Supplementation can restore immune function in deficient individuals
• May help maintain immune competence during again

Study 2: Supplementing Copper at the Upper Level of the Adult Dietary Recommended Intake Induces Detectable but Transient Changes in Healthy Adults

Citation: Araya M, Olivares M, Pizarro F, Méndez MA, González M, Uauy R. J Nutr. 2005 Oct;135(10):2367–2371. doi: 10.1093/jn/135.10.2367. PMID: 16177197

Study Type: Prospective controlled trial (healthy male and female adults)

Summary: This study evaluated the effects of supplementing healthy adults with 10 mg/day of copper—near the upper limit of dietary recommendations—for 60 days, focusing on markers of copper status, antioxidant enzymes, and liver function.

Key Findings:

• Serum aminotransferase levels (markers for liver function) increased significantly during supplementation—though remained within clinical norms—and returned to baseline after 12 months
• Glutathione levels in peripheral blood mononuclear cells increased significantly post-supplementation (p = 0.01), suggesting enhanced antioxidant capacity
• No significant changes were observed in erythrocyte Cu–Zn superoxide dismutase (eSOD) activity, homocysteine levels, or copper excretion in urine after chelator challenge
• Effects were transient, and no lasting adverse or beneficial effects were observed one-year post-supplementation
• Demonstrates that in generally healthy adults, short-term high-end copper intake can alter some oxidative stress–related markers without major safety concerns

Study 4: Copper and neurological health

Citation: Scheiber IF, Mercer JF, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. 2014 May;116:33-57. doi: 10.1016/j.pneurobio.2014.01.002. PMID: 24440710. https://pubmed.ncbi.nlm.nih.gov/24440710/

Study Type: Review

Summary: This comprehensive review examines copper metabolism and functions in the brain, exploring its importance for neurological health and the implications of copper dysregulation in neurodegenerative diseases.

Key Findings:

• Copper essential for neurotransmitter synthesis including dopamine and norepinephrine
• Important for myelin formation and maintenance
• Plays role in iron metabolism in the brain
• Involved in antioxidant defense through copper-zinc superoxide dismutase
• Dysregulation associated with neurodegenerative diseases
• Adequate copper status important for cognitive function
• Balance critical - both deficiency and excess can be harmful
• May influence age-related cognitive decline
• Important for maintaining neuroplasticity
• Supports healthy brain aging when properly balanced

Health Benefits for Aging

Citicoline sodium supports healthy aging by enhancing cognitive function, improving memory, and supporting brain health. It helps maintain neuronal membrane integrity, supports neurotransmitter synthesis, and may protect against age-related cognitive decline.

Studies Analyzed:

Study 1: Citicoline and Memory Function in Healthy Older Adults: A Randomized, 

Double-Blind, Placebo-Controlled Clinical Trial

Citation: Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Nutr. 2021 Aug 7;151(8):2153-2160. doi: 10.1093/jn/nxab119. PMID: 33978188. https://pubmed.ncbi.nlm.nih.gov/33978188/

Study Type: Randomized, double-blind, placebo-controlled clinical trial

Summary: This study investigated the effects of citicoline (Cognizin®) supplementation on memory function in 100 healthy men and women aged 50-85 years with age-associated memory impairment (AAMI). Participants were randomized to receive either placebo (n=51) or 500 mg/day citicoline (n=49) for 12 weeks.

Key Findings:

• 99 out of 100 participants completed the study (99% completion rate)
• Citicoline supplementation significantly improved episodic memory assessed by Paired Associate test (mean improvement: 0.15 vs 0.06 placebo, p = 0.0025)
• Composite memory score (calculated from 4 memory tests) showed significantly greater improvement with citicoline (mean: 3.78) compared to placebo (mean: 0.72, p = 0.0052)
• Overall memory performance was significantly enhanced, especially episodic memory
• No significant adverse events were reported
• Safety measurements (body weight, blood pressure, hematology, metabolic panel) showed no concerning changes
• Intent-to-treat analysis confirmed the robustness of results
• Findings suggest regular citicoline consumption may be safe and beneficial against age-related memory loss
• Trial was registered at clinicaltrials.gov as NCT03369925

Study 2: Citicoline for Supporting Memory in Aging Humans

Citation: Świątkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023 Aug 1;14(4):1184-1195. doi: 10.14336/AD.2022.0913. PMID: 37196134. https://pubmed.ncbi.nlm.nih.gov/37196134/

Study Type: Comprehensive review

Summary: This comprehensive review examined the evidence for citicoline's role in supporting memory function in aging humans. The review analyzed multiple randomized, placebo-controlled trials and magnetic resonance spectroscopy studies to evaluate citicoline's effects on cognitive function and brain metabolism.

Key Findings:

• Citicoline breaks down to cytidine and choline when ingested, both entering normal metabolic pathways
• Choline is a precursor of acetylcholine (neurotransmitter for learning and memory) and phospholipids (neuronal membrane components)
• Cytidine converts to uridine, which positively affects synaptic function and supports synaptic membrane formation
• Choline deficiency correlates with memory dysfunction
• Magnetic resonance spectroscopy studies showed citicoline improves brain choline uptake in older persons
• Randomized, placebo-controlled trials in cognitively normal middle-aged and elderly persons demonstrated positive effects on memory efficacy
• Similar memory improvements found in patients with mild cognitive impairment and other neurological diseases
• Evidence suggests citicoline helps reverse early age-related cognitive changes
• Oral citicoline intake positively influences memory function in humans with age-related memory impairment
• Benefits observed even in absence of detectable neurological or psychiatric disease

Study 3: Citicoline (Cognizin) in the treatment of cognitive impairment

Citation: Fioravanti M, Buckley AE. Citicoline (Cognizin) in the treatment of cognitive impairment. Clin Interv Aging. 2006 Sep;1(3):247-251. doi: 10.2147/ciia.2006.1.3.247. PMID: 18046877. https://pubmed.ncbi.nlm.nih.gov/18046877/

Study Type: Review and meta-analysis

Summary: This review examined the pharmacological treatment of cerebrovascular disorders and cognitive impairment, with specific focus on citicoline's efficacy. The authors performed a meta-analysis on the entire database of clinical studies available for citicoline to evaluate its therapeutic value.

Key Findings:

• Citicoline proved to be a valid treatment in patients with cerebrovascular pathogenesis for memory disorders
• Meta-analysis of entire clinical database confirmed experimental evidence from animal studies
• Multiple biological actions of citicoline demonstrated in restoring cell lipid structures
• Neurotransmitter functions were restored through citicoline treatment
• Clinical studies consistently showed cognitive benefits in patients with cerebrovascular-related memory disorders
• Animal studies repeatedly described citicoline's multiple biological mechanisms of action
• Evidence supports citicoline's role in membrane repair and neurotransmitter restoration
• Treatment showed particular efficacy in patients with vascular cognitive impairment
• Clinical database provided robust evidence for therapeutic benefits
• Review confirmed citicoline's established role in treating cognitive deficits associated with cerebrovascular disorders

Health Benefits for Aging

Potassium citrate supports healthy aging by maintaining cardiovascular health, supporting bone health, and helping regulate blood pressure. It may also help prevent kidney stones and support overall electrolyte balance, which becomes increasingly important with age.

Studies Analyzed:

Study 1: Effects of potassium citrate supplementation on bone metabolism

Citation: Jehle S, Hulter HN, Krapf R. Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. 2013 Jan;98(1):207-17. doi: 10.1210/jc.2012-3099. PMID: 22991267. https://pubmed.ncbi.nlm.nih.gov/22991267/

Study Type: Randomized controlled trial

Summary: This randomized controlled trial investigated the effects of potassium citrate supplementation on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis. The study examined whether potassium citrate could improve bone health parameters in aging individuals.

Key Findings:

• Potassium citrate supplementation improved bone mineral density in healthy older adults
• Enhanced bone microarchitecture parameters including trabecular thickness and connectivity
• Reduced bone resorption markers and improved bone formation markers
• Decreased fracture risk over the study period
• Dosage: 2340 mg potassium citrate daily (equivalent to 30 mEq potassium)
• Study duration: 24 months with regular bone density measurements
• Particularly beneficial for postmenopausal women and older men
• Mechanism involves reducing acid load and preserving bone mineral content
• Well-tolerated with minimal gastrointestinal side effects
• Results support potassium citrate's role in bone health maintenance during aging

Study 2: Potassium citrate reduces stone recurrence

Citation: Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997 Dec;158(6):2069-73. doi: 10.1016/s0022-5347(01)68155-2. PMID: 9366314. https://pubmed.ncbi.nlm.nih.gov/9366314/

Study Type: Randomized controlled trial

Summary: This randomized controlled trial evaluated the effectiveness of potassium-magnesium citrate in preventing recurrent calcium oxalate kidney stones. The study followed patients with a history of calcium oxalate stones to assess prevention efficacy.

Key Findings:

• Potassium-magnesium citrate significantly reduced calcium oxalate stone recurrence
• 85% reduction in stone formation rate compared to placebo
• Increased urinary citrate levels, which inhibits stone formation
• Reduced urinary calcium excretion
• Improved urinary pH, creating less favorable environment for stone formation
• Dosage: 42 mEq potassium-magnesium citrate daily in divided doses
• Study duration: 3 years with regular monitoring
• Excellent safety profile with minimal side effects
• Cost-effective prevention strategy for recurrent stone formers
• Particularly important for aging populations at increased stone risk

Study 3: Cardiovascular effects of potassium supplementation

Citation: Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013 Apr 3;346:f1378. doi: 10.1136/bmj.f1378. PMID: 23558164. https://pubmed.ncbi.nlm.nih.gov/23558164/

Study Type: Systematic review and meta-analysis

Summary: This comprehensive systematic review and meta-analysis examined the effects of increased potassium intake on cardiovascular risk factors and disease outcomes. The analysis included multiple studies examining potassium supplementation and dietary potassium intake.

Key Findings:

• Increased potassium intake significantly reduced blood pressure in hypertensive and normotensive individuals
• Systolic blood pressure reduced by 3.49 mmHg and diastolic by 1.96 mmHg
• 24% reduction in stroke risk with higher potassium intake
• Reduced risk of coronary heart disease and total cardiovascular disease
• Benefits observed across different populations and age groups
• Optimal intake appears to be 3500-4700 mg potassium daily
• Potassium citrate form well-absorbed and effective
• Particularly beneficial for older adults at higher cardiovascular risk
• Mechanism involves improved endothelial function and reduced arterial stiffness
• Safety excellent when kidney function normal

Study 4: Potassium and metabolic health

Citation: Stone MS, Martyn L, Weaver CM. Potassium Intake, Bioavailability, Hypertension, and Glucose Control. Nutrients. 2016 Jul 22;8(7):444. doi: 10.3390/nu8070444. PMID: 27455317. https://pubmed.ncbi.nlm.nih.gov/27455317/

Study Type: Review

Summary: This comprehensive review examined the relationship between potassium intake, bioavailability, and various health outcomes including hypertension and glucose control. The review analyzed evidence for potassium's role in metabolic health.

Key Findings:

• Adequate potassium intake essential for glucose control and insulin sensitivity
• Potassium deficiency associated with increased diabetes risk
• Improved insulin sensitivity observed with potassium supplementation
• Enhanced glucose tolerance in both healthy and diabetic individuals
• Potassium citrate shows superior bioavailability compared to other forms
• Helps counteract sodium's negative effects on blood pressure and metabolism
• Important for maintaining electrolyte balance during aging
• Supports healthy kidney function and reduces proteinuria
• Optimal intake often not achieved through diet alone, especially in older adults
• Supplementation may be necessary to achieve health benefits

Health Benefits for Aging

Creatine monohydrate supports healthy aging by maintaining muscle mass and strength, supporting brain function, and potentially improving cognitive performance, especially in older adults. It helps preserve physical function and may support neurological health during aging.

Studies Analyzed:

Study 1: Effects of Creatine Monohydrate on Endurance Performance in a Trained Population: A Systematic Review and Meta-analysis

Citation: Fernández-Landa J, Santibañez-Gutierrez A, Todorovic N, Stajer V, Ostojic SM. Effects of Creatine Monohydrate on Endurance Performance in a Trained Population: A Systematic Review and Meta-analysis. Sports Med. 2023 May;53(5):1017-1027. doi: 10.1007/s40279-023-01823-2. PMID: 36877404. https://pubmed.ncbi.nlm.nih.gov/36877404/

Study Type: Systematic Review and Meta-analysis

Summary: This systematic review and meta-analysis evaluated the effects of creatine monohydrate supplementation on endurance performance in a trained population. The search strategy followed PRISMA guidelines, exploring PubMed/MEDLINE, Web of Science, and Scopus databases. Only human experimental trials with a placebo group were included. Methodological quality was assessed using the PEDro scale. A total of 13 studies were included.

Key Findings:

• Creatine monohydrate supplementation was shown to be ineffective on endurance performance in a trained population
• Meta-analysis pooled data from studies evaluating supplementation effects
• Results suggest creatine's primary benefits are for high-intensity, short-duration activities rather than endurance
• Trained athletes may have different responses compared to untrained individuals
• Study quality varied, with most studies showing moderate methodological quality
• Loading protocols typically involved 20g/day for 5-7 days followed by maintenance doses
• Individual variation in response to creatine supplementation was noted
• Future research should focus on specific populations and exercise modalities

Study 2: Effects of Creatine Supplementation on Brain Function and Health

Citation: Forbes SC, Cordingley DM, Cornish SM, Gualano B, Roschel H, Ostojic SM, Rawson ES, Roy BD, Prokopidis K, Giannos P, Candow DG. Effects of Creatine Supplementation on Brain Function and Health. Nutrients. 2022 Feb 22;14(5):921. doi: 10.3390/nu14050921. PMID: 35267907. https://pubmed.ncbi.nlm.nih.gov/35267907/

Study Type: Narrative Review

Summary: This narrative review summarizes existing research on creatine supplementation's effects on brain function and health. It discusses creatine's ability to increase brain creatine content in humans and its potential for attenuating symptoms of concussion, mild traumatic brain injury, and depression. The review also explores creatine's impact on cognition (especially regarding sleep deprivation), its effects on neurological and mental health conditions, and its neuroprotective role following traumatic brain injury or concussion.

Key Findings:

• Preliminary studies indicate that creatine supplementation (and guanidinoacetic acid; GAA) can increase brain creatine content in humans
• Creatine has shown some promise for attenuating symptoms of concussion, mild traumatic brain injury and depression
• Its effect on neurodegenerative diseases appears to be lacking
• The review summarizes research on creatine supplementation on total creatine and phosphocreatine (PCr) content
• GAA as an alternative or adjunct to creatine supplementation on brain creatine uptake
• Impact of creatine on cognition with a focus on sleep deprivation
• Effects on various neurological and mental health conditions
• Recent advances on creatine supplementation as a neuroprotective supplement following traumatic brain injury or concussion
• Brain creatine levels can be increased through supplementation, particularly in individuals with lower baseline levels

Study 3: Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials

Citation: Prokopidis K, Giannos P, Triantafyllidis KK, Kechagias KS, Forbes SC, Candow DG. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023 Apr 10;81(4):416-427. doi: 10.1093/nutrit/nuac064. PMID: 35984306. https://pubmed.ncbi.nlm.nih.gov/35984306/

Study Type: Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Summary: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to determine the effects of creatine supplementation on memory performance in healthy humans. The literature was searched through the PubMed, Web of Science, Cochrane Library, and Scopus databases from inception until September 2021. Ten RCTs examining the effect of creatine supplementation compared with placebo on measures of memory in healthy individuals met the inclusion criteria for systematic review, 8 of which were included in the meta-analysis.

Key Findings:

• Creatine supplementation enhanced measures of memory performance in healthy individuals, especially in older adults (66-76 years)
• Creatine dose ranged from approximately 2.2-20 g/day
• Duration of intervention ranged from 5 days to 24 weeks
• Older adults showed greater memory improvements compared to younger individuals
• Effects were most pronounced in tasks requiring rapid processing and working memory
• Benefits observed across different memory domains including short-term and working memory
• Vegetarians may show greater response due to lower baseline creatine levels
• Safety profile excellent with minimal adverse effects reported
• Optimal dosing and duration still require further investigation

Study 4: The Effects of Creatine Monohydrate Loading on Exercise Recovery in Active Women throughout the Menstrual Cycle

Citation: Gordon AN, Moore SR, Patterson ND, Hostetter ME, Cabre HE, Hirsch KR, Hackney AC, Smith-Ryan AE. The Effects of Creatine Monohydrate Loading on Exercise Recovery in Active Women throughout the Menstrual Cycle. Nutrients. 2023 Aug 13;15(16):3567. doi: 10.3390/nu15163567. PMID: 37630756.  https://pubmed.ncbi.nlm.nih.gov/37630756/

Study Type: Randomized Controlled Trial, Cross-Over Study

Summary: This randomized, double-blind, cross-over study evaluated the effect of creatine monohydrate loading on exercise recovery in 39 active women (mean age: 24.6 ± 5.9 years) across their menstrual cycle. Participants were randomized to a creatine monohydrate group (n = 19) or a non-caloric placebo group (n = 20). Heart rate variability (HRV) and repeated sprint performance were measured before and after supplementation in both follicular/low hormone and luteal/high hormone phases.

Key Findings:

• Creatine monohydrate could help counteract performance decrements caused by the high hormone phase in active women
• 20 g per day in 4 × 5 g doses used for loading protocol
• Heart rate variability improvements observed with creatine supplementation
• Repeated sprint performance better maintained during luteal phase with creatine
• Hormonal fluctuations throughout menstrual cycle affect exercise performance and recovery
• Creatine supplementation may be particularly beneficial for women during certain phases of menstrual cycle
• Study highlights importance of considering sex-specific responses to supplementation
• Recovery metrics improved more consistently with creatine compared to placebo
• Results suggest creatine may help maintain training quality throughout menstrual cycle

Health Benefits for Aging

L-leucine supports healthy aging by promoting muscle protein synthesis, maintaining muscle mass, and supporting metabolic health. It's particularly important for preventing age-related muscle loss (sarcopenia) and maintaining physical function during aging.

Studies Analyzed:

Study 1: Leucine supplementation and intensive training

Citation: Jackman SR, Witard OC, Philp A, Wallis GA, Baar K, Tipton KD. Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans. Front Physiol. 2017 Jun 7;8:390. doi: 10.3389/fphys.2017.00390. PMID: 28638350. https://pubmed.ncbi.nlm.nih.gov/28638350/

Study Type: Clinical Study

Summary: This study investigated the effects of branched-chain amino acid (BCAA) ingestion, with emphasis on leucine, on muscle protein synthesis following resistance exercise in humans. The research examined the anabolic response to BCAA supplementation in the context of exercise training.

Key Findings:

• BCAA ingestion, particularly leucine, stimulates muscle myofibrillar protein synthesis
• Enhanced protein synthesis response following resistance exercise
• Leucine acts as a key trigger for muscle protein synthesis pathways
• mTOR pathway activation observed with leucine supplementation
• Optimal timing of supplementation important for maximizing benefits
• Dose-response relationship exists for leucine and protein synthesis
• Effects most pronounced when combined with resistance training
• Study supports leucine's role in muscle maintenance and growth
• Particularly relevant for aging populations at risk for muscle loss

Study 2: Leucine-enriched essential amino acid supplementation during moderate steady state exercise enhances postexercise muscle protein synthesis

Citation: Pasiakos SM, McClung HL, McClung JP, Margolis LM, Andersen NE, Cloutier GJ, Pikosky MA, Rood JC, Fielding RA, Young AJ. Leucine-enriched essential amino acid supplementation during moderate steady state exercise enhances postexercise muscle protein synthesis. Am J Clin Nutr. 2011 Sep;94(3):809-18. doi: 10.3945/ajcn.111.017061. PMID: 21775557. https://pubmed.ncbi.nlm.nih.gov/21775557/

Study Type: Randomized controlled trial

Summary: This randomized controlled trial examined the effects of leucine-enriched essential amino acid supplementation during moderate steady-state exercise on postexercise muscle protein synthesis in healthy adults.

Key Findings:

• Leucine-enriched essential amino acid supplementation enhanced postexercise muscle protein synthesis
• Effects observed during moderate steady-state exercise conditions
• Supplementation timing during exercise was effective
• Enhanced recovery and adaptation to exercise training
• Leucine content critical for maximizing protein synthesis response
• Study demonstrates practical application for exercise nutrition
• Benefits observed in healthy adult population
• Results support leucine's role in exercise recovery and adaptation
• Implications for maintaining muscle mass during aging

Study 3: The role of leucine in weight loss diets and glucose homeostasis

Citation: Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006 Jan;136(1 Suppl):319S-23S. doi: 10.1093/jn/136.1.319S. PMID: 16365106. https://pubmed.ncbi.nlm.nih.gov/16365106/

Study Type: Review

Summary: This review examines the potential importance of leucine in the treatment of obesity and metabolic syndrome. It discusses leucine's role in weight management, glucose homeostasis, and metabolic health.

Key Findings:

• Leucine plays important role in weight loss diets and glucose homeostasis
• Helps preserve lean muscle mass during caloric restriction
• Supports metabolic rate maintenance during weight loss
• Improves insulin sensitivity and glucose metabolism
• May help prevent age-related metabolic decline
• Particularly important during periods of caloric restriction
• Supports healthy body composition changes
• Evidence suggests benefits for metabolic syndrome management
• Role in maintaining muscle mass critical for healthy aging
• May help prevent sarcopenic obesity in older adults

Study 4: Leucine and aging muscle

Citation: Dardevet D, Rémond D, Peyron MA, Papet I, Savary-Auzeloux I, Mosoni L. Muscle wasting and resistance of muscle anabolism: the "anabolic threshold concept" for adapted nutritional strategies during sarcopenia. ScientificWorldJournal. 2012;2012:269531. doi: 10.1100/2012/269531. PMID: 23326214. https://pubmed.ncbi.nlm.nih.gov/23326214/

Study Type: Review

Summary: This review discusses the concept of "anabolic threshold" and how leucine supplementation can help overcome anabolic resistance in aging muscle. It examines nutritional strategies for preventing and treating sarcopenia.

Key Findings:

• Aging muscle develops "anabolic resistance" requiring higher protein/leucine intake
• Leucine supplementation can help overcome this anabolic threshold
• Higher leucine doses needed in older adults compared to young adults
• Timing of leucine intake important for maximizing anabolic response
• Combination with resistance exercise enhances effectiveness
• Nutritional strategies must be adapted for aging populations
• Leucine acts as a key regulator of muscle protein synthesis
• Supplementation may help prevent and treat sarcopenia
• Evidence supports leucine's role in healthy aging and muscle maintenance
• Practical implications for dietary recommendations in older adults

Health Benefits for Aging

Glycine supports healthy aging by improving metabolic function, reducing inflammation, and supporting collagen synthesis for skin and joint health. It may help maintain muscle mass and improve sleep quality, both crucial for healthy aging.

Studies Analyzed:

Study 1: Neuroprotective effects of glycine for therapy of acute ischaemic stroke

Citation: Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS, Yakovleva EV. Neuroprotective effects of glycine for therapy of acute ischaemic stroke. Cerebrovasc Dis. 2000 Jan-Feb;10(1):49-60. doi: 10.1159/000016025. PMID: 10629347. https://pubmed.ncbi.nlm.nih.gov/10629347/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This clinical trial assessed the safety and efficacy of glycine in 200 patients with acute ischemic stroke in the carotid artery territory. Patients were divided into four groups receiving placebo, 0.5g/day, 1.0g/day, or 2.0g/day of glycine for 5 days.

Key Findings:

• Glycine treatment was safe with only mild sedation observed in 4.5% of patients
• Doses of 1.0-2.0g/day showed tendency toward decreased 30-day mortality (5.9-10% vs 14% in placebo)
• Significant improvement in clinical outcomes on Orgogozo Stroke Scale and Scandinavian Stroke Scale (p < 0.01)
• Favorable functional outcomes on Barthel index (p < 0.01 for 1.0g/day vs placebo)
• Early normalization of autoantibody levels to NMDA-binding proteins (p < 0.01 vs placebo)
• Reduction of excitatory amino acids (glutamate, aspartate) and increase in inhibitory amino acids (GABA)
• Reduced lipid peroxidation products in cerebrospinal fluid (p < 0.05 vs placebo)

Study 2: Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults 

Improves Multiple Aging Hallmarks

Citation: Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, Minard CG, Taffet GE, Sekhar RV. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):75-89. doi: 10.1093/gerona/glac135. PMID: 35975308. https://pubmed.ncbi.nlm.nih.gov/35975308/

Study Type: Randomized, placebo-controlled clinical trial

Summary: This study examined whether GlyNAC (combination of glycine and N-acetylcysteine) supplementation could improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and aging hallmarks in older adults. Twenty-four older adults and 12 young adults were studied, with older adults randomized to receive either GlyNAC or placebo for 16 weeks.

Key Findings:

• Older adults had significant glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, endothelial dysfunction, insulin resistance, and multiple aging hallmarks compared to young adults
• GlyNAC supplementation for 16 weeks was safe and well-tolerated
• GlyNAC improved/corrected glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, endothelial dysfunction, insulin resistance, and multiple aging hallmarks
• Improvements included better physical function, muscle strength, gait speed, 6-minute walk test performance, body composition, and blood pressure
• The study demonstrates GlyNAC as an effective nutritional supplement that improves and reverses multiple age-associated abnormalities to promote health in aging humans
• Clinical trial registration: NCT01870193

Study 3: Effects of glycine on metabolic syndrome components: a review

Citation: Review study (PMID: 35013990) from original file https://pubmed.ncbi.nlm.nih.gov/35013990/

Study Type: Review

Summary: This 2021 review explores how glycine—traditionally deemed "non-essential"—might actually be conditionally essential in humans, especially those with metabolic syndrome. It compiles evidence on glycine's impact across several metabolic markers.

Key Findings:

• Individuals with metabolic syndrome have significantly lower plasma glycine levels
• Interventions like lifestyle changes, weight loss, exercise, and certain medications that improve metabolic health also raise circulating glycine levels
• Glycine supplementation shows promise in improving insulin resistance, weight management, lipid profiles, and blood pressure
• The review suggests glycine supplementation may be clinically beneficial for treating metabolic syndrome

Health Benefits for Aging

Taurine supports healthy aging by protecting against cellular senescence, maintaining mitochondrial function, reducing DNA damage, and suppressing inflammaging. Taurine levels naturally decline with age, and supplementation may help extend both health span and lifespan.

Studies Analyzed:

Study 1: Taurine deficiency as a driver of aging

Citation: Singh P, Gollapalli K, Mangiola S, Schranner D, Yusuf MA, Chamoli M, Shi SL, Bastos BL, Nair T, Riermeier A, Vayndorf EM, Wu JZ, Nilakhe A, Nguyen CQ, Muir M, Kiflezghi MG, Foulger A, Junker A, Devine J, Sharan K, Chinta SJ, Rajput S, Rane A, Baumert P, Schönfelder M, Iavarone F, di Lorenzo G, Kumari S, Gupta A, Sarkar R, Khyriem C, Chawla AS, Sharma A, et al. Taurine deficiency as a driver of aging. Science. 2023 Jun 9;380(6649):eabn9257. doi: 10.1126/science.abn9257. PMID: 37289866. https://pubmed.ncbi.nlm.nih.gov/37289866/

Study Type: Comprehensive experimental study across multiple species

Summary: This landmark study investigated taurine's role in aging across mice, monkeys, and humans. Researchers found that circulating taurine concentrations decline with aging in all three species and tested whether reversing this decline through supplementation could impact health span and lifespan.

Key Findings:

• Universal age-related decline: Circulating taurine concentrations decline with aging in mice, monkeys, and humans
• Health span extension: Taurine supplementation increased health span (period of healthy living) in mice and monkeys
• Lifespan extension: Taurine supplementation increased lifespan in mice
• Cellular senescence reduction: Taurine reduced cellular senescence, a key hallmark of aging
• Telomerase protection: Taurine protected against telomerase deficiency
• Mitochondrial function: Taurine suppressed mitochondrial dysfunction associated with aging
• DNA damage reduction: Taurine decreased DNA damage accumulation
• Inflammaging attenuation: Taurine attenuated inflammaging (chronic low-grade inflammation with aging)
• Disease correlation: In humans, lower taurine concentrations correlated with several age-related diseases
• Exercise response: Taurine concentrations increased after acute endurance exercise in humans
• Cross-species validation: Benefits observed across worms, rodents, and primates
• Clinical trial potential: Results suggest clinical trials in humans are warranted to test whether taurine deficiency drives aging
• Mechanistic insights: Taurine acts through multiple pathways to combat aging hallmarks

Study 2: Does taurine prolong lifespan by improving heart function?

Citation: Schaffer SW, Ramila KC, Jong CJ, Shetewy A, Shimada K, Ito T, Azuma J, Cioffi E. Does taurine prolong lifespan by improving heart function? Adv Exp Med Biol. 2015;803:555-70. doi: 10.1007/978-3-319-15126-7_45. PMID: 25833527. https://pubmed.ncbi.nlm.nih.gov/25833527/

Study Type: Review

Summary: This comprehensive review examined the relationship between taurine and cardiovascular health in the context of aging and longevity. The authors investigated whether taurine's life-extending effects are mediated through improvements in heart function, analyzing the mechanisms by which taurine supports cardiac health throughout the aging process.

Key Findings:

• Cardiovascular aging protection: Taurine may prolong lifespan through specific improvements in heart function
• Calcium signaling regulation: Taurine affects calcium signaling pathways crucial for cardiac function
• Cardiomyopathy prevention: Taurine deficiency linked to cardiomyopathies and metabolic dysfunction
• Post-translational protein processing: Taurine influences protein processing and phosphorylation in cardiac tissue
• Cardiac aging mechanisms: Review explores how taurine addresses age-related cardiac dysfunction
• Longevity pathway: Heart function improvement represents a key mechanism for taurine's longevity effects
• Metabolic support: Taurine supports cardiac metabolism and energy production
• Protective effects: Taurine provides protective action against various cardiovascular stressors
• Age-related decline: Cardiac taurine levels decline with aging, contributing to heart dysfunction
• Therapeutic potential: Taurine supplementation may represent a therapeutic approach for cardiac aging
• Mechanistic insights: Multiple pathways through which taurine supports cardiovascular health and longevity
• Clinical relevance: Findings suggest taurine's importance for maintaining cardiac health throughout aging

Study 3: Effects of chronic taurine administration on gene expression, protein translation and phosphorylation in the rat hippocampus

Citation: Toyoda A, Koike H, Nishihata K, Iio W, Goto T. Effects of chronic taurine administration on gene expression, protein translation and phosphorylation in the rat hippocampus. Adv Exp Med Biol. 2015;803:473-80. doi: 10.1007/978-3-319-15126-7_37. PMID: 25833519. https://pubmed.ncbi.nlm.nih.gov/25833519/

Study Type: Experimental research study

Summary: This study investigated the molecular effects of chronic taurine administration on the hippocampus, a brain region crucial for memory and cognitive function. Researchers examined how long-term taurine supplementation affects gene expression, protein synthesis, and phosphorylation patterns in hippocampal tissue.

Key Findings:

• Gene expression modulation: Chronic taurine administration significantly affects gene expression patterns in the hippocampus
• Protein synthesis regulation: Taurine influences protein translation processes in hippocampal neurons
• Phosphorylation changes: Taurine administration alters phosphorylation patterns of nerve tissue proteins
• Hippocampal protection: Taurine provides protective effects on hippocampal metabolism and function
• Molecular mechanisms: Study reveals specific molecular pathways through which taurine supports brain health
• Chronic administration benefits: Long-term taurine supplementation produces sustained molecular changes
• Nerve tissue protein effects: Taurine specifically affects nerve tissue proteins crucial for brain function
• Post-translational modifications: Taurine influences protein processing and post-translational modifications
• Cognitive support: Hippocampal changes suggest taurine's role in supporting cognitive function during aging
• Neuroprotective mechanisms: Molecular changes indicate taurine's neuroprotective properties
• Brain aging support: Findings suggest taurine may help maintain brain function throughout aging
• Therapeutic potential: Results support taurine's potential as a cognitive health supplement

Health Benefits for Aging

L-Valine supports healthy aging by promoting muscle protein synthesis, maintaining muscle mass, and supporting metabolic health. As a branched-chain amino acid, it plays crucial roles in energy metabolism and may help prevent age-related muscle loss and metabolic dysfunction.

Studies Analyzed:

Study 1: Branched chain amino acids, aging and age-related health

Citation: Le Couteur DG, Solon-Biet SM, Cogger VC, Ribeiro R, de Cabo R, Raubenheimer D, Cooney GJ, Simpson SJ. Branched chain amino acids, aging and age-related health. Ageing Res Rev. 2020 Dec;64:101198. doi: 10.1016/j.arr.2020.101198. PMID: 33132154. https://pubmed.ncbi.nlm.nih.gov/33132154/

Study Type: Comprehensive review

Summary: This comprehensive review examined the physiological roles of branched-chain amino acids (BCAA: leucine, valine, isoleucine) in aging and age-related health outcomes. The review analyzed the complex relationships between BCAA levels, dietary manipulation, and various aging phenotypes including body composition, sarcopenia, obesity, and metabolic health.

Key Findings:

• Key physiological roles: BCAAs have essential roles in protein synthesis regulation, metabolism, food intake, and aging processes
• Complex relationships: Studies show apparently inconsistent conclusions about BCAA relationships with age-related changes, which can be resolved by understanding BCAAs as signaling molecules
• Bidirectional mechanisms: BCAAs have bidirectional mechanistic relationships with aging phenotypes
• Body composition effects: BCAAs influence age-related changes in body composition and muscle mass
• Sarcopenia prevention: BCAAs play important roles in preventing age-related muscle loss (sarcopenia)
• Metabolic health: BCAAs affect insulin and glucose metabolism in aging
• Nutritional context matters: Effects of BCAAs are influenced by background nutritional composition, macronutrient ratios, and amino acid balance
• Dietary manipulation opportunities: Understanding BCAA interactions with other dietary components provides opportunities for influencing age-related outcomes

Signaling molecule function: BCAAs function as important signaling molecules beyond their role as protein building blocks

• Aging biology impact: BCAAs directly influence aging biology itself, not just age-related symptoms

Therapeutic potential: Manipulation of dietary BCAAs together with macronutrient ratios and other amino acids may improve aging outcomes

• Clinical implications: Findings support targeted BCAA supplementation strategies for healthy aging

Study 2: Valine improves mitochondrial function and protects against oxidative stress

Citation: Sharma S, Zhang X, Azhar G, Patyal P, Verma A, KC G, Wei JY. Valine improves mitochondrial function and protects against oxidative stress. Biosci Biotechnol Biochem. 2023 Dec 13;88(2):168-176. doi: 10.1093/bbb/zbad169. PMID: 38093456. https://pubmed.ncbi.nlm.nih.gov/38093456/

Study Type: In vitro experimental study

Summary: This study investigated the effect of valine on mitochondrial function and oxidative stress in vitro. The research examined valine's role in mitochondrial biogenesis, dynamics, and protection against oxidative damage using C2C12 muscle cells and various mitochondrial function assays.

Key Findings:

• Mitochondrial function improvement: Valine increased expression of genes involved in mitochondrial biogenesis and dynamics
• Enhanced oxygen consumption: Valine treatment improved oxygen consumption rate (OCR) and overall ATP generation in mitochondria
• Transcriptional activation: Valine enhanced transcriptional activity of PGC-1α, PGC-1β, and other mitochondrial regulatory genes
• Oxidative stress protection: Valine significantly reduced ROS production and maintained OCR during H2O2-mediated oxidative stress
• Mitochondrial biogenesis: Study suggests mitochondrial biogenesis is improved with valine treatment
• Complex regulation: Valine upregulates mitochondrial function at electron transport complex levels (I, II, and IV)
• Energy metabolism: Increased total ATP production in C2C12 cells following valine treatment
• Protein synthesis support: Valine acts as necessary BCAA important for protein synthesis and skeletal muscle growth
• Lipid metabolism benefits: Valine plays favorable function in lipid metabolism
• Anti-inflammatory properties: Valine demonstrates anti-inflammatory properties
• Cellular protection: Findings demonstrate valine protects cells against oxidative damage
• Metabolic enhancement: Valine could act as anaplerotic metabolite driving tricarboxylic acid cycle
• Respiratory chain activity: Increased OCR reflects improved mitochondrial respiratory chain complex activity
• Glycolysis modulation: Reduced ECAR (extracellular acidification rate) due to enhanced fatty acid oxidation

Study 3: Prospective association between plasma amino acids and healthy aging in older adults

Citation: González-Beltrán D, Yévenes-Briones H, Lana A, Cárdenas-Valladolid J, Salinero-Fort MÁ, Rodríguez-Artalejo F, Lopez-Garcia E, Caballero FF. Prospective association between plasma amino acids and healthy aging in older adults. J Intern Med. 2025 Jun 12;298(2):123-134. doi: 10.1111/joim.20105. PMID: 40501124. https://pubmed.ncbi.nlm.nih.gov/40501124/

Study Type: Longitudinal cohort study

Summary: This longitudinal study examined the relationship between plasma concentrations of nine amino acids and healthy aging in 859 community-dwelling Spanish adults aged 65 and older from the Seniors-ENRICA 2 cohort. Participants were followed for 5 years, with healthy aging defined as delay in onset of chronic conditions, optimal physical functioning, and no cognitive impairment.

Key Findings:

• Study population: 859 participants with baseline mean age of 70.9 years (SD = 4.0), 51.6% men
• Longitudinal design: 5-year follow-up period measuring plasma amino acid concentrations at baseline and follow-up
• Healthy aging definition: Delay in chronic disease onset, optimal physical functioning, and preserved cognitive function
• Valine association: Lower plasma valine concentrations prospectively associated with healthy aging [OR per 1-SD increase = 0.79 (95% CI: 0.71, 0.86), p < 0.001]
• BCAA pattern: Lower concentrations of all branched-chain amino acids (valine, leucine, isoleucine) associated with healthy aging
• Alanine association: Lower plasma alanine also associated with healthy aging [OR = 0.78 (95% CI: 0.72, 0.86)]
• Non-significant amino acids: No significant associations found for glutamine, glycine, histidine, and aromatic amino acids
• Robust methodology: Multilevel mixed effect logistic models adjusted for age, sex, socioeconomic status, and lifestyle behaviors
• Community-dwelling population: Study focused on independently living older adults
• Prospective design: First study to assess relationship between specific amino acids and healthy aging prospectively
• Clinical implications: Lower BCAA levels may be biomarkers of successful aging rather than deficiency
• Metabolic insights: Findings suggest complex relationship between amino acid metabolism and aging processes
• Population health relevance: Results applicable to older adult populations for healthy aging strategies

Health Benefits for Aging

L-Lysine supports healthy aging by promoting protein synthesis, maintaining muscle mass and strength, and supporting immune function. It plays important roles in collagen formation, calcium absorption, and may help prevent age-related muscle loss and functional decline.

Studies Analyzed:

Study 1: Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women

Citation: Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S. Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition. 2004 May;20(5):445-51. doi: 10.1016/j.nut.2004.01.009. PMID: 15105032. https://pubmed.ncbi.nlm.nih.gov/15105032/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This double-blind study conducted at two separate sites examined whether a combination of nutrients (HMB, arginine, and lysine) could prevent age-related muscle loss and improve strength and functionality in elderly women. 50 women (mean age 76.7 years) were randomized to placebo (n=23) or experimental treatment (2g HMB, 5g arginine, 1.5g lysine daily; n=27) for 12 weeks.

Key Findings:

• Functional improvement: 17% improvement in "get-up-and-go" functionality test in experimental group (-2.3 ± 0.5 s) vs no change in placebo (0.0 ± 0.5 s; P = 0.002)
• Strength gains: Increased limb circumference, leg strength, and handgrip strength (all P < 0.05)
• Body composition: Positive trends in fat-free mass (P = 0.08)
• Protein synthesis: Whole-body protein synthesis increased approximately 20% in treatment group vs placebo (P = 0.03)
• Study design: Double-blind, placebo-controlled design conducted at two separate sites
• Target population: Elderly women with mean age 76.7 years
• Duration: 12-week intervention period
• Measurement technique: Used 15N-glycine tracer technique over 24-hour free-living period
• Muscle health strategy: Targeted nutrition approach combining protein synthesis support (arginine, lysine) with protein breakdown inhibition (HMB)
• Clinical significance: Results suggest targeted nutrition can affect muscle health in elderly women
• Functional outcomes: Improvements in multiple measures of physical function and strength
• Metabolic benefits: Enhanced protein metabolism supporting muscle maintenance
• Age-related decline prevention: Strategy effectively blunted gradual muscle loss occurring with aging

Study 2: Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), 

L-arginine, and L-lysine

Citation: Baier S, Johannsen D, Abumrad N, Rathmacher JA, Nissen S, Flakoll P. Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine. JPEN J Parenter Enteral Nutr. 2009 Jan-Feb;33(1):71-82. doi: 10.1177/0148607108322403. PMID: 19164608. https://pubmed.ncbi.nlm.nih.gov/19164608/

Study Type: Randomized, double-blind, controlled trial

Summary: This year-long study examined whether daily supplementation with an amino acid cocktail could improve age-associated changes in protein turnover and lean body mass in elderly people. 77 elderly participants (76±1.6 years; 39 women, 38 men) were randomly assigned to either isonitrogenous control supplement (n=37) or HMB/Arg/Lys treatment (n=40) for one year.

Key Findings:

• Lean tissue preservation: In HMB/Arg/Lys group, lean tissue increased over the year while control group showed no change
• Body composition improvements: HMB/Arg/Lys increased body cell mass (BIA) by 1.6% (P=0.002) and lean mass (DXA) by 1.2% (P=0.05) compared to control
• Protein turnover enhancement: Rates of protein turnover significantly increased 8% and 12% in HMB/Arg/Lys group at 3 and 12 months respectively
• Control group decline: Protein turnover decreased 11% and 9% in control group at 3 and 12 months (P<0.01)
• Long-term study design: One-year duration providing robust evidence for sustained benefits
• Dual measurement methods: Used both bioelectrical-impedance analysis (BIA) and dual energy x-ray absorptiometry (DXA)
• Protein metabolism assessment: Used primed/intermittent oral doses of 15N-glycine to estimate whole-body protein turnover
• Age-related muscle loss prevention: Addressed major contributing factor to mobility loss in elderly
• Both sexes included: Study included both elderly men and women
• Double-blind design: Rigorous methodology with isonitrogenous control
• Clinical significance: Simple amino acid cocktail effectively increased protein turnover and lean tissue
• Sustained benefits: Effects maintained throughout entire year-long study period
• Metabolic enhancement: Demonstrated improved protein metabolism in aging population

Study 3: Oral Treatment with L-lysine and L-arginine Reduces Anxiety and Basal Cortisol Levels in Healthy Humans

Citation: Smriga M, Ando T, Akutsu M, Furukawa Y, Miwa K, Morinaga Y. Biomed Res. 2007 Apr;28(2):85–90. doi: 10.2220/biomedres.28.85. PMID: 17510493. https://pubmed.ncbi.nlm.nih.gov/17510493/sciencedirect.com+4pubmed.ncbi.nlm.nih.gov+4pubmed.ncbi.nlm.nih.gov+4

Study Type: Double-blind, randomized, placebo-controlled trial in healthy adults

Summary: This RCT investigated whether one week of oral supplementation with L-lysine (2.64 g/day) plus L-arginine (2.64 g/day) could reduce anxiety (trait and stress-induced state anxiety) and stress hormone levels in healthy individuals with high trait anxiety.

Key Findings:

• Significantly reduced trait anxiety compared to placebo
• Attenuated state anxiety induced by cognitive stress tasks
• Lowered basal salivary cortisol levels in male subjects, indicating reduced stress response
• Also decreased salivary chromogranin-A, a sympathetic nervous system marker, in males
• Suggests that L-lysine (in combination with L-arginine) supports reduction of chronic anxiety and stress-related hormonal responses in otherwise healthy adults

Health Benefits for Aging

L-Isoleucine supports healthy aging by promoting muscle protein synthesis, maintaining muscle mass, and supporting energy metabolism. As a branched-chain amino acid, it plays important roles in muscle recovery, glucose regulation, and may help prevent age-related muscle loss and metabolic dysfunction.

Studies Analyzed:

Study 1: The Impact of a Large Bolus Dose of L-leucine and L-isoleucine on Enteroendocrine and Pancreatic Hormones, and Glycemia in Healthy, Inactive Adults

Citation: Newmire DE, Rivas E, Deemer SE, Willoughby DS, Ben-Ezra V. Nutrients. 2019 Nov 4;11(11):2650. doi: 10.3390/nu11112650. PMID: 31689951. https://pubmed.ncbi.nlm.nih.gov/31689951/ Nature+12PubMed+12twu-ir.tdl.org+12

Study Type: Randomized, crossover trial in healthy adults

Summary: This study examined how a single bolus dose of L-isoleucine (and L-leucine) taken 30 minutes before an oral glucose load affects gut hormones (GLP-1, GIP), insulin, and blood glucose response in healthy, inactive adults.

Key Findings:

• Lisoleucine significantly increased GIP (glucose-dependent insulinotropic peptide) concentrations compared to both leucine and placebo (p = 0.03) PMC+3PubMed+3ResearchGate+3
• There was no effect on GLP1, insulin, or glucose concentrations in response to the glucose challenge cambridge.org+14PubMed+14PMC+14
• Indicates that L-isoleucine can modulate intestinal incretin response (GIP) without altering glycemia or insulin, suggesting specific hormone-level effects independent of immediate glucose regulation
• Demonstrates a subtle yet notable physiological effect of L-isoleucine on endocrine signaling in humans

Study 2: Deficiency in the Essential Amino Acids l-Isoleucine, l-Leucine and l-Histidine and Clinical Measures as Predictors of Moderate Depression in Elderly Women: A Discriminant Analysis Study

Citation: Solís-Ortiz S, Arriaga-Avila V, Trejo-Bahena A, Guevara-Guzmán R. Deficiency in the Essential Amino Acids l-Isoleucine, l-Leucine and l-Histidine and Clinical Measures as Predictors of Moderate Depression in Elderly Women: A Discriminant Analysis Study. Nutrients. 2021 Oct 29;13(11):3875. doi: 10.3390/nu13113875. PMID: 34836128. https://pubmed.ncbi.nlm.nih.gov/34836128/

Study Type: Cross-sectional discriminant analysis study

Summary: This study investigated the relationship between essential amino acid deficiencies and depressive symptoms in elderly women without major depression. The research compared 36 elderly women with moderate depressive symptoms to 71 with minimal depressive symptoms, analyzing plasma concentrations of 19 amino acids along with depression scales and cognitive measures.

Key Findings:

• Study population: 107 elderly women without major depression, severe mood disorders, or psychosis
• Group comparison: 36 women with moderate depressive symptoms vs 71 with minimal symptoms
• Amino acid deficiencies: Moderate depression group had significantly lower levels of l-histidine, l-isoleucine, and l-leucine
• Depression assessment: Used Beck Depression Inventory (BDI) and Geriatric Depression Scale (GDS) scores
• Cognitive measures: Included global cognitive scores in the analysis
• Discriminant analysis: Seven predictors identified as important for group classification
• Higher depression scores: Moderate depression group had higher BDI and GDS scores
• Cognitive differences: Moderate depression group showed higher cognitive scores (potentially compensatory)
• Comorbidity patterns: Moderate depression group had fewer comorbidities
• Metabolic implications: Deficient amino acids involved in metabolism, protein synthesis, inflammation, and neurotransmission
• Neurotransmitter connection: Findings suggest amino acid deficiencies may contribute to mood regulation beyond traditional neurotransmitter precursor deficits
• Clinical relevance: Results indicate potential for amino acid supplementation in managing mood symptoms in elderly women
• Branched-chain amino acids: Isoleucine and leucine deficiencies highlight importance of BCAA in mental health
• Aging-specific findings: Study focused on non-clinical elderly population, providing insights into subclinical depression

Study 3: Exercise, amino acids, and aging in the control of human muscle protein synthesis

Citation: Walker DK, Dickinson JM, Timmerman KL, Drummond MJ, Reidy PT, Fry CS, Gundermann DM, Rasmussen BB. Exercise, amino acids, and aging in the control of human muscle protein synthesis. Med Sci Sports Exerc. 2011 Dec;43(12):2249-58. doi: 10.1249/MSS.0b013e318223b037. PMID: 21606874. https://pubmed.ncbi.nlm.nih.gov/21606874/

Study Type: Review of human skeletal muscle protein metabolism research

Summary: This comprehensive review discusses recent research characterizing the acute regulation of mammalian target of rapamycin complex (mTORC) 1 signaling and muscle protein synthesis (MPS) by exercise, amino acid nutrition, and aging. The review focuses on how essential amino acids, including isoleucine, interact with exercise and aging to control muscle protein synthesis.

Key Findings:

• Exercise response: Resistance exercise in fasted state stimulates mixed MPS within 1 hour, remaining elevated for 48 hours
• mTORC1 requirement: Activation of mTORC1 signaling and enhanced translation initiation required for contraction-induced MPS increase
• Blood flow restriction: Low-intensity BFR exercise stimulates MPS and mTORC1 signaling similar to high-intensity resistance exercise
• Essential amino acid response: mTORC1 signaling required for EAA-induced increase in MPS
• Synergistic effects: EAA ingestion shortly after resistance exercise enhances MPS and mTORC1 signaling vs exercise or EAAs alone
• Age-related impairment: Older adults show impaired skeletal muscle response to anabolic stimuli
• Reduced exercise response: Older adults less able to activate mTORC1 or increase MPS during first 24h post-exercise recovery
• BFR overcomes aging: Blood flow restriction exercise can overcome age-related impairments
• Sufficient EAA response: Aging not associated with reduced EAA response when content is sufficient
• Clinical applications: Exercise combined with EAA effective for muscle repair/growth in athletes
• Sarcopenia countermeasure: EAA combined with resistance exercise useful for sarcopenia and muscle wasting conditions
• Translation initiation: Enhanced translation initiation critical for muscle protein synthesis
• Therapeutic potential: Strategies combining exercise and amino acids show promise for age-related muscle loss

Health Benefits for Aging

L-Phenylalanine supports healthy aging by serving as a precursor to important neurotransmitters like dopamine and norepinephrine, supporting cognitive function and mood regulation. It plays important roles in protein synthesis, maintaining muscle mass, and supporting neurological health during aging.

Studies Analyzed:

Study 1: The Phenylalanine Requirement of Elderly Men and Women Measured by 

Direct 13C Carbon Oxidation Method Is Similar to That of Young Adults

Citation: Martin KE, Pencharz PB, Rafii M, Ball RO, Szwiega S, Elango R, Courtney-Martin G. The Phenylalanine Requirement of Elderly Men and Women Measured by Direct 13C Carbon Oxidation Method Is Similar to That of Young Adults. J Nutr. 2019 Jul 4;149(10):1776-1784. doi: 10.1093/jn/nxz137. PMID: 31271193. https://pubmed.ncbi.nlm.nih.gov/31271193/

Study Type: Controlled metabolic study using direct amino acid oxidation method

Summary: This study determined the dietary phenylalanine requirement of adults aged >65 years using the direct amino acid oxidation method. Twelve subjects (6 men, 6 women) aged 73.8 ± 6.7 years were studied to measure the oxidation of l-[1-13C]phenylalanine to 13CO2 in response to graded phenylalanine intakes in the presence of excess tyrosine.

Key Findings:

• Study population: 12 elderly subjects (6 men, 6 women) aged 73.8 ± 6.7 years
• BMI characteristics: Men 26.4 ± 4.8 kg/m², women 25.2 ± 4.4 kg/m²
• Phenylalanine intake range: 7.20 to 40.0 mg·kg⁻¹·d⁻¹ for total of 66 studies
• Isocaloric diet: Study diets were isocaloric and isonitrogenous

Protein provision: 1.0 g·kg⁻¹·d⁻¹ and energy at 1.5 × resting energy expenditure (REE)

• Amino acid balance: Excess tyrosine and alanine provided to balance nitrogen
• Adaptation period: Two days prior adaptation to milkshake diet providing protein at 1.0 g·kg⁻¹·d⁻¹
• Mean requirement: 9.03 mg·kg⁻¹·d⁻¹ phenylalanine requirement in elderly
• Upper 95% CI: 15.9 mg·kg⁻¹·d⁻¹ (approximating recommended dietary allowance)
• Comparison to young adults: Similar to previously derived estimates of 9.1 and 13.6 mg·kg⁻¹·d⁻¹ in young adults
• Muscle protein synthesis implications: Higher protein needs of elderly not driven by increased phenylalanine requirement
• Methodological rigor: Direct 13C carbon oxidation method provides precise measurement
• Clinical significance: Current recommendations based on young adults appear appropriate for elderly
• Protein metabolism insight: Suggests other factors drive higher protein needs in aging
• Nutritional guidance: Supports evidence-based dietary recommendations for elderly populations

Study 2: Intake of seven essential amino acids improves cognitive function and psychological and social function in middle-aged and older adults: a double-blind, randomized, placebo-controlled trial

Citation: Koga M, Yagi D, Chiba D, Inagaki A, Inoue M, Tsukamoto-Yasui M, Takado M, Sato H, Fujiwara Y. Intake of seven essential amino acids improves cognitive function and psychological and social function in middle-aged and older adults: a double-blind, randomized, placebo-controlled trial. Front Nutr. 2020 Nov 26;7:586166. doi: 10.3389/fnut.2020.586166. PMID: 7724102. https://pmc.ncbi.nlm.nih.gov/articles/PMC7724102/

Study Type: Double-blind, randomized, placebo-controlled trial

Summary: This study examined the effects of seven essential amino acids (Amino LP7) including phenylalanine on cognitive function in 105 middle-aged and older adults (aged 55+) with subjective forgetfulness. Participants were randomized to receive placebo, 3g/day, or 6g/day of Amino LP7 for 12 weeks. The amino acid mixture contained leucine, phenylalanine, lysine, isoleucine, histidine, valine, and tryptophan in specific ratios.

Key Findings:

• The 6g/day group showed significant improvement in TMT-B (Trail Making Test Part B) performance by 14.6 seconds compared to placebo (p = 0.04)
• TMT-B measures attention, cognitive flexibility, and working memory - functions related to frontal lobe activity
• The 6g/day group also showed improvements in psychological health (WHO-5-J, p = 0.03), social engagement (JST-IC, p = 0.01), and social interaction (LSNS-6, p = 0.02)
• No significant effects were observed with the 3g/day dose
• Daily phenylalanine intake in the 6g group was 1.70g
• No safety concerns or adverse effects were reported
• The intervention specifically improved working memory and executive function without affecting processing speed
• Results suggest phenylalanine and other essential amino acids may have antidepressant-like effects and support frontal lobe function

Study 3: Effects of L-Phenylalanine on Gastroenteropancreatic Hormones, Glucose, Appetite, and Energy Intake in Healthy Adults

Citation: Amin A, Lind L, Wallenius V, Kullberg J, Bergström J, Pellegrini M, Marcus C, Blomqvist M. Diabetes Obes Metab. 2021 Jun;23(6):1596–1604. doi: 10.1111/dom.14300. PMID: 32991046. https://pubmed.ncbi.nlm.nih.gov/32991046/

Study Type: Randomized, double-blind, placebo-controlled crossover trial in healthy adults

Summary: This study assessed the acute effects of a single 10 g oral dose of L-phenylalanine (compared to D-phenylalanine and placebo) on key gastroenteropancreatic hormones (insulin, glucagon, GIP, PYY, GLP-1), blood glucose, subjective appetite, and energy intake in healthy participants.

Key Findings:

• Increased insulin and glucagon levels observed after Lphenylalanine ingestion—compared to both placebo and Dphenylalanine (p < 0.05)
• GIP (glucosedependent insulinotropic polypeptide) levels were elevated following Lphenylalanine versus placebo and Dphenylalanine (p = 0.0420 vs DPhe; p = 0.0249 vs placebo)
• Reduced postprandial glucose area under the curve (AUC₇₀–₁₅₀min) compared to placebo (p = 0.0317)
• No significant effects on subjective appetite or energy intake
• Demonstrates that Lphenylalanine modulates hormonal signaling to support glycemic control—without affecting hunger or energy consumption

Health Benefits for Aging

L-threonine supports healthy aging by promoting protein synthesis, maintaining immune function, and supporting collagen production. It plays important roles in wound healing, muscle maintenance, and overall protein metabolism in older adults.

Studies Analyzed:

Study 1: Effects of 12 Weeks of Essential Amino Acids Supplementation on Muscle Strength and Muscular Fatigue Risk in Elderly Individuals

Citation: Negro M, Parise G, Coratella G, et al. Effects of 12 Weeks of Essential Amino Acids (EAA)-Based Multi-Ingredient Nutritional Supplementation on Muscle Function and Neuromuscular Fatigue in Elderly Subjects. Eur J Sport Sci. 2019;19(10):1380–1390. doi: 10.1080/17461391.2019.1602081. PMID: 31021358. https://pubmed.ncbi.nlm.nih.gov/31021358/

Study Type: Randomized, double-blind, placebo-controlled trial in healthy elderly adults

Summary: Assessed the effects of a daily multi-ingredient supplement containing EAAs (with anabolic profiles) on muscle strength, muscle fatigue, and functional performance over a 12-week period.

Key Findings:

• Modest but significant improvements in muscle strength compared to placebo
• Reduced neuromuscular fatigue during performance tests
• Enhanced functional capacity in mobility-related tasks
• No adverse effects reported, suggesting safety and tolerability

Study 2: Association Between EAA and Muscle Strength in Older Adults

Citation: Identified via nutritional epidemiological data — Cheung SN, Wong CH, et al. Associations between Essential Amino Acid Intake and Muscle Strength in U.S. Adults Aged ≥65 Years: Cross-Sectional Analysis. Nutrients.2024;16(5):? (pre-publication details). https://pmc.ncbi.nlm.nih.gov/articles/PMC11325666/

Study Type: Cross-sectional observational study in community-dwelling older adults

Summary: Investigated usual dietary intake of EAAs and their relationship with muscle strength and physical function in older U.S. adults.

Key Findings:

• Higher habitual EAA intake was associated with increased muscle strength and better physical performance
• Suggestive evidence that adequate EAA consumption supports better musculoskeletal health in older adults
• Reinforces the importance of dietary EAAs in aging populations

Study 3: Effect of aerobic exercise training and essential amino acid supplementation for 24 weeks on physical function, body composition, and muscle metabolism in healthy, independent older adults: a randomized clinical trial

Citation: Markofski MM, Jennings K, Timmerman KL, Dickinson JM, Fry CS, Borack MS, Reidy PT, Deer RR, Randolph A, Rasmussen BB, Volpi E. Effect of Aerobic Exercise Training and Essential Amino Acid Supplementation for 24 Weeks on Physical Function, Body Composition, and Muscle Metabolism in Healthy, Independent Older Adults: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1598-1604. doi: 10.1093/gerona/gly109. PMID: 29750251. https://pubmed.ncbi.nlm.nih.gov/29750251/ PubMed

Study Type: Double-blind, randomized clinical trial (2×2 factorial: 15 g/day EAA vs placebo; aerobic exercise vs habitual activity; 24 weeks)

Summary: Evaluated chronic EAA supplementation with/without aerobic exercise on strength, function, body composition, and muscle protein synthesis in healthy, nonfrail older adults.

Key Findings:

• Aerobic exercise improved VO₂peak and walking speed regardless of supplement
• EAA + exercise uniquely increased muscle strength and amplified acute EAA-stimulated MPS post-intervention
• Lean mass did not change significantly across groups
• Demonstrates functional and metabolic benefits of pairing EAA with exercise in healthy older adults. 

Health Benefits for Aging

L-histidine supports healthy aging by playing crucial roles in protein synthesis, immune function, and antioxidant activity. It helps maintain muscle mass, supports wound healing, and may help prevent age-related muscle loss (sarcopenia).

Studies Analyzed:

Study 1: Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement

Citation: Holeček M. Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement. Nutrients. 2020 Mar 22;12(3):848. doi: 10.3390/nu12030848. PMID: 32235743. https://pubmed.ncbi.nlm.nih.gov/32235743/

Study Type: Comprehensive review

Summary: This comprehensive review examined L-histidine's unique roles in human health, including its functions in proton buffering, metal ion chelation, antioxidant activity, and various physiological processes. The review analyzed decades of research on histidine supplementation across multiple health conditions.

Key Findings:

• L-histidine has unique roles in proton buffering, metal ion chelation, and scavenging reactive oxygen/nitrogen species
• Essential for erythropoiesis and the histaminergic system
• Several histidine-rich proteins (hemoproteins, histidine-rich glycoproteins, histatins) have specific functions
• Histidine-containing dipeptides (particularly carnosine) provide additional benefits
• Decades of experience confirmed effectiveness as component of organ preservation solutions
• Effective for myocardial protection in cardiac surgery
• Potential benefits for neurological disorders, metabolic syndrome, diabetes, inflammatory conditions
• May improve muscle performance during strenuous exercise
• No signs of toxicity, mutagenic activity, or allergic reactions reported
• Contraindicated in liver disease due to hepatic enlargement and ammonia increases
• Decreases branched-chain amino acids in blood plasma
• Wide therapeutic potential based on unique chemical properties and physiological functions

Study 2: Aging-Related Sarcopenia: Metabolic Characteristics and Therapeutic Strategies

Citation: Chen Y, Wu J. Aging-Related Sarcopenia: Metabolic Characteristics and Therapeutic Strategies. Aging Dis. 2024 Apr 7;16(2):1003-1022. doi: 10.14336/AD.2024.0407. PMID: 38739945. https://pubmed.ncbi.nlm.nih.gov/38739945/

Study Type: Comprehensive review

Summary: This comprehensive review examined the metabolic characteristics of aging-related sarcopenia and potential therapeutic strategies. The study analyzed current clinical research on sarcopenia metabolomics and the underlying pathophysiological mechanisms affecting skeletal muscle aging.

Key Findings:

• Sarcopenia affects considerable portion of older adults, leading to frailty, fractures, hospitalization, and mortality
• Estimated cost of sarcopenia hospitalizations in US over age 40 is approximately $4.04 billion annually
• Muscle strength and mass peak in 20s-30s, then decline after age 50
• 25% reduction in muscle fiber number observed in older individuals
• Significant reduction in type II fast muscle fibers, particularly in peripheral muscle regions
• Aging muscles characterized by intermuscular adipose tissue infiltration and matrix deposition
• Motor unit reorganization with reduced neuronal innervation and neuromuscular junction changes
• Decreased physical activity triggers metabolic remodeling in skeletal muscles
• Aging leads to decline in absorption/utilization of carbohydrates, fats, and proteins
• Inflammatory milieu diminishes glucose uptake, exacerbating insulin resistance
• Impaired insulin signaling contributes to proteolysis and anabolic resistance
• Hyperglycemia impairs muscle integrity through advanced glycosylation end products (AGEs)
• Metabolomics identified valuable biomarkers for early sarcopenia diagnosis
• Skeletal muscle exhibits dynamic metabolic activities representing ~40% of total body mass

Study 3: Tolerance to Graded Dosages of Histidine Supplementation in Healthy Human Adults

Citation: Gheller ME, Vermeylen F, Handzlik MK, et al. Tolerance to graded dosages of histidine supplementation in healthy human adults. Am J Clin Nutr. 2020 Nov 11;112(5):1358–1367. doi: 10.1093/ajcn/nqaa210. PMID: 32766885

Study Type: Controlled clinical trial (graded dose supplementation in healthy adults)

Summary: This study assessed the safety and tolerability of escalating doses of L-histidine (4, 8, 12, and 16 g/day) over four weeks in healthy adult men and women, with a three-week recovery period.

Key Findings:

• No changes in vital signs or body composition occurred at any dosage
• Plasma histidine rose significantly at 12 g/day and 16 g/day (P < 0.05); blood urea nitrogen also increased with higher doses (P ≤ 0.013)
• At 12 g/day, ferritin levels decreased vs. 4 g/day (P = 0.038); at 16 g/day, AST increased and serum zinc decreased (P ≤ 0.011)
• All changes remained within normal clinical ranges; maximum safe dose (NOAEL) was determined to be 8 g/day based on these markers
• Establishes a safety threshold for Lhistidine supplementation in healthy populations

Health Benefits for Aging

This essential amino acid is important for building proteins, repairing tissues, and supporting liver function. It also plays a role in the growth of new blood vessels and may help with conditions like Parkinson's disease and allergies.

Study 1: The Minimum Methionine Requirement for Adults Aged ≥60 Years Is the Same in Males and Females 

Citation: Paoletti A, Pencharz PB, Ball RO, Kong D, Xu L, Elango R, Courtney-Martin G. The Minimum Methionine Requirement for Adults Aged ≥60 Years Is the Same in Males and Females. Nutrients. 2023 Sep 23;15(19):4112. doi: 10.3390/nu15194112. PMID: 37836396. https://pmc.ncbi.nlm.nih.gov/articles/PMC10574673/ 

Study Type: Controlled intervention study using indicator amino acid oxidation (IAAO) method 

Summary: This study aimed to determine the minimum methionine requirement in healthy older adults using the indicator amino acid oxidation (IAAO) method. The minimum methionine requirement in the presence of excess dietary cysteine had not been previously determined in older adults.

Key Findings: 

• 15 healthy adults ≥60 years of age studied 
• Seven methionine intakes tested (0 to 20 mg/kg/d) plus excess dietary cysteine (40 mg/kg/d) 
• Oxidation of indicator L-[1-13C] phenylalanine (F13CO2) used to estimate mean minimum methionine requirement 
• Change-point mixed-effect model used for analysis 
• No statistical difference between male and female requirement estimates 
• Mean minimum methionine requirement: 5.1 mg/kg/d (95% CI: 3.67, 6.53 mg/kg/d) 
• First study to estimate minimum methionine requirement in healthy older adults
• Requirement same between sexes and consistent with previous estimates in young adults 
• Findings relevant for current recommendations for increased plant food consumption 
• Results help establish appropriate balance of methionine and cysteine intake for sulphur amino acid requirements 
• Study provides evidence-based recommendations for methionine intake in aging population 
• Important for protein synthesis and metabolic health in older adults

Study 2: Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial 

Citation: Thompson MA, Bauer BA, Loehrer LL, Cha SS, Mandrekar JN, Sood A, Wahner-Roedler DL. Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial. J Altern Complement Med. 2009 May;15(5):523-9. doi: 10.1089/acm.2008.0402. PMID: 19422296. https://pubmed.ncbi.nlm.nih.gov/19422296/ 

Study Type: Double-blind, placebo-controlled, randomized clinical trial 

Summary: This study aimed to determine if exogenous S-adenosyl-L-methionine (AdoMet), a commonly used nutritional supplement, increases the level of plasma homocysteine (Hcy), a potential cardiovascular risk factor, in healthy human subjects. 

Key Findings: 

• 52 healthy human volunteers studied at Mayo Clinic, Rochester, Minnesota 
• Subjects received placebo or AdoMet (800 mg per day) for 4 weeks 
• Homocysteine levels measured before and after administration of AdoMet or placebo
• Primary outcome: change in homocysteine level; Secondary outcomes: interim Hcy determination (at 2 weeks) and changes in hsCRP, lipids, and alanine aminotransferase 
• No statistically significant change in homocysteine between groups 
• No statistically significant differences in change in Hcy or hsCRP levels at 2 or 4 weeks • Small but statistically significant increase (p < 0.04) in alanine aminotransferase at week 2 
• Statistically significant decrease (p < 0.04) in total cholesterol in AdoMet group compared with placebo 
• AdoMet at 800 mg daily for 4 weeks does not significantly affect homocysteine levels in blood 
• Study demonstrates safety profile of S-adenosyl-L-methionine supplementation 
• Results suggest AdoMet supplementation does not increase cardiovascular risk through homocysteine elevation

Study 3: S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis 

Citation: Guo T, Chang L, Xiao Y, Liu Q. S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis. PLoS One. 2015 Mar 16;10(3):e0122124. doi: 10.1371/journal.pone.0122124. PMID: 25781462. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122124 

Study Type: Systematic review and meta-analysis 

Summary: This systematic review and meta-analysis examined the effectiveness of S-adenosyl-L-methionine (SAMe) therapy in chronic liver disease. The researchers searched globally recognized electronic databases including PubMed, the Cochrane Database and EMBASE to retrieve relevant randomized controlled trials of chronic liver disease published over 20 years. 

Key Findings: 

• 12 RCTs from 11 studies examining 705 patients included in the research 
• Searched databases from May 1994 to May 2014 for chronic liver disease studies 
• For liver function: significant differences found between levels of total bilirubin (TBIL) and aspartate transaminase (AST) 
• No studies identified significant differences regarding alanine transaminase (ALT) levels 
• Analysis of adverse events and long-term prognosis showed no significant differences between SAMe and placebo groups 
• Subgroup analysis of gravidas and children showed significant difference in pruritus score 
• Results regarding ursodeoxycholic acid (UDCA) and stronger neo-minophagen C (SNMC) indicated both treatments were more effective than SAMe in certain chronic liver diseases 
• SAMe could be used as basis of medication regimen for liver function improvement due to its safety 
• SAMe demonstrated limited clinical value in treatment of certain chronic liver diseases

Study 4: Effects of S-adenosyl-L-methionine on cognitive and vigilance functions in the elderly 

Citation: Fontanari D, Di Palma C, Giorgetti G, Violante F, Voltolina M. Effects of S-adenosyl-L-methionine on cognitive and vigilance functions in the elderly. Current Therapeutic Research. 1994;55:682-689. doi: Not available. PMID: Not available. https://www.sciencedirect.com/science/article/pii/S0011393X05808033 

Study Type: Controlled clinical trial 

Summary: This study examined the effects of S-adenosyl-L-methionine (SAMe) on cognitive and vigilance functions in elderly patients with impaired cognition associated with primary or secondary organic brain syndrome. Forty elderly patients were treated with SAMe for 2 months, with patients scoring 17 or higher on Hamilton's Rating Scale for Depression excluded from the study. 

Key Findings: 

• 40 elderly patients with impaired cognition and vigilance functions associated with primary or secondary organic brain syndrome 
• Patients with depression (HRSD score ≥17) excluded from study 
• SAMe dosing schedule: 400 mg intravenously during first 20 days, then 200 mg intramuscularly plus 400 mg orally twice daily for another 40 days 
• Examinations performed using Mini-Mental State Examination (MMSE) and Sandoz Clinical Assessment Geriatric Scale (SCAG) 
• Assessments conducted at baseline (time 0), day 20, and day 60 of treatment 
• Statistically significant differences (P<0.01) observed in MMSE and SCAG total scores on day 60 versus baseline 
• Significant improvements observed in 4 out of 19 items on SCAG versus baseline on day 20 
• Significant improvements observed in 13 out of 19 items on SCAG versus baseline on day 60 
• No adverse side effects reported during the study 
• SAMe-induced improvement in cognitive functions demonstrated in elderly patients 
• Study provides evidence for SAMe's role in improving cognitive performance in aging population 
• Results suggest SAMe may be beneficial for age-related cognitive decline
• Treatment showed progressive improvement over time (better results at day 60 vs day 20) 
• Study demonstrates safety and efficacy of SAMe for cognitive enhancement in elderly

Health Benefits for Aging

This essential amino acid is a precursor to serotonin and melatonin, which help regulate mood, sleep, and anxiety. It may also aid in pain relief and weight management.

Study 1: The Effect of L-Tryptophan Supplementation on the Mental State of the Elderly 

Citation: Chojnacki C, Popławski T, Chojnacka-Białas M, Błaszczyk M, Klupinska G. The Effect of L-Tryptophan Supplementation on the Mental State of the Elderly-A Randomized, Placebo-Controlled, Double-Blind Study. Nutrients. 2023 Feb 7;15(4):847. doi: 10.3390/nu15040847. PMID: 3683920 https://pubmed.ncbi.nlm.nih.gov/36839204/

Study Type: Randomized, placebo-controlled, double-blind study 

Summary: This study investigated the effect of L-tryptophan supplementation on the mental state of elderly individuals. 60 elderly subjects were randomized to receive either L-tryptophan (1 g/day) or placebo for 6 weeks. 

Key Findings: 

• L-tryptophan supplementation significantly improved mood, as measured by the Geriatric Depression Scale. 
• The supplementation group showed significant improvements in cognitive function, including attention and memory. 
• The study suggests that L-tryptophan supplementation may be a safe and effective way to improve mental state in the elderly.

Study 2: L-Tryptophan in the treatment of premenstrual dysphoria 

Citation: Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry. 1999 Feb 1;45(3):313-20. doi: 10.1016/s0006-3223(98)00005-5. PMID: 10023508 https://pubmed.ncbi.nlm.nih.gov/10023508/

Study Type: Placebo-controlled clinical trial 

Summary: This study investigated the efficacy of L-tryptophan in the treatment of premenstrual dysphoria. 37 women with premenstrual dysphoria were randomized to receive either L-tryptophan (6 g/day) or placebo for 17 days before menstruation. 

Key Findings: 

• L-tryptophan supplementation significantly reduced symptoms of premenstrual dysphoria, including irritability, tension, and mood swings.
• The study provides evidence for the therapeutic potential of L-tryptophan in managing premenstrual dysphoria.

Study 3: Treatment of chronic insomnia with L-tryptophan 

Citation: Demisch K, Bauer J, Georgi K, Stratmann U. Treatment of chronic insomnia with L-tryptophan. Psychopharmacology (Berl). 1987;93(1):1-7. doi: 10.1007/BF00176188. PMID: 3432357. https://pubmed.ncbi.nlm.nih.gov/3432357/ 

Study Type: Double-blind, placebo-controlled crossover study 

Summary: This study investigated the effect of L-tryptophan on chronic insomnia. 15 patients with chronic insomnia were treated with L-tryptophan (2 g/night) or placebo for 4 weeks in a crossover design. 

Key Findings: 

• L-tryptophan supplementation significantly improved sleep quality, as measured by polysomnography. 
• The supplementation group showed a significant reduction in sleep latency and an increase in total sleep time. 
• The study suggests that L-tryptophan may be an effective treatment for chronic insomnia.

Study 4: A tryptophan-enriched cereal improves sleep in elderly 

Citation: Bravo R, Matito S, Cubero J, Paredes SD, Franco L, Rivero M, Rodríguez AB, Barriga C. A tryptophan-enriched cereal improves sleep in elderly. Arch Gerontol Geriatr. 2013 May-Jun;56(3):485-90. doi: 10.1016/j.archger.2012.11.005. PMID: 22622709. https://pmc.ncbi.nlm.nih.gov/articles/PMC3705114/

Study Type: Randomized, double-blind, placebo-controlled study 

Summary: This study investigated the effect of a tryptophan-enriched cereal on sleep in the elderly. 56 elderly subjects were randomized to receive either a tryptophan-enriched cereal or a placebo cereal for 3 weeks. 

Key Findings: 

• The tryptophan-enriched cereal significantly improved sleep quality, as measured by actigraphy. 
• The supplementation group showed a significant reduction in sleep latency and an increase in sleep efficiency. 
• The study suggests that a tryptophan-enriched diet may be a useful strategy for improving sleep in the elderly.

Health Benefits for Aging

L-proline supports healthy aging by promoting collagen synthesis, supporting wound healing, and potentially maintaining skin health. It plays important roles in tissue repair and maintenance, helping preserve structural integrity during aging.

Studies Analyzed:

Study 1: Proline restores mitochondrial function and reverses aging hallmarks in senescent cells

Citation: Choudhury D, Rong N, Senthil Kumar HV, Swedick S, Samuel RZ, Mehrotra P, Toftegaard J, Rajabian N, Thiyagarajan R, Podder AK, Wu Y, Shahini S, Seldeen KL, Troen B, Lei P, Andreadis ST. Proline restores mitochondrial function and reverses aging hallmarks in senescent cells. Cell Rep. 2024 Feb 27;43(2):113738. doi: 10.1016/j.celrep.2024.113738. PMID: 38354087. https://pubmed.ncbi.nlm.nih.gov/38354087/

Study Type: Research Study

Summary: This study investigates the role of proline in reversing cellular senescence. It reports that NANOG restores the expression of key enzymes in the proline biosynthesis pathway and that senescent mesenchymal stem cells' mitochondrial respiratory impairment is alleviated through proline supplementation. The study focuses on cellular mechanisms and uses mesenchymal stem cells.

Key Findings:

• Proline restores mitochondrial function in senescent cells
• Induces mitophagy by activating AMP-activated protein kinase α and upregulating Parkin expression
• Mitigates aging hallmarks including DNA damage, senescence-associated β-galactosidase
• Reduces inflammatory cytokine expressions and impaired myogenic differentiation capacity
• NANOG transcription factor regulates proline biosynthesis pathway
• Proline supplementation can reverse cellular senescence markers
• Mitochondrial respiratory function improved with proline treatment
• Study demonstrates potential anti-aging effects at cellular level
• Proline biosynthesis pathway becomes dysregulated during aging
• Supplementation may help restore youthful cellular function

Study 2: Beneficial effect of L-Proline supplementation on the quality of human spermatozoa

Citation: Moradi M, Moradi B, Hashemian AH, Bakhtiari M, Khazaei M, Esmaeili F, Aghaz F, Faramarzi A. Beneficial effect of L-Proline supplementation on the quality of human spermatozoa. Andrologia. 2022 Aug;54(8):e14486. doi: 10.1111/and.14486. PMID: 35716071. https://pubmed.ncbi.nlm.nih.gov/35716071/

Study Type: Human study

Summary: This study explored the antioxidant effects of L-Proline on human spermatozoa quality. The research investigated how L-Proline supplementation affects sperm parameters and oxidative stress markers in human subjects.

Key Findings:

• L-Proline supplementation improved sperm quality parameters
• Demonstrated antioxidant effects on human spermatozoa
• Reduced oxidative stress markers in sperm samples
• Improved sperm motility and viability
• Enhanced sperm concentration and morphology
• L-Proline acts as an osmolyte and antioxidant in reproductive cells
• May help protect sperm from oxidative damage
• Supplementation showed dose-dependent effects on sperm quality
• Results suggest potential therapeutic applications for male fertility
• Study highlights L-Proline's role in cellular protection and function

Health Benefits for Aging

MSM supports healthy aging by improving skin health, reducing inflammation, supporting joint function, and providing sulfur for collagen synthesis. It helps maintain skin elasticity, hydration, and firmness while supporting overall connective tissue health.

Studies Analyzed:

Study 1: Beauty from within: Oral administration of a sulfur-containing supplement methylsulfonylmethane improves signs of skin ageing

Citation: Muizzuddin N, Benjamin R. Beauty from within: Oral administration of a sulfur-containing supplement methylsulfonylmethane improves signs of skin ageing. Int J Vitam Nutr Res. 2022 Jul;92(3-4):182-191. doi: 10.1024/0300-9831/a000643. PMID: 32083522. https://pubmed.ncbi.nlm.nih.gov/32083522/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This study was conducted in two parts: Part I was a pilot study with 20 participants taking either 3g/day MSM or placebo for 16 weeks, and Part II was a dose-response study with 63 participants taking either 1g or 3g/day MSM for 16 weeks. The study evaluated skin aging parameters including wrinkles, texture, hydration, firmness, and elasticity.

Key Findings:

• Facial wrinkle reduction: Oral MSM (3g/day) significantly reduced facial wrinkles compared to placebo (p < 0.05)
• Skin roughness improvement: Significant reduction in skin roughness compared to placebo (p < 0.05)
• Skin firmness enhancement: Significant improvement in skin firmness from baseline (p < 0.05)
• Elasticity improvement: MSM supplementation improved skin elasticity measurements
• Hydration benefits: Significant improvement in skin hydration levels
• Dose-response relationship: Higher dose (3g/day) more effective than lower dose (1g/day) for some parameters
• Low-dose effectiveness: Even 1g/day appeared sufficiently effective in reducing facial signs of aging
• Multiple aging parameters: MSM addressed multiple aspects of skin aging simultaneously
• Instrumental validation: Benefits confirmed through both visual assessment and instrumental measurements
• Consumer perception: Participants reported improved skin appearance and texture
• Safety profile: No adverse effects reported during 16-week supplementation period
• Sulfur compound benefits: MSM provides sulfur for collagen synthesis and connective tissue support

Study 2: The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial

Citation: Miller L, Thompson K, Pavlenco C, Mettu VS, Haverkamp H, Skaufel S, Basit A, Prasad B, Larsen J. The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial. Nutrients. 2021 Oct 15;13(10):3620. doi: 10.3390/nu13103620. PMID: 34684497. https://pubmed.ncbi.nlm.nih.gov/34684497/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This study investigated whether MSM supplementation improves 

cardiometabolic health and markers of inflammation and oxidative status in 22 overweight or obese adults. Participants received either placebo (white rice flour) or 3g MSM daily for 16 weeks. Measurements occurred at baseline and after 4, 8, and 16 weeks, including fasting glucose, insulin, blood lipids, blood pressure, body composition, metabolic rate, and markers of inflammation and oxidative status.

Key Findings:

• HDL cholesterol elevation: High-density lipoprotein cholesterol was significantly elevated at 8 weeks (p = 0.008) and 16 weeks (p = 0.013) compared to baseline
• Improved cholesterol profile: MSM supplementation improved the cholesterol profile by resulting in higher levels of beneficial HDL cholesterol
• Cardiometabolic benefits: MSM demonstrated potential for improving cardiometabolic health in overweight and obese adults
• Anti-inflammatory effects: MSM is a naturally occurring compound that demonstrates antioxidant and anti-inflammatory effects
• Metabolic function improvement: Interventions to decrease inflammation and improve metabolic function hold promise for obesity-related disease prevention
• Sustained benefits: HDL improvements were maintained throughout the 16-week supplementation period
• Safety profile: No adverse effects reported during the study period
• Obesity-related health: MSM may help address metabolic dysfunction associated with overweight and obesity
• Cardiovascular protection: Higher HDL cholesterol levels are associated with reduced cardiovascular disease risk
• Oxidative status support: MSM supplementation may improve markers of oxidative status
• Inflammation reduction: MSM's anti-inflammatory properties may contribute to metabolic health improvements
• Clinical relevance: Findings suggest MSM could be beneficial for cardiovascular health in aging adults

Study 3: Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial

Citation: Toguchi A, Noguchi N, Kanno T, Yamada A. Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2023 Jun 30;15(13):2995. doi: 10.3390/nu15132995. PMID: 37447322. https://pubmed.ncbi.nlm.nih.gov/37447322/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This study investigated the effects of MSM supplementation on knee quality of life in participants with mild knee pain. The study used the Japanese Knee Osteoarthritis Measure (JKOM) and Japanese Orthopaedic Association (JOA) scores to evaluate knee function and quality of life over 12 weeks of supplementation.

Key Findings:

• Improved knee quality of life: JKOM total scores at 12 weeks were significantly better in MSM group (8.1 points) compared to placebo (10.9 points), with difference of -2.8 points (p = 0.046)
• Health condition improvement: Health condition scores at 12 weeks in MSM group were significantly lower than placebo group (difference = -0.6, p = 0.027), indicating improvement
• Pain and stiffness reduction: JKOM pain and stiffness scores showed significant between-group difference (-0.5, p = 0.032)
• Daily activity improvement: MSM improved knee pain during daily activities such as stair use, knee bending, standing up from sitting, and walking
• Pain-related benefits: Pain-related questions Q2, Q3, and Q8 improved in MSM group at week 12 compared with placebo group
• Antioxidant mechanism: Direct antioxidant effects of MSM in the knee may have contributed to pain relief rather than reducing inflammation
• Quality of life focus: JKOM questionnaire focuses on quality of life related to knee osteoarthritis based on Japanese lifestyle
• Correlation with knee pain: JKOM pain and stiffness items strongly correlated with medial and lateral knee osteoarthritis pain
• Physical dysfunction reduction: MSM shown to be effective in reducing pain and physical dysfunction, consistent with previous WOMAC index studies
• Joint health support: MSM supplementation supports joint health and function in aging adults
• Safety profile: No adverse effects reported during the 12-week study period
• Clinical relevance: Findings suggest MSM may help maintain joint health and mobility during aging

Health Benefits for Aging

Hyaluronic acid supports healthy aging by maintaining skin hydration and elasticity, reducing joint stiffness, and supporting wound healing. It helps preserve the skin's youthful appearance and maintains joint mobility, both critical for aging well.

Studies Analyzed:

Study 1: Ingestion of an Oral Hyaluronan Solution Improves Skin Parameters

Citation: Göllner I, Voss W, von Hehn U, Kammerer S. Ingestion of an Oral Hyaluronan Solution Improves Skin Hydration, Wrinkle Reduction, Elasticity, and Skin Roughness: Results of a Clinical Study. J Evid Based Complementary Altern Med. 2017 Oct;22(4):816-823. doi: 10.1177/2156587217743640. Epub 2017 Dec 4. PMID: 29228816. https://pubmed.ncbi.nlm.nih.gov/29228816/

Study Type: Clinical practice study

Summary: This study evaluated the effect of an oral hyaluronic acid preparation diluted in a cascade-fermented organic whole food concentrate supplemented with biotin, vitamin C, copper, and zinc on skin parameters. Twenty female subjects aged 45-60 years with healthy skin took the product once daily for 40 days.

Key Findings:

• Significant increase in skin elasticity after 40 days of supplementation
• Significant increase in skin hydration levels
• Significant decrease in skin roughness
• Significant decrease in wrinkle depths
• The supplement was well-tolerated with no side effects noted throughout the study
• Objective skin parameters were assessed at baseline, 20 days, and 40 days
• The formulation included hyaluronic acid plus biotin, vitamin C, copper, and zinc for synergistic effects

Study 2: Oral hyaluronan relieves knee pain: a review

Citation: Oe M, Tashiro T, Yoshida H, Nishiyama H, Masuda Y, Maruyama K, Koikeda T, Maruya R, Fukui N. Oral hyaluronan relieves knee pain: a review. Nutr J. 2016 Jan 27;15:11. doi: 10.1186/s12937-016-0128-2. PMID: 26818459. https://pubmed.ncbi.nlm.nih.gov/26818459/

Study Type: Review of randomized, double-blinded, placebo-controlled trials

Summary: This review examined randomized, double-blinded, placebo-controlled trials conducted between 2008 and 2015 that investigated the effectiveness of oral hyaluronic acid for treating symptoms associated with synovitis, particularly knee pain.

Key Findings:

• Oral hyaluronic acid proven effective for treatment of symptoms associated with synovitis
• Particularly effective for knee pain relief
• Provides relief of synovial effusion or inflammation
• Improves muscular knee strength
• The mechanism involves receptor binding in the intestinal epithelia
• Hyaluronic acid is particularly abundant in synovial fluid
• The review confirms both efficacy and safety of oral hyaluronic acid supplementation
• Clinical trials demonstrate consistent benefits for joint health and mobility

Study 3: Clinical comparison of oral administration and viscosupplementation of hyaluronic acid in early knee osteoarthritis

Citation: Ricci M, Micheloni GM, Berti M, Perusi F, Sambugaro E, Vecchini E, Magnan B. Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis. Musculoskelet Surg. 2017 Apr;101(1):45-49. doi: 10.1007/s12306-016-0428-x. Epub 2016 Sep 28. PMID: 27681813. https://pubmed.ncbi.nlm.nih.gov/27681813/

Study Type: Randomized controlled trial

Summary: This study compared the effectiveness of intra-articular hyaluronic acid injections versus oral hyaluronic acid supplementation in 60 patients (32 males, 28 females) aged 40-70 years with early knee osteoarthritis. Group A received three weekly intra-articular injections of 1.6% hyaluronic acid, while Group B received oral Syalox 300 Plus® (300mg HA + 100mg Boswellia serrata extract) for 20 days followed by Syalox 150® (150mg HA) for another 20 days.

Key Findings:

• Both treatment groups showed significant improvement in American Knee Society Score (AKSS)
• Both groups showed significant reduction in Visual Analogue Scale (VAS) pain scores
• Better results were observed in younger patients (under 60) with intra-articular injections (Group A)
• Better results were observed in older patients (over 60) with oral supplementation (Group B)
• Both oral and injectable hyaluronic acid demonstrated beneficial therapeutic effects for early osteoarthritis
• The study suggests a combined therapy approach: first local infiltrations, then oral composition
• Treatment was evaluated at baseline and after 3 months

Study 4: Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period

Citation: Oe M, Sakai S, Yoshida H, Okado N, Kaneda H, Masuda Y, Urushibata O. Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period. Clin Cosmet Investig Dermatol. 2017 Jul 18;10:267-273. doi: 10.2147/CCID.S141845. PMID: 28761365.  https://pubmed.ncbi.nlm.nih.gov/28761365/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This 12-week study evaluated the anti-wrinkle effects of oral hyaluronic acid in 60 Japanese subjects aged 22-59 years with crow's feet wrinkles. Subjects were randomly assigned to receive either HA 2k (molecular weight ~2,000), HA 300k (molecular weight ~300,000) at 120mg/day, or placebo.

Key Findings:

• Both HA groups showed better sulcus volume ratio, wrinkle area ratio, and wrinkle volume ratio compared to placebo
• After 8 weeks, the HA 300k group showed significantly diminished wrinkles compared to placebo
• Skin luster and suppleness significantly improved after 12 weeks in all HA groups compared to baseline
• Both low molecular weight (2k) and high molecular weight (300k) HA were effective
• Oral HA inhibits skin wrinkles and improves overall skin condition
• The study used objective image analysis of skin wrinkle replicas for evaluation
• Both molecular weight forms of HA demonstrated bioavailability and effectiveness
• No significant adverse effects were reported during the 12-week treatment period

Health Benefits for Aging

Citicoline sodium supports healthy aging by enhancing cognitive function, improving memory, and supporting brain health. It helps maintain neuronal membrane integrity, supports neurotransmitter synthesis, and may protect against age-related cognitive decline.

Studies Analyzed:

Study 1: Citicoline and Memory Function in Healthy Older Adults: A Randomized, 

Double-Blind, Placebo-Controlled Clinical Trial

Citation: Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Nutr. 2021 Aug 7;151(8):2153-2160. doi: 10.1093/jn/nxab119. PMID: 33978188. https://pubmed.ncbi.nlm.nih.gov/33978188/

Study Type: Randomized, double-blind, placebo-controlled clinical trial

Summary: This study investigated the effects of citicoline (Cognizin®) supplementation on memory function in 100 healthy men and women aged 50-85 years with age-associated memory impairment (AAMI). Participants were randomized to receive either placebo (n=51) or 500 mg/day citicoline (n=49) for 12 weeks.

Key Findings:

• 99 out of 100 participants completed the study (99% completion rate)
• Citicoline supplementation significantly improved episodic memory assessed by Paired Associate test (mean improvement: 0.15 vs 0.06 placebo, p = 0.0025)
• Composite memory score (calculated from 4 memory tests) showed significantly greater improvement with citicoline (mean: 3.78) compared to placebo (mean: 0.72, p = 0.0052)
• Overall memory performance was significantly enhanced, especially episodic memory
• No significant adverse events were reported
• Safety measurements (body weight, blood pressure, hematology, metabolic panel) showed no concerning changes
• Intent-to-treat analysis confirmed the robustness of results
• Findings suggest regular citicoline consumption may be safe and beneficial against age-related memory loss
• Trial was registered at clinicaltrials.gov as NCT03369925

Study 2: Citicoline for Supporting Memory in Aging Humans

Citation: Świątkiewicz M, Grieb P. Citicoline for Supporting Memory in Aging Humans. Aging Dis. 2023 Aug 1;14(4):1184-1195. doi: 10.14336/AD.2022.0913. PMID: 37196134. https://pubmed.ncbi.nlm.nih.gov/37196134/

Study Type: Comprehensive review

Summary: This comprehensive review examined the evidence for citicoline's role in supporting memory function in aging humans. The review analyzed multiple randomized, placebo-controlled trials and magnetic resonance spectroscopy studies to evaluate citicoline's effects on cognitive function and brain metabolism.

Key Findings:

• Citicoline breaks down to cytidine and choline when ingested, both entering normal metabolic pathways
• Choline is a precursor of acetylcholine (neurotransmitter for learning and memory) and phospholipids (neuronal membrane components)
• Cytidine converts to uridine, which positively affects synaptic function and supports synaptic membrane formation
• Choline deficiency correlates with memory dysfunction
• Magnetic resonance spectroscopy studies showed citicoline improves brain choline uptake in older persons
• Randomized, placebo-controlled trials in cognitively normal middle-aged and elderly persons demonstrated positive effects on memory efficacy
• Similar memory improvements found in patients with mild cognitive impairment and other neurological diseases
• Evidence suggests citicoline helps reverse early age-related cognitive changes
• Oral citicoline intake positively influences memory function in humans with age-related memory impairment
• Benefits observed even in absence of detectable neurological or psychiatric disease

Study 3: Citicoline (Cognizin) in the treatment of cognitive impairment

Citation: Fioravanti M, Buckley AE. Citicoline (Cognizin) in the treatment of cognitive impairment. Clin Interv Aging. 2006 Sep;1(3):247-251. doi: 10.2147/ciia.2006.1.3.247. PMID: 18046877. https://pubmed.ncbi.nlm.nih.gov/18046877/

Study Type: Review and meta-analysis

Summary: This review examined the pharmacological treatment of cerebrovascular disorders and cognitive impairment, with specific focus on citicoline's efficacy. The authors performed a meta-analysis on the entire database of clinical studies available for citicoline to evaluate its therapeutic value.

Key Findings:

• Citicoline proved to be a valid treatment in patients with cerebrovascular pathogenesis for memory disorders
• Meta-analysis of entire clinical database confirmed experimental evidence from animal studies
• Multiple biological actions of citicoline demonstrated in restoring cell lipid structures
• Neurotransmitter functions were restored through citicoline treatment
• Clinical studies consistently showed cognitive benefits in patients with cerebrovascular-related memory disorders
• Animal studies repeatedly described citicoline's multiple biological mechanisms of action
• Evidence supports citicoline's role in membrane repair and neurotransmitter restoration
• Treatment showed particular efficacy in patients with vascular cognitive impairment
• Clinical database provided robust evidence for therapeutic benefits
• Review confirmed citicoline's established role in treating cognitive deficits associated with cerebrovascular disorders

Health Benefits for Aging

This fatty substance is vital for brain health, as it protects nerve cells and helps them communicate. It can improve memory, focus, and cognitive function, especially with age.

Study 1: Phosphatidylserine and the human brain

Citation: Glade MJ, Smith K. Phosphatidylserine and the human brain. Nutrition. 2015 Jun;31(6):781-6. doi: 10.1016/j.nut.2014.10.014. Epub 2014 Nov 4. PMID: 25933483. https://pubmed.ncbi.nlm.nih.gov/25933483/ 

Study Type: Comprehensive review 

Summary: This study assessed the roles and importance of phosphatidylserine (PS), an endogenous phospholipid and dietary nutrient, in human brain biochemistry, physiology, and function. A scientific literature search was conducted on MEDLINE for relevant articles regarding PS and the human brain published before June 2014, with 127 articles selected for inclusion in this review. 

Key Findings: 

• Large body of scientific evidence describes interactions among PS, cognitive activity, cognitive aging, and retention of cognitive functioning ability 
• Phosphatidylserine is required for healthy nerve cell membranes and myelin 
• Aging of human brain is associated with biochemical alterations and structural deterioration that impair neurotransmission 
• Exogenous PS (300-800 mg/d) is absorbed efficiently in humans and crosses the blood-brain barrier 
• PS safely slows, halts, or reverses biochemical alterations and structural deterioration in nerve cells 
• PS supports human cognitive functions including formation of short-term memory 
• PS supports consolidation of long-term memory and ability to create new memories 
• PS supports ability to retrieve memories and learn and recall information 
• PS supports ability to focus attention and concentrate 
• PS supports ability to reason and solve problems and language skills 
• PS supports ability to communicate and locomotor functions 
• PS especially supports rapid reactions and reflexes 
• Review demonstrates PS crosses blood-brain barrier and provides neuroprotective effects 
• Evidence shows PS supplementation can improve cognitive performance in aging populations 
• PS supplementation shown to be safe and well-tolerated in human studies

Study 2: The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study 

Citation: Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clin Interv Aging. 2013;8:557-63. doi: 10.2147/CIA.S40348. Epub 2013 May 21. PMID: 23723695. https://pubmed.ncbi.nlm.nih.gov/23723695/ 

Study Type: Single-center, open-label pilot study 

Summary: This exploratory study evaluated the efficacy and safety of soybean-derived phosphatidylserine (SB-PS) (300 mg/day) in improving cognitive performance in elderly with memory complaints, following a short duration of 12 weeks' SB-PS administration. 30 elderly volunteers with memory complaints (age range 50–90 years) participated in the study. 

Key Findings: 

• SB-PS was administered daily for 12 weeks to 30 elderly volunteers with memory complaints 
• Cognitive performance determined by computerized test battery and Rey Auditory Verbal Learning Test (Rey-AVLT) 
• SB-PS supplementation significantly increased memory recognition (P = 0.004) •
• SB-PS supplementation significantly increased memory recall (P = 0.006) 
• SB-PS supplementation significantly increased executive functions (P = 0.004) 
• SB-PS supplementation significantly increased mental flexibility (P = 0.01) 
• Rey-AVLT indicated that following SB-PS administration, total learning improved significantly (P = 0.013) 
• Immediate recall improved significantly (P = 0.007) following SB-PS administration 
• Unexpected results from safety tests suggested SB-PS significantly reduces both systolic (P = 0.043) and diastolic (P = 0.003) blood pressure 
• SB-PS consumption was well tolerated, and no serious adverse events were reported during study 
• Study demonstrates SB-PS may have favorable effects on cognitive function in elderly with memory complaints 
• Study suggests SB-PS is safe for human consumption and may serve as safe alternative to phosphatidylserine extracted from bovine cortex 
• Results encourage further extended studies to establish safety and efficacy of SB-PS treatment

Study 3: Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial 

Citation: Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-74. doi: 10.1159/000310330. Epub 2010 Jun 3. PMID: 20523044. https://pubmed.ncbi.nlm.nih.gov/20523044/ 

Study Type: Double-blind, placebo-controlled trial 

Summary: This study evaluated the efficacy of a novel preparation of PS containing omega-3 long-chain polyunsaturated fatty acids attached to its backbone (PS-DHA) in non-demented elderly with memory complaints. 157 participants were randomized to receive either PS-DHA or placebo for 15 weeks. 

Key Findings: 

• 157 participants randomized to receive either PS-DHA or placebo for 15 weeks 
• 131 participants
• completed study although 9 were excluded from efficacy analysis due to protocol violation 
• Efficacy measures assessed at baseline and endpoint included Rey Auditory Verbal Learning Test, Rey Complex Figure Test, and computerized cognitive battery 
• Clinicians' Global Impression of Change assessed following 7 and 15 weeks of treatment 
• At endpoint, verbal immediate recall was significantly improved in PS-DHA group compared to placebo group 
• Post-hoc analysis revealed subset of participants with relatively good cognitive performance at baseline had significant treatment-associated improvements 
• Improvements seen in immediate and delayed verbal recall, learning abilities, and time to copy complex figure 
• Favorable results were further supported by responder analysis 
• Results indicate PS-DHA may improve cognitive performance in non-demented elderly with memory complaints 
• Post-hoc analysis of subgroups suggests participants with higher baseline cognitive status were most likely to respond to PS-DHA 
• Study demonstrates safety and potential efficacy of PS-DHA combination • Results suggest PS-DHA supplementation may be particularly beneficial for individuals with better baseline cognitive function

Study 4: Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints 

Citation: Kato-Kataoka A, Sakai M, Ebina R, Nonaka C, Asano T, Miyamori T. Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. J Clin Biochem Nutr. 2010 Nov;47(3):246-55. doi: 10.3164/jcbn.10-62. Epub 2010 Sep 29. PMID: 21103034. https://pubmed.ncbi.nlm.nih.gov/21103034/ 

Study Type: Double-blind, randomized controlled study 

Summary: This study investigated the effects of soybean-derived phosphatidylserine (Soy-PS) on the cognitive functions of elderly Japanese subjects with memory complaints. Seventy-eight elderly people with mild cognitive impairment (50-69 years old) were randomly allocated to take Soy-PS (100 mg, 300 mg/day) or placebo for 6 months. 

Key Findings: 

• 78 elderly people with mild cognitive impairment (50-69 years old) randomly allocated to take Soy-PS (100 mg, 300 mg/day) or placebo for 6 months 
• No difference in blood markers and vital signs during Soy-PS treatment 
• No side effects caused by Soy-PS treatment were observed 
• Neuropsychological test scores were similarly increased in all groups including placebo group 
• In subjects with relatively low score at baseline, memory scores in PS treated groups were significantly increased against baseline 
• Memory scores in placebo group remained unchanged in low baseline score subjects 
• Memory improvements in Soy-PS-treated groups were mostly attributed to increase in delayed verbal recall 
• Delayed verbal recall is a memory ability attenuated in earliest stage of dementia 
• Soy-PS used in study is considered as safety food ingredient 
• 6 months of Soy-PS supplementation could improve memory functions of elderly with memory complaints 
• Study demonstrates particular benefit for individuals with lower baseline cognitive performance 
• Results suggest Soy-PS may help prevent early cognitive decline • Study provides evidence for long-term safety of soybean-derived phosphatidylserine supplementation

Study 5: Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration 

Citation: Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano). 1993 Apr;5(2):123-33. doi: 10.1007/BF03324139. PMID: 8323999. https://pubmed.ncbi.nlm.nih.gov/8323999/ 

Study Type: Double-blind, placebo-controlled multicenter study 

Summary: This large multicenter study assessed the therapeutic efficacy and safety of oral treatment with phosphatidylserine (BC-PS) vs placebo (300 mg/day for 6 months) in geriatric patients with cognitive impairment. A total of 494 elderly patients (age between 65 and 93 years), with moderate to severe cognitive decline, were recruited in 23 Geriatric or General Medicine Units in Northeastern Italy. 

Key Findings: 

• 494 elderly patients (age between 65 and 93 years) with moderate to severe cognitive decline recruited from 23 Geriatric or General Medicine Units in Northeastern Italy 
• Patients had moderate to severe cognitive decline according to Mini Mental State Examination and Global Deterioration Scale 
• 69 patients dropped out within 6-month trial period 
• Patients examined just before starting therapy, and 3 and 6 months thereafter 
• Efficacy of treatment compared to placebo measured using Plutchik Geriatric Rating Scale and Buschke Selective Reminding Test 
• Statistically significant improvements in phosphatidylserine-treated group compared to placebo observed in behavioral parameters 
• Statistically significant improvements in phosphatidylserine-treated group compared to placebo observed in cognitive parameters 
• Clinical evaluation and laboratory tests demonstrated BC-PS was well tolerated 
• Results are clinically important since patients were representative of geriatric population commonly met in clinical practice 
• Study represents one of largest controlled trials of phosphatidylserine in elderly with cognitive decline 
• Results demonstrate efficacy of phosphatidylserine supplementation in real-world clinical populations 
• Study provides strong evidence for safety and tolerability of phosphatidylserine in elderly patients 
• Findings support use of phosphatidylserine as therapeutic intervention for age-related cognitive decline

Health Benefits for Aging

L-theanine supports healthy aging by promoting relaxation without sedation, reducing stress and anxiety, and improving sleep quality. It may also support cognitive function and provide neuroprotective effects, helping maintain mental clarity during aging.

Studies Analyzed:

Study 1: L-theanine, a natural constituent in tea, and its effect on mental state

Citation: Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8. PMID: 18296328. https://pubmed.ncbi.nlm.nih.gov/18296328/

Study Type: Review

Summary: This review examines L-theanine, a unique amino acid found in tea, and its effects on mental state and cognitive performance. The review covers studies on L-theanine's ability to promote relaxation without drowsiness.

Key Findings:

• L-theanine promotes relaxation without causing drowsiness
• Can cross the blood-brain barrier and influence brain activity
• Increases alpha brain wave activity associated with relaxed alertness
• May improve attention and cognitive performance
• Generally well-tolerated with no significant side effects reported

Study 2: The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent

Citation: Nathan PJ, Lu K, Gray M, Oliver C. The neuropharmacology of L-
theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive
enhancing agent. J Herb Pharmacother. 2006;6(2):21-30. PMID: 17182482.
https://pubmed.ncbi.nlm.nih.gov/17182482/

Study Type: Review

Summary: This comprehensive review examines the neuropharmacological properties of L-theanine, focusing on its potential neuroprotective and cognitive enhancing effects. The review covers preclinical and clinical studies on L-theanine's mechanisms of action.

Key Findings:

• L-theanine demonstrates neuroprotective properties
• May enhance cognitive function through multiple mechanisms
• Modulates neurotransmitter systems including GABA, dopamine, and serotonin
• Shows potential for reducing stress and anxiety
• May improve sleep quality without sedation
• Generally safe with minimal side effects

Study 3: L-theanine reduces psychological and physiological stress responses

Citation: Kimura K, Ozeki M, Juneja LR, Ohira H. L-theanine reduces psychological and physiological stress responses. Biol Psychol. 2007 Jan;74(1):39-45. doi: 10.1016/j.biopsycho.2006.06.006. Epub 2006 Aug 22. PMID: 16930802. https://pubmed.ncbi.nlm.nih.gov/16930802/

Study Type: Randomized controlled trial

Summary: This study investigated the effects of L-theanine on psychological and physiological stress responses in healthy adults. Participants received either L-theanine or placebo before undergoing stress-inducing tasks.

Key Findings:

• L-theanine significantly reduced psychological stress responses
• Reduced physiological stress markers including cortisol levels
• Improved subjective stress ratings compared to placebo
• Enhanced relaxation without causing drowsiness
• Dosage: 200mg L-theanine showed optimal effects
• Effects observed within 1 hour of administration
• No adverse effects reported during the study period

Health Benefits for Aging

Medium Chain Triglycerides provide an alternative fuel source for the brain, supporting cognitive function and potentially protecting against age-related cognitive decline. MCTs are rapidly absorbed and converted to ketones, which can cross the blood-brain barrier and provide energy when glucose metabolism is impaired.

Studies Analyzed:

Study 1: The effects of medium chain triglyceride (MCT) supplementation using a C8:C10 ratio of 30:70 on cognitive performance in healthy young adults

Citation: Ashton JS, Roberts JW, Wakefield CJ, Page RM, MacLaren DPM, Marwood S, Malone JJ. The effects of medium chain triglyceride (MCT) supplementation using a C8:C10 ratio of 30:70 on cognitive performance in healthy young adults. Physiol Behav. 2021 Feb 1;229:113252. doi: 10.1016/j.physbeh.2020.113252. PMID: 33220329. https://pubmed.ncbi.nlm.nih.gov/33220329/

Study Type: Randomized controlled trial

Summary: This study examined the effects of MCT supplementation on cognitive performance in 30 healthy young adults divided into three groups (placebo, 12g MCT/day, 18g MCT/day) for 4 weeks. The MCT supplement had a C8:C10 ratio of 30:70. Participants underwent weekly cognitive testing including Trail Making, Digit Span, Spatial Span, Covert Shift of Attention, and Rapid Visual Information Processing tests.

Key Findings:

• Cognitive enhancement after 2-3 weeks: MCT ingestion significantly enhanced performance in multiple cognitive tasks compared to placebo (ps<0.001)
• Working memory improvement: Significant improvements in Trail Making A/B and Digit Span Forwards/Backwards tests
• Spatial processing benefits: Significant main effect of group in Spatial Span Backwards (p = 0.002)
• Dose-response threshold: Minimal difference between 12g and 18g MCT/day groups, suggesting possible threshold at 12g MCT/day
• Time-dependent effects: Main effects of time observed after 2-3 weeks of supplementation (ps<0.05)
• Selective cognitive benefits: Improvements seen in working memory and task switching, but null results in attention and reaction time tasks
• Alternative brain fuel: Brain can utilize MCTs as alternative fuel to glucose, supporting cognitive function
• Short-term supplementation effective: Benefits observed within 2-3 weeks of consistent supplementation
• Optimal ratio identified: C8:C10 ratio of 30:70 demonstrated cognitive benefits in healthy adults

Study 2: Potential benefits of medium chain fatty acids in aging and neurodegenerative disease

Citation: Dunn E, Zhang B, Sahota VK, Augustin H. Potential benefits of medium chain fatty acids in aging and neurodegenerative disease. Front Aging Neurosci. 2023 Aug 23;15:1230467. doi: 10.3389/fnagi.2023.1230467. PMID: 37680538. https://pubmed.ncbi.nlm.nih.gov/37680538/

Study Type: Comprehensive review

Summary: This comprehensive review examined the potential benefits of medium chain fatty acids (MCFAs) in aging and neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. The review analyzed the metabolic benefits of MCFAs and their effects on multiple disease-related pathways in the context of healthy aging and neurodegeneration.

Key Findings:

• Aging as primary risk factor: Individuals over 65 are more likely to suffer from neurodegenerative disease, with prevalence increasing with age
• Superior ketone generation: MCT-based diets more efficient at generating ketone bodies used as secondary energy source for neurons and astrocytes
• Alternative mode of action: MCFAs work beyond ketone production via improving mitochondrial biogenesis and glutamate receptor inhibition
• Autophagy stimulation: MCFAs shown to stimulate autophagy, which is disrupted in aging and neurodegeneration
• Mitochondrial function restoration: MCFAs restore mitochondrial function found to be disrupted in aging and neurodegeneration
• Multiple pathway action: MCFAs act on multiple disease-related pathways, emerging as compounds with notable potential to promote healthy aging
• Neurodegeneration amelioration: MCFAs have potential to ameliorate neurodegeneration through metabolic effects
• Secondary energy source: Ketone bodies provide alternative fuel when glucose metabolism is impaired in aging brain
• Clinical correlation: Ketone levels alone do not closely correlate with improved clinical symptoms, suggesting additional mechanisms
• Metabolic benefits: MCFAs linked to treatment of both aging and neurodegenerative disease via effects on metabolism

Study 3: Effect of medium-chain triglycerides supplements and walking on health-related quality of life in sedentary, healthy middle-aged, and older adults with low BMIs: a randomized, double-blind, placebo-controlled, parallel-group trial

Citation: Ishikawa H, Kojima K, Watanabe S, Nosaka N, Mutoh T. Effect of medium-chain triglycerides supplements and walking on health-related quality of life in sedentary, healthy middle-aged, and older adults with low BMIs: a randomized, double-blind, placebo-controlled, parallel-group trial. Front Nutr. 2023 Nov 23;10:1296896. doi: 10.3389/fnut.2023.1296896. PMID: 38075217. https://pubmed.ncbi.nlm.nih.gov/38075217/

Study Type: Randomized, double-blind, placebo-controlled, parallel-group trial

Summary: This study evaluated the combined effects of 12-week MCT supplementation and moderate-intensity walking exercise on subjective health and quality of life in 120 middle-aged and older adults (aged 60-74) with low BMIs (<24 kg/m²) and no exercise habits. Three MCT supplement groups with different doses and fatty acid compositions were compared with a control group using the SF-36v2 questionnaire.

Key Findings:

• Physical QOL improvements: Significant improvements in Physical Functioning and General Health subscale scores compared to control
• Mental QOL benefits: Significant improvements in mental QOL summary scores compared to control
• Combined intervention effective: Combination of continuous MCT intake and walking exercise improved health-related quality of life (HRQOL)
• Subjective health enhancement: Improved subjective physical and mental health in sedentary, healthy middle-aged and older adults
• Previous research support: MCT intake (6g daily) previously shown to improve physical function and body composition in older people
• Mitochondrial benefits: MCTs increase mitochondrial biosynthesis and fatty acid oxidation-related gene expression
• Fatigue reduction: Case studies report reduction in subjective fatigue with continuous MCT intake
• Fat oxidation increase: Continuous MCT intake increases fat oxidation during exercise in normal weight and overweight individuals
• Nursing care benefits: MCT supplementation improved blood albumin levels, grip strength, walking speed, and muscle mass in nursing home residents
• Healthy life expectancy: Study addresses gap between average life expectancy and healthy life expectancy (approximately 10 years)
• Dose-response investigation: Three different MCT supplement groups investigated effects of varying doses and fatty acid compositions

Health Benefits for Aging

L-glutathione is a powerful antioxidant that supports healthy aging by protecting cells from oxidative stress, supporting immune function, and maintaining cellular detoxification processes. It plays crucial roles in reducing inflammation and supporting overall cellular health in aging adults.

Studies Analyzed:

Study 1: Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency

Citation: Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, Minard CG, Taffet GE, Sekhar RV. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):75-89. doi: 10.1093/gerona/glac135. PMID: 35975308. https://pubmed.ncbi.nlm.nih.gov/35975308/

Study Type: Randomized clinical trial

Summary: This study examined the effects of GlyNAC (glycine and N-acetylcysteine) supplementation on glutathione deficiency and aging hallmarks in 24 older adults (aged 70-80) compared to 12 younger adults (aged 21-30). Older adults received GlyNAC supplementation for 16 weeks in a randomized, double-blind, placebo-controlled design.

Key Findings:

• GlyNAC supplementation significantly corrected glutathione deficiency in older adults
• Reduced oxidative stress (measured by TBARS and F2-isoprostanes)
• Improved mitochondrial dysfunction and fatty-acid oxidation
• Decreased inflammation markers (TNF-α, IL-6, CRP)
• Enhanced physical function including gait speed, grip strength, and exercise capacity
• Improved cognitive function and reduced insulin resistance
• Corrected multiple aging hallmarks including genomic instability and cellular senescence
• No adverse effects were reported during the 16-week intervention
• Benefits were sustained throughout the study period
• Glutathione levels increased by 35% compared to placebo group

Study 2: Oral Glutathione Supplementation Increases Body Stores and Enhances Immune Function

Citation: Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled
trial of oral glutathione supplementation on body stores of glutathione. Eur J
Nutr. 2015 Aug;54(5):747–758. doi: 10.1007/s00394-015-0850-x. PMID: 24791752.
https://pubmed.ncbi.nlm.nih.gov/24791752/

Study Type: Double-blind, randomized, placebo-controlled trial in healthy adults

Summary: Investigated the effects of daily oral glutathione (250 or 1,000 mg/day) for 6 months on systemic glutathione levels, oxidative stress markers, and immune function.

Key Findings:

• Significantly increased body stores of GSH: enhanced blood GSH compartment storage
• Decrease in the oxidized-to-reduced glutathione ratio, indicating reduced oxidative stress
• Natural killer (NK) cell cytotoxicity more than doubled in the high-dose group versus placebo at 3 months (P < 0.05)
• Demonstrates that oral GSH can safely boost antioxidant capacity and immune activity in healthy individuals

Study 3: Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation

Citation: Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A,
Taffet GE, Jahoor F. Deficient synthesis of glutathione underlies oxidative stress in
aging and can be corrected by dietary cysteine and glycine supplementation.
Am J Clin Nutr. 2011 Jul;94(1):847-853. doi: 10.3945/ajcn.110.003483. PMID:
21795440. https://pubmed.ncbi.nlm.nih.gov/21795440/

Study Type: Controlled intervention study

Summary: This study investigated glutathione deficiency in elderly humans and tested whether supplementation with glutathione precursors (cysteine and glycine) could restore glutathione levels and reduce oxidative stress. The study compared young adults (20-40 years) with elderly adults (60-75 years) and tested the effects of 2-week supplementation.

Key Findings:

• Elderly subjects had significantly lower glutathione synthesis rates compared to young adults
• Glutathione deficiency in elderly was due to marked reduction in synthesis, not increased breakdown
• Dietary supplementation with cysteine and glycine for 2 weeks fully restored glutathione synthesis in elderly
• Glutathione concentrations were completely normalized after supplementation
• Oxidative stress markers (TBARS, F2-isoprostanes) were significantly lowered after supplementation
• Oxidant damage markers were reduced to levels comparable to young adults
• The intervention was well-tolerated with no adverse effects
• Results suggest a practical and effective approach to decreasing oxidative stress in aging
• Supplementation provided sustained benefits throughout the study period

Health Benefits for Aging

Nicotinamide riboside supports healthy aging by boosting NAD+ levels, which are crucial for cellular energy metabolism, DNA repair, and mitochondrial function. It may help maintain cardiovascular health and support cellular longevity pathways.

Studies Analyzed:

Study 1: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Citation: Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016 Oct 10;7:12948. doi: 10.1038/ncomms12948. PMID: 27721479. https://pubmed.ncbi.nlm.nih.gov/27721479/

Study Type: Clinical trial and preclinical study

Summary: This study investigated the bioavailability and metabolism of nicotinamide riboside (NR) in both mice and humans, examining its unique properties as an NAD+ precursor and its oral bioavailability.

Key Findings:

• Nicotinamide riboside is uniquely bioavailable when taken orally
• Effectively raises NAD+ levels in both mice and humans
• Shows dose-dependent increases in NAD+ metabolites
• Well-tolerated with no significant adverse effects
• Demonstrates superior bioavailability compared to other NAD+ precursors
• Single doses of 100-1000mg showed measurable increases in NAD+ levels
• Peak blood levels achieved within 2-3 hours of administration

Study 2: Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Citation: Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018 Mar 29;9(1):1286. doi: 10.1038/s41467-018-03421-7. PMID: 29599478. https://pubmed.ncbi.nlm.nih.gov/29599478/

Study Type: Randomized, double-blind, placebo-controlled trial

Summary: This study examined the safety and efficacy of chronic nicotinamide riboside supplementation in healthy middle-aged and older adults (55-79 years). Participants received either 1000mg/day NR or placebo for 6 weeks.

Key Findings:

• Chronic NR supplementation was well-tolerated with minimal side effects
• Significantly elevated NAD+ levels in peripheral blood mononuclear cells
• NAD+ levels increased by ~60% compared to baseline
• No significant changes in clinical safety markers
• Maintained elevated NAD+ levels throughout the 6-week period
• Most common side effects were mild and included nausea and fatigue in <10% of participants
• Demonstrates long-term safety and efficacy in aging population

Study 3: Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

Citation: Remie CME, Roumans KHM, Moonen MPB, Connell NJ, Havekes B, Mevenkamp J, Lindeboom L, de Wit VHW, van de Weijer T, Aarts SABM, Lutgens E, Schomakers BV, Elfrink HL, Zapata-Pérez R, Houtkooper RH, Auwerx J, Hoeks J, Schrauwen-Hinderling VB, Phielix E, Schrauwen P. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr. 2020 Aug 1;112(2):413-426. doi: 10.1093/ajcn/nqaa072. PMID: 32320006. https://pubmed.ncbi.nlm.nih.gov/32320006/

Study Type: Randomized, double-blinded, placebo-controlled, crossover intervention study

Summary: This study examined the effects of 6-week nicotinamide riboside (NR) supplementation on insulin sensitivity, mitochondrial function, and metabolic health parameters in 13 healthy overweight or obese men and women using comprehensive metabolic phenotyping.

Key Findings:

• Markers of increased NAD+ synthesis (nicotinic acid adenine dinucleotide and methyl nicotinamide) were elevated in skeletal muscle after NR vs placebo
• NR increased body fat-free mass (62.65% ± 2.49% vs 61.32% ± 2.58% in placebo; change: 1.34% ± 0.50%, P = 0.02)
• NR increased sleeping metabolic rate
• Acetylcarnitine concentrations in skeletal muscle increased with NR (4558 ± 749 vs 3025 ± 316 pmol/mg dry weight in placebo; change: 1533 ± 683 pmol/mg, P = 0.04)
• Capacity to form acetylcarnitine upon exercise was higher with NR (2.99 ± 0.30 vs 2.40 ± 0.33 mmol/kg wet weight in placebo; change: 0.53 ± 0.21 mmol/kg, P = 0.01)
• Dosage: 1000 mg/day for 6 weeks
• Study included hyperinsulinemic-euglycemic clamps, magnetic resonance spectroscopy, muscle biopsies, and assessment of mitochondrial function
• No other significant metabolic health effects were observed

Study 4: Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults

Citation: Freeberg KA, Craighead DH, Martens CR, You Z, Chonchol M, Seals DR. Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults. Front Cardiovasc Med. 2022 May 10;9:881703. doi: 10.3389/fcvm.2022.881703. PMID: 35620522. https://pubmed.ncbi.nlm.nih.gov/35620522/

Study Type: Randomized, double-blind, placebo-controlled clinical trial protocol

Summary: This study protocol describes a randomized controlled trial investigating 3 months of oral nicotinamide riboside supplementation for decreasing systolic blood pressure and arterial stiffness in 94 midlife and older adults (age ≥ 50 years) with above-normal SBP (120-159 mmHg).

Key Findings:

• Study designed to establish safety and efficacy of nicotinamide riboside for cardiovascular health
• Aging is primary risk factor for cardiovascular diseases; age-related increases in SBP link advancing age to CVD risk
• Key mechanism: stiffening of large elastic arteries due to oxidative stress, inflammation, and vascular smooth muscle tone
• NAD+ declines with advancing age and chronic disease
• NAD+ precursor supplementation may improve cardiovascular health
• Primary outcome: casual (resting) systolic blood pressure
• Secondary outcomes: 24-hour SBP and aortic stiffness
• Dosage: 500 mg nicotinamide riboside, 2×/day (NIAGEN®) for 3 months
• Study population: midlife and older adults with above-normal SBP at increased CVD risk
• Clinical trial registration: NCT03821623
• Single-site parallel-group design with 47 participants per group

Health Benefits for Aging

This antioxidant helps cells produce energy, supports heart health, and may help regulate blood sugar. It also plays a role in protecting cells from damage, which can contribute to aging and some diseases.

Study 1: Coenzyme Q10 Supplementation in Aging and Disease 

Citation: Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P. Coenzyme Q10 Supplementation in Aging and Disease. Front Physiol. 2018;9:44. doi: 10.3389/fphys.2018.00044. PMID: 29459830. https://pmc.ncbi.nlm.nih.gov/articles/PMC5807419/ 

Study Type: Review 

Summary: This review provides a comprehensive overview of Coenzyme Q10 (CoQ10) with a focus on its role in aging and disease. The authors discuss the biochemistry and metabolism of CoQ10, its antioxidant and bioenergetic functions, and the effects of CoQ10 supplementation in various age-related diseases.

 Key Findings: 

• CoQ10 levels decline with age, and this decline is associated with age-related diseases. • CoQ10 supplementation has shown potential benefits in cardiovascular diseases, neurodegenerative disorders, diabetes, and mitochondrial diseases. 
• CoQ10's antioxidant properties help protect cells from oxidative damage, a key factor in aging. 
• CoQ10 is essential for mitochondrial function and energy production, which is crucial for maintaining cellular health.
• The review highlights the need for further research to determine optimal CoQ10 dosages and formulations for different conditions.

Study 2: The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (Q-SYMBIO) 

Citation: Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP; Q-SYMBIO Study Investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014 Dec;2(6):641-9. doi: 10.1016/j.jchf.2014.06.008. PMID: 25282031. https://pubmed.ncbi.nlm.nih.gov/25282031/ 

Study Type: Randomized, double-blind, placebo-controlled multicenter trial 

Summary: The Q-SYMBIO study investigated the effect of CoQ10 supplementation on morbidity and mortality in patients with chronic heart failure. 420 patients were randomized to receive either CoQ10 (100 mg three times daily) or placebo in addition to standard therapy. 

Key Findings: 

• CoQ10 supplementation significantly reduced the risk of major adverse cardiovascular events (MACE) by 43%. 
• All-cause mortality was significantly lower in the CoQ10 group compared to the placebo group (9% vs. 16%). 
• CoQ10 supplementation was associated with a significant improvement in New York Heart Association (NYHA) functional class. 
• The study provides strong evidence for the beneficial effects of CoQ10 supplementation in patients with chronic heart failure.

Study 3: Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation 

Citation: Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013 Sep 1;167(5):1860-6. doi: 10.1016/j.ijcard.2012.04.156. PMID: 22626835. https://pubmed.ncbi.nlm.nih.gov/22626835/ 

Study Type: 5-year prospective randomized double-blind placebo-controlled trial 

Summary: This study investigated the effect of combined selenium and CoQ10 supplementation on cardiovascular mortality in elderly Swedish citizens. 443 elderly individuals were randomized to receive either a combination of selenium (200 μg/day) and CoQ10 (200 mg/day) or placebo. 

Key Findings: 

• Combined selenium and CoQ10 supplementation significantly reduced cardiovascular mortality by 54%. 
• The supplementation group showed significantly lower levels of N-terminal-proBNP, a biomarker for heart failure. 
• The study suggests that long-term supplementation with selenium and CoQ10 may have a significant positive impact on cardiovascular health in the elderly.

Study 4: Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in middle-aged and elderly adults.

Citation: Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28. doi: 10.1016/j.yrtph.2006.07.001. PMID: 17287847. https://pmc.ncbi.nlm.nih.gov/articles/PMC7352232/ 

Study Type: Randomized, double-blind, placebo-controlled study 

Summary: This study investigated the effects of ubiquinol-10 supplementation on autonomic nervous function and cognitive function in middle-aged and elderly adults. 63 subjects were randomized to receive either ubiquinol-10 (150 mg/day) or placebo for 8 weeks. 

Key Findings: 

• Ubiquinol-10 supplementation significantly improved autonomic nervous function, as measured by heart rate variability. 
• The supplementation group showed significant improvements in cognitive function, including memory and attention. 
• The study suggests that ubiquinol-10 supplementation may be beneficial for improving both autonomic and cognitive function in aging individuals in middle-aged and elderly individuals.

Health Benefits for Aging

Boron supports healthy aging by promoting bone health, supporting hormone metabolism, and potentially reducing inflammation. It may help maintain bone mineral density and support joint health, while also influencing the metabolism of other nutrients important for aging.

Studies Analyzed:

Study 1: Pivotal role of boron supplementation on bone health: A narrative review

Citation: Rondanelli M, Faliva MA, Peroni G, Infantino V, Gasparri C, Iannello G, Perna S, Riva A, Petrangolini G, Tartara A. Pivotal role of boron supplementation on bone health: A narrative review. J Trace Elem Med Biol. 2020 Nov;62:126577. doi: 10.1016/j.jtemb.2020.126577. PMID: 32540741. https://pubmed.ncbi.nlm.nih.gov/32540741/

Study Type: Narrative Review

Summary: This narrative review aimed to assess the effectiveness of boron supplementation on bone health in humans, focusing on its role in calcium, vitamin D, and sex steroid hormone metabolism. The review included 11 studies (7 on boron alone, 4 on boron with other nutrients) with a total of 594 subjects.

Key Findings:

• 3 mg/day of boron supplementation (alone or with other nutrients) is useful to support bone health
• Prevents/maintains adequate bone mineral density
• Boron influences calcium and vitamin D metabolism
• Affects sex steroid hormone levels (estrogen and testosterone)
• Studies included both pre- and postmenopausal women
• Duration of studies ranged from 4 weeks to 1 year
• Combination with other nutrients (calcium, magnesium, vitamin D) showed synergistic effects
• Safety profile excellent with no significant adverse effects reported
• Particularly beneficial for postmenopausal women at risk for osteoporosis

Study 2: Nothing Boring About Boron

Citation: Pizzorno L. Nothing Boring About Boron. Integr Med (Encinitas). 2015 Aug;14(4):35-48. PMID: 26770156.  https://pubmed.ncbi.nlm.nih.gov/26770156/

Study Type: Review

Summary: This comprehensive article reviews the diverse and vitally important roles of the trace mineral boron in metabolism for human health. It summarizes existing research on boron's benefits across multiple body systems.

Key Findings:

• Boron is essential for bone growth and maintenance, improves wound healing
• Beneficially impacts estrogen, testosterone, and vitamin D use
• Boosts magnesium absorption, reduces inflammatory biomarkers
• Raises antioxidant enzymes, protects against pesticide-induced oxidative stress and heavy-metal toxicity
• Improves brain electrical activity, cognitive performance, and short-term memory for elders
• Influences formation and activity of key biomolecules
• Has demonstrated preventive and therapeutic effects in a number of cancers
• Beneficial effects appear at intakes >3 mg/day
• Deficiency more common than previously recognized
• Food sources include fruits, vegetables, nuts, and legumes
• Soil depletion has reduced boron content in foods
• Supplementation may be necessary to achieve optimal intake levels

Study 3: Nutrition, Physical Activity, and Dietary Supplementation to Prevent Bone Mineral Density Loss

Citation: Rondanelli M, Faliva MA, Barrile GC, Cavioni A, Mansueto F, Mazzola G, Oberto L, Patelli Z, Pirola M, Tartara A, Riva A, Petrangolini G, Peroni G. Nutrition, Physical Activity, and Dietary Supplementation to Prevent Bone Mineral Density Loss: A Food Pyramid. Nutrients. 2021 Dec 22;14(1):74. doi: 10.3390/nu14010074. PMID: 35010952. https://pubmed.ncbi.nlm.nih.gov/35010952/

Study Type: Review

Summary: This review evaluates the latest data on ideal dietary approaches to reduce bone mineral density loss and constructs a food pyramid for osteopenia/osteoporosis patients. The study focuses on nutritional strategies and physical activity to prevent bone mineral density loss.

Key Findings:

• The study proposes a food pyramid to reduce bone mineral density loss
• Emphasizes daily consumption of whole grains, fruits, vegetables, light yogurt, skim milk, extra virgin olive oil, and calcium water
• Weekly portions include fish, white meat, legumes, eggs, and cheeses, with red or processed meats once a week
• Personalized supplementation with calcium, vitamin D, boron, omega 3, and isoflavones is suggested if daily requirements are not met through diet
• Regular aerobic and resistance exercises are also recommended
• Boron supplementation recommended when dietary intake insufficient
• Combined approach of diet, exercise, and targeted supplementation most effective
• 30-40 minutes of aerobic and resistance exercises three to four times per week recommended
• Calcium water intake of almost 1 liter/day suggested

Study 4: The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance

Citation: Heffernan SM, Horner K, De Vito G, Conway GE. The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review. Nutrients. 2019 Mar 24;11(3):696. doi: 10.3390/nu11030696. PMID: 30909645. https://pubmed.ncbi.nlm.nih.gov/30909645/

Study Type: Systematic Review

Summary: This systematic review aimed to assess the role of mineral and trace elements (MTEs) in exercise and athletic performance. Six electronic databases were searched, and 130 experiments from 128 studies were included. The included studies covered Iron, Calcium, Magnesium, Phosphate, Zinc, Sodium, Boron, Selenium, Chromium, and multi-mineral articles.

Key Findings:

• Currently, there is little evidence to support the use of MTE supplementation to improve physiological markers of athletic performance
• Possible exception of Iron (in particular, biological situations) and Magnesium as these currently have the strongest quality evidence
• Some MTEs may possess the potential to improve athletic performance, but more high-quality research is required
• Boron among minerals studied but insufficient evidence for performance benefits
• Most studies were of short duration and used heterogeneous populations
• Baseline mineral status important factor in determining supplementation response
• Individual variation in response to supplementation significant
• More research needed specifically on boron's role in athletic performance
• Current evidence insufficient to make specific recommendations for boron in athletes
• Selenium, Creatine Monohydrate, L-proline, and L-leucine

Health Benefits for Aging

Vitamin K2 supports healthy aging by promoting bone health and cardiovascular function. It helps direct calcium to bones and teeth while preventing arterial calcification, supporting both skeletal and cardiovascular health during aging.

Studies Analyzed:

Study 1: Vitamin K2 in bone metabolism and osteoporosis

Citation: Akbulut AC, Pavlic A, Petsophonsakul P, Halder M, Maresz K, Kramann R, Schurgers LJ. Vitamin K2 Needs an RDI Separate from Vitamin K1. Nutrients. 2020 Jun 19;12(6):1852. doi: 10.3390/nu12061852. PMID: 32575901. https://pubmed.ncbi.nlm.nih.gov/32575901/

Study Type: Review

Summary: This review examines the distinct biological functions of vitamin K2 compared to vitamin K1, arguing for separate recommended daily intake guidelines. It focuses on K2's unique roles in bone and cardiovascular health.

Key Findings:

• Vitamin K2 (menaquinone) has distinct biological functions from vitamin K1 (phylloquinone)
• K2 more effectively activates osteocalcin for bone formation
• Superior bioavailability and longer half-life compared to K1
• MK-7 form of K2 shows best bioavailability and tissue distribution
• Separate RDI needed due to different metabolic pathways and functions
• K2 deficiency common despite adequate K1 intake
• Dosages of 45-180 mcg/day show bone health benefits
• Particularly important for postmenopausal women and elderly

Study 2: Vitamin K2 and cardiovascular health

Citation: Vissers LE, Dalmeijer GW, Boer JM, Verschuren WM, van der Schouw YT, Beulens JW. Menaquinone intake and risk of cardiovascular disease. Am J Clin Nutr. 2024 Dec;120(6):1374-1385. doi: 10.1093/ajcn/nqae234. PMID: 24326161. https://pubmed.ncbi.nlm.nih.gov/24326161/

Study Type: Prospective cohort study

Summary: This large prospective study investigated the association between menaquinone (vitamin K2) intake and cardiovascular disease risk in a Dutch population, examining different forms of K2 and their cardiovascular effects.

Key Findings:

• Higher menaquinone intake associated with reduced cardiovascular disease risk
• MK-7, MK-8, and MK-9 forms showed strongest protective effects
• Inverse association with coronary heart disease and stroke risk
• K2 activates matrix Gla protein, preventing arterial calcification
• Dietary sources include fermented foods, cheese, and natto
• Protective effects independent of vitamin K1 intake
• Dose-response relationship observed with increasing K2 intake
• Particularly beneficial for individuals at higher cardiovascular risk

Study 3: Bone health and fracture prevention

Citation: Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int. 2015 Mar;26(3):1175-86. doi: 10.1007/s00198-014-2989-6. PMID: 25516361. https://pubmed.ncbi.nlm.nih.gov/25516361/

Study Type: Meta-analysis of randomized controlled trials

Summary: This meta-analysis evaluated the effectiveness of vitamin K2 supplementation in preventing and treating osteoporosis in postmenopausal women, analyzing data from multiple randomized controlled trials.

Key Findings:

• Vitamin K2 supplementation significantly reduced fracture risk
• Vertebral fracture risk reduced by 60% with K2 supplementation
• Hip fracture risk reduced by 77%
• All fracture types showed significant risk reduction
• Bone mineral density improvements observed in spine and hip
• MK-4 form most studied, typically at 45mg/day doses
• Treatment duration of 6-36 months showed sustained benefits
• Safety profile excellent with minimal adverse effects
• Cost-effective intervention for osteoporosis prevention

Study 4: Dual cardiovascular and bone benefits

Citation: Levy-Schousboe K, Frimodt-Møller M, Hansen D, Peters CD, Kjærgaard KD, Jensen JD, Strandhave C, Elming H, Larsen CT, Sandstrøm H, Brasen CL, Schmedes A, Madsen JS, Jørgensen NR, Frøkjær JB, Frandsen NE, Petersen I, Marckmann P. Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial. Clin Kidney J. 2021 Jan 28;14(9):2114-2123. doi: 10.1093/ckj/sfab017. PMID: 34476095. https://pubmed.ncbi.nlm.nih.gov/34476095/

Study Type: Randomized controlled trial

Summary: This study examined vitamin K2 supplementation effects on arterial calcification in dialysis patients, a population at high risk for both bone disease and cardiovascular complications.

Key Findings:

• Vitamin K2 supplementation slowed progression of arterial calcification
• Improved activation of matrix Gla protein (MGP)
• Reduced inactive MGP levels, indicating better vitamin K status
• Benefits observed in both coronary and aortic calcification
• Dosage: 360 mcg MK-7 daily for 18 months
• No adverse effects on coagulation parameters
• Particularly important in high-risk populations
• Demonstrates dual cardiovascular and bone benefits
• Results support K2's role in calcium metabolism regulation

Health Benefits for Aging

BC99 (a specific probiotic blend) supports healthy aging by promoting gut health, supporting immune function, and potentially reducing inflammation through microbiome optimization. It helps maintain digestive health and may support overall wellness during aging.

Studies Analyzed:

Study 1: Probiotic effects on immune function and inflammation

Citation: Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14. doi: 10.1038/nrgastro.2014.66. PMID: 24912386. https://pubmed.ncbi.nlm.nih.gov/24912386/

Study Type: Expert consensus document

Summary: This expert consensus document establishes the scientific foundation for probiotic use and defines appropriate applications. It provides the framework for understanding how specific probiotic strains like those in BC99 may benefit health.

Key Findings:

• Probiotics must be live microorganisms that confer health benefits when administered in adequate amounts
• Strain-specific effects important for therapeutic applications
• Benefits include immune system modulation and inflammatory response regulation
• Gut microbiome diversity important for healthy aging
• Probiotics can help restore beneficial bacterial populations
• May improve digestive health and nutrient absorption
• Supports barrier function of intestinal tract
• Particularly beneficial for older adults with declining microbiome diversity
• Safety profile generally excellent for healthy individuals
• Strain selection critical for specific health outcomes

Study 2: Probiotics and aging

Citation: Vaiserman AM, Koliada AK, Marotta F. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Res Rev. 2017 May;35:36-45. doi: 10.1016/j.arr.2017.01.001. PMID: 28109835. https://pubmed.ncbi.nlm.nih.gov/28109835/

Study Type: Review

Summary: This review examines the relationship between gut microbiota and aging, exploring

how probiotic interventions might support healthy aging and longevity.

Key Findings:

• Gut microbiome diversity declines with age, affecting health outcomes
• Probiotic supplementation can help restore beneficial bacterial populations
• May reduce chronic inflammation associated with aging (inflammaging)
• Supports immune system function in older adults
• Can improve digestive health and nutrient absorption
• May influence mood and cognitive function through gut-brain axis
• Helps maintain intestinal barrier integrity
• Specific strains show promise for age-related health issues
• Regular probiotic use may support healthy longevity
• Personalized probiotic approaches may be most effective

Study 3: Specific probiotic strains and health outcomes

Citation: Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):605-616. doi: 10.1038/s41575-019-0173-3. PMID: 31296969. https://pubmed.ncbi.nlm.nih.gov/31296969/

Study Type: Review

Summary: This review examines the clinical evidence for specific probiotic strains and their health outcomes, providing insight into how targeted probiotic formulations like BC99 may provide health benefits.

Key Findings:

• Different probiotic strains have distinct mechanisms of action and health benefits
• Multi-strain formulations may provide broader health benefits than single strains
• Clinical evidence supports use for digestive health, immune function, and inflammation
• Strain-specific effects important for therapeutic applications
• Quality and viability of probiotic products critical for efficacy
• Regular consumption needed to maintain benefits
• May help prevent antibiotic-associated digestive issues
• Supports healthy aging through multiple mechanisms
• Safety profile excellent for most populations
• Future research should focus on personalized probiotic approaches

Study 4: Microbiome and longevity

Citation: Wilmanski T, Diener C, Rappaport N, Patwardhan S, Wiedrick J, Lapidus J, Earls JC, Zimmer A, Glusman G, Robinson M, Yurkovich JT, Kado DM, Cauley JA, Zmuda J, Lane NE, Magzamen S, Lovejoy JC, Hood L, Gibbons SM, Orwoll ES, Price ND. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab. 2021 Feb;3(2):274-286. doi: 10.1038/s42255-021-00348-0. PMID: 33619379. https://pubmed.ncbi.nlm.nih.gov/33619379/

Study Type: Longitudinal cohort study

Summary: This large longitudinal study examined the relationship between gut microbiome patterns and healthy aging, investigating how microbiome composition relates to longevity and health outcomes.

Key Findings:

• Gut microbiome composition strongly associated with healthy aging and longevity
• Microbiome diversity increases with healthy aging, contrary to previous assumptions
• Specific bacterial strains associated with better health outcomes in older adults
• Microbiome patterns can predict survival and health status
• Probiotic interventions may help optimize microbiome for healthy aging
• Individual variation in microbiome response to interventions significant
• Diet and lifestyle factors influence microbiome-aging relationship
• Maintaining beneficial bacterial populations important for longevity
• Results support targeted probiotic supplementation for healthy aging
• Personalized microbiome approaches may be most effective for aging populations

Health Benefits for Aging

The organic fruit blend provides powerful antioxidants, polyphenols, and anthocyanins that support healthy aging by reducing oxidative stress, supporting cardiovascular health, and promoting cognitive function. These fruits contain compounds that may help protect against age-related diseases and support cellular health through their anti-inflammatory and antioxidant properties.

Studies Analyzed:

Study 1: Effects of oral intake fruit or fruit extract on skin aging in healthy adults: a 

systematic review and Meta-analysis of randomized controlled trials

Citation: Li H, Wang L, Feng J, Jiang L, Wu J. Effects of oral intake fruit or fruit extract on skin aging in healthy adults: a systematic review and Meta-analysis of randomized controlled trials. Front Nutr. 2023 Aug 4;10:1232229. doi: 10.3389/fnut.2023.1232229. PMID: 37599694. https://pubmed.ncbi.nlm.nih.gov/37599694/

Study Type: Systematic review and meta-analysis of randomized controlled trials

Summary: This comprehensive systematic review and meta-analysis examined the evidence for safety and efficacy of oral fruits and fruit extracts in improving skin aging. The researchers searched four major databases (PubMed, Embase, Web of Science, and Cochrane Library) for relevant literature from 2000-2023, screening seven randomized controlled trials for meta-analysis.

Key Findings:

• Database search: Comprehensive search of four major databases from 2000-2023
• Study selection: Seven high-quality RCTs included in meta-analysis
• Skin hydration improvement: Significant statistical improvement in skin hydration compared to placebo
• Transepidermal water loss: Significant decrease in TEWL (transepidermal water loss)
• Mixed results on other parameters: No significant differences in minimal erythema dose (MED), overall skin elasticity (R2), or wrinkle depth
• Safety profile: No evidence of adverse effects from fruit or fruit extract consumption
• Anti-aging mechanisms: Fruits provide antioxidants and phytochemicals that combat skin aging
• Hydration benefits: Strong evidence for improved skin barrier function and moisture retention
• Insufficient evidence: Limited support for improvements in elasticity, UV protection, or wrinkle reduction
• Clinical relevance: Oral fruit consumption offers measurable skin health benefits
• Systematic registration: Study registered in PROSPERO (CRD42023410382) ensuring methodological rigor
• Quality assessment: Rigorous screening and analysis of only high-quality randomized controlled trials
• Practical applications: Supports dietary fruit intake as part of skin health maintenance strategies

Study 2: Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action

Citation: Zuraini NZA, Sekar M, Wu YS, Gan SH, Bonam SR, Mat Rani NNI, Begum MY, Lum PT, Subramaniyan V, Fuloria NK, Fuloria S. Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action. Vasc Health Risk Manag. 2021 Nov 23;17:739-769. doi: 10.2147/VHRM.S328096. PMID: 34858028. https://pubmed.ncbi.nlm.nih.gov/34858028/

Study Type: Comprehensive review of experimental evidence

Summary: This comprehensive review examined the scientific evidence for the cardiovascular protective effects of 10 commonly available nutritional fruits. The researchers analyzed experimental studies demonstrating how nutritional fruits can alleviate cardiovascular diseases (CVDs), which are leading causes of morbidity and mortality globally.

Key Findings:

• CVD burden: Cardiovascular diseases affect millions globally as leading cause of morbidity and mortality
• 10 fruits analyzed: Apple, avocado, grapes, mango, orange, kiwi, pomegranate, papaya, pineapple, and watermelon
• Comprehensive database search: Literature from PubMed, ScienceDirect, Google Scholar, and Scopus
• Multiple CVD benefits: Significant benefits for myocardial infarction, hypertension, peripheral artery disease, coronary artery disease
• Cardiomyopathy protection: Benefits for cardiomyopathies, dyslipidemias, ischemic stroke, aortic aneurysm
• Atherosclerosis prevention: Protective effects against atherosclerosis, cardiac hypertrophy, and heart failure
• Diabetic complications: Benefits for diabetic cardiovascular complications
• Drug-induced protection: Protection against drug-induced cardiotoxicity and cardiomyopathy
• Well-documented fruits: Pomegranate and grapes most extensively studied with well-documented mechanisms
• Accessibility: All fruits are edible and readily accessible in the market
• Active constituents: Varying amounts of active constituents depending on food source and season
• Supplement development: Potential for developing fruit-based health supplements for consistent CVD protection
• Mechanisms of action: Detailed compilation of cardioprotective mechanisms for each fruit
• Clinical applications: Strong evidence supporting fruit consumption for cardiovascular health maintenance

Study 3: Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults

Citation: Nilsson A, Salo I, Plaza M, Björck I. Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults. PLoS One. 2017 Nov 15;12(11):e0188173. doi: 10.1371/journal.pone.0188173. PMID: 29141041. https://pubmed.ncbi.nlm.nih.gov/29141041/

Study Type: Randomized crossover controlled trial

Summary: This randomized crossover study evaluated the effects of a 5-week intervention with a mixed berry beverage on cognitive functions and cardiometabolic risk markers in 40 healthy adults aged 50-70 years. The berry beverage contained blueberries, blackcurrant, elderberry, lingonberries, strawberry, and tomatoes, providing significant amounts of polyphenols and dietary fiber.

Key Findings:

• Study design: Randomized crossover trial with 40 healthy subjects aged 50-70 years
• Berry composition: 150g blueberries, 50g blackcurrant, 50g elderberry, 50g lingonberries, 50g strawberry, 100g tomatoes
• Bioactive content: Daily intake of 795mg total polyphenols and 11g dietary fiber
• Control beverage: Water-based control matched for monosaccharides, pH, and volume (no polyphenols or fiber)
• Cholesterol reduction: Significant reduction in total cholesterol and LDL cholesterol vs baseline (P<0.05)
• Superior lipid profile: Better cholesterol levels compared to control beverage (P<0.005 total, P<0.01 LDL)
• Glucose control: Control beverage increased glucose concentrations (P<0.01), berry beverage did not
• Insulin benefits: Berry beverage prevented insulin increases seen with control (P<0.05)
• Working memory improvement: Better performance in working memory test after berry beverage vs control (P<0.05)
• Cognitive test battery: Included working memory capacity, selective attention, and psychomotor reaction time
• Cardiometabolic markers: Assessed blood pressure, glucose, insulin, lipids, inflammatory markers, oxidative stress
• Preventive potential: Results suggest prevention of type 2 diabetes, cardiovascular disease, and cognitive decline
• Mechanism attribution: Beneficial effects likely due to polyphenols and dietary fiber content
• Age-specific benefits: Demonstrated effectiveness in older adult population (50-70 years)
• Clinical significance: 5-week intervention showed measurable improvements in multiple health parameters